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Summary 
Each stage of the mRNA life cycle, from its transcription and processing in the nucleus, to its export into 
the cytoplasm where it is translated and eventually degraded, is subject to elaborate control. Although 
commonly viewed as discrete and independent events, the different stages of gene expression are often 
physically and functionally linked. The first chapter of this thesis is focused on the conserved Polymerase 
Associated Factor 1 complex (Paf1C), which regulates multiple steps of the RNA polymerase II 
transcription cycle as well as events downstream of transcript synthesis such as polyadenylation of mRNAs 
and export of nascent transcripts. Recent studies in the fission yeast Schizosaccharomyces pombe uncovered 
an additional role of Paf1C as an antagonist of RNAi-directed transcriptional gene silencing. In Paf1C 
mutant strains, ectopically expressed small RNAs (siRNAs) mediate gene repression by inducing de novo 
heterochromatin formation at the target locus in the nucleus. Although euchromatic loci in wild type cells 
seem refractory to this repressive mechanism, the induced silent gene state in Paf1C mutants can be 
inherited across generations even in the absence of the original siRNA source. In mammalian somatic cells, 
the existence of a nuclear RNAi pathway that can similarly modulate gene expression by modifying the 
underlying chromatin environment is highly debatable. However, the discovery of Paf1C as a negative 
regulator of this process in fission yeast raised the question of whether the complex performs similar 
repressive functions in higher organisms. Therefore, one of the goals of my PhD project was to test if in the 
absence of the Paf1 complex, siRNAs can initiate de novo heterochromatin formation in mammals, using 
mouse embryonic stem cells (mESCs) as a model system. However, by examining Paf1C conditional knock 
out cells expressing endogenous siRNAs, I did not find any supporting evidence for the existence of a 
nuclear RNAi silencing mechanism that can be regulated by the mammalian Paf1 complex. 
Although Paf1C is conserved from yeast to humans, the complex in higher eukaryotes has an additional 
subunit, Ski8/Wdr61, which is also part of the helicase Ski complex functioning in cytoplasmic RNA decay. 
In human cells, Ski8/Wdr61 is thought to bridge the two complexes, suggesting that Paf1C might affect 
other stages of RNA processing or decay in the nucleus via its association with the Ski complex. Thus, 
another goal of my PhD project was to elucidate the functional role of the interaction between the Paf1 and 
Ski complexes in mammalian cells. In contrast to previous studies, my data suggest that in mESC the two 
complexes are not physically or functionally linked, even though they contain a common subunit. Further 
investigation of the mammalian Ski complex provided additional support for independent roles of the two 
complexes in transcription and cytoplasmic RNA decay.  
The above findings became the basis for my second PhD project, described in the second chapter of the 
thesis. This was part of a collaborative effort examining the two major cytoplasmic mRNA degradation 
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pathways in mES cells. In the cytoplasm, mRNAs can be degraded in the 5′-3′ direction by the 
exoribonuclease Xrn1 or in the 3′-5′ direction by the RNA exosome. The latter pathway requires the 
function of the Ski complex, comprising the scaffold protein Ski3/Ttc37, two copies of Ski8/Wdr61 and 
the RNA helicase Ski2/Skiv2l. The Ski complex is suggested to facilitate substrate passage through the 
exosome channel during 3′-5′ decay. RNA degradation has been extensively studied in the yeast 
Saccharomyces cerevisiae, where Xrn1 seems to be the predominant route for mRNA decay, whereas the 
3′-5′ Ski-exosome pathway is thought to function redundantly with Xrn1, and contribute more significantly 
to RNA surveillance. In mammalian cells, the specific endogenous targets of the two pathways are poorly 
defined and it remains unclear if certain mRNAs can be preferentially degraded via one route, and if so, 
what factors could mediate such specificity. In addition, cytoplasmic RNA degradation is widely influenced 
by translation, consistent with recent cryo-EM structures capturing the yeast Ski complex or Xrn1 bound 
directly to translating ribosomes. It is currently unknown whether this physical link between the translation 
and RNA degradation machineries is conserved in mammals. Furthermore, it is unclear to what extent each 
decay pathway interacts with translation, and what factors might influence this process.  
We combined crosslinking and analysis of cDNA (CRAC) with ribosome profiling in mES cells to examine 
the two major cytoplasmic RNA decay pathways and how they are linked to translation. Our approach 
allowed us to determine the direct transcriptome-wide RNA targets of Xrn1 and the Ski complex helicase 
Skiv2l in unperturbed cells and identify a subset of transcripts whose steady-state levels depend on the 3′-
5′ pathway. Strikingly, although we found that both pathways are physically linked to translation, Skiv2l 
binding to RNA was exclusively dictated by ribosome occupancy and was heavily dependent on the 
translational status of the substrate. Our data reveal diverse triggers of RNA decay, including specific amino 
acid codons and RNA sequences that seem to impede ribosome elongation. We further identified a novel 
interaction between the Ski complex and the higher-eukaryote-specific RNA binding protein Aven. We 
showed that Aven and Skiv2l function closely to oppose aberrant translation, with Aven helping to prevent 
ribosome stalling at structured regions, while Skiv2l eliminates transcripts when these events accumulate. 
Interestingly, the Aven-Skiv2l pathway acts on a wide range of substrates, including mRNAs, uORFs and 
most surprisingly on small-ORF-containing RNAs derived from transcription of non-coding regions. As 
Aven is conserved from Drosophila to humans, this work uncovered a higher-eukaryote-specific pathway 
that coordinates cytoplasmic 3′-5′ RNA decay. 
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Chapter 1 
INTRODUCTION 
1. The Paf1 complex is a versatile regulator of PolII transcription 
Transcription by RNA PolII is a complex, highly regulated process that is fundamental to the control of 
gene expression in eukaryotic cells. In addition to the core transcriptional machinery, multiple other protein 
complexes and accessory factors are required to coordinate the different phases of transcription. One of 
these players is the Polymerase-Associated Factor 1 complex (Paf1C), which performs multiple functions 
throughout the transcriptional cycle. It is a highly conserved protein complex that was first identified in 
Saccharomyces cerevisiae as a positive regulator of PolII-transcribed genes (Tomson and Arndt, 2013). S. 
cerevisiae Paf1C is composed of five subunits – Paf1, Ctr9, Cdc73, Rtf1 and Leo1, which directly associate 
with the transcribing polymerase from the promoter to the 3′ end formation site of genes. The complex 
regulates multiple events during the transcription cycle including: promoter-proximal polymerase pausing, 
promoting histone modifications associated with active transcription and recruitment of 3′ end processing 
factors necessary for proper termination of transcription (Van Oss et al., 2017). Through this broad range 
of regulatory functions, Paf1C has been implicated in cellular processes ranging from regulation of gene 
expression and DNA-damage repair to cell cycle progression, and is dysregulated in several diseases 
(Tomson and Arndt, 2013). 
Although none of the Paf1C subunits have an enzymatic activity, the complex coordinates interactions of 
multiple factors with the PolII machinery and thus impacts transcription at multiple levels. Ctr9 is a 
tetratricopeptide repeat-containing (TPR) structural protein, Cdc73 has a C-terminal Ras-like domain, 
which facilitates association of the complex to chromatin (Amrich et al., 2012), and Rtf1 contains a Plus3 
domain which binds single-stranded DNA (de Jong et al., 2008). Leo1 and Paf1, however, do not seem to 
possess any distinct structural domains (Tomson and Arndt, 2013). The Paf1 complex is not essential for 
viability in S. cerevisiae, although loss of Ctr9 or Paf1 causes growth defects (Betz et al., 2002). This is in 
line with observations that these two subunits are central to the overall stability of the complex (Chu et al., 
2013). Unlike S. cerevisiae, some Paf1C components in higher eukaryotes seem to be essential 
(Bahrampour and Thor, 2016; Mosimann et al., 2006).   
Initial evidence that Paf1C positively impacts transcription is based on the direct interaction of the complex 
with PollII (Shi et al.; Wade et al., 1996) and its localization to actively transcribed genes as assessed by 
chromatin immunoprecipitation (Krogan et al., 2002; Pokholok et al., 2002). This is partially mediated by 
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Cdc73, which has been shown to bind directly to PolII and facilitate recruitment of the complex (Mueller 
et al., 2004; Shi et al., 1997). Paf1C has genetic and physical links with elongation factors such as Spt4-
Spt5 and Spt16-Pob3 (Krogan et al., 2002; Squazzo et al., 2002) and has been suggested to help bring FACT 
and Spt6 to actively transcribed genes (Adelman et al., 2006). Further evidence that Paf1C facilitates 
transcription comes from in vitro studies, demonstrating the ability of the human complex to stimulate PolII 
elongation both independently and in synergy with the elongation factor TFIIS (Kim et al., 2010).  
Several recent studies describe a novel role of the Paf1 complex as a regulator of PolII promoter-proximal 
pausing in metazoans (Chen et al., 2015; Yu et al., 2015). Many developmentally and environmentally 
regulated genes harbor a paused PolII 20-60nt downstream of the transcription start site, which can be 
released into productive transcription in response to appropriate stimuli, thus facilitating rapid induction of 
gene expression (Liu et al., 2015). Loss of Paf1 in Drosophila and human cells leads to a redistribution of 
paused PolII from promoters into the gene bodies. This is accompanied by an increase in nascent and mature 
transcript levels, suggesting that the absence of Paf1C stimulates the release of paused PolII into productive 
elongation (Chen et al., 2015). According to proposed mechanistic models, depletion of Paf1C facilitates 
PolII CTD phosphorylation on serine 2 by SEC (Ser2P kinase super elongation complex), thereby 
promoting transcription into the gene body (Chen et al., 2015). Interestingly, another study using different 
human cell lines reports that Paf1C can have both a positive and negative impact on paused PolII, suggesting 
its role as a regulator of promoter-proximal pausing can be cell- and context-dependent (Yu et al., 2015). 
Transcription by PolII in eukaryotes is accompanied by dynamic changes in the underlying chromatin and 
the Paf1 complex has also been shown to affect the deposition of several co-transcriptional histone 
modifications. Components of the Paf1 complex interact with the ubiquitin ligase Rad6-Bre1 to stimulate 
monoubiquitylation of a conserved lysine on histone H2B (H2Bub) (Ng et al., 2003; Wood et al., 2003). 
This mark promotes an open and accessible chromatin conformation (Fierz et al., 2011) and is a prerequisite 
for establishing two other histone modification, histone H3 lysine 4 (H3-K4) and lysine 79 (H3-K79) 
methylation, with important roles in transcription (Zhu et al., 2005b). Loss of yeast Paf1C has also been 
shown to reduce levels of the conserved H3 K36 methylation mark which is usually found in actively 
transcribed genes (Chu et al., 2007). However, this might reflect a more indirect effect, since loss of Paf1C 
reduces PolII CTD Ser2 phosphorylation levels, leading to destabilization of the H3K36 methyltransferase 
SET2 (Fuchs et al., 2012). 
In addition to its effects on chromatin, PolII pausing and elongation, Paf1C is also implicated in the later 
stages of the transcriptional cycle and contributes to proper 3′ end formation of polyadenylated transcripts. 
In S. cerevisiae loss of Paf1C subunits is linked to shortening of the polyA tail of transcripts as well as an 
increase in usage of distal polyA sites, leading to production of longer transcripts (Mueller et al., 2004; 
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Penheiter et al., 2005). In line with these observations, PafC can physically interact with the yeast 
polyadenylation factor Cft1 in a PolII independent manner, thus perhaps facilitating contacts between the 
transcription and polyadenylation machineries (Nordick et al., 2008). Furthermore, human Cdc73 has been 
shown to associate with the CPSF complex (Cleavage and Polyadenylation Specificity Factors) and the 
cleavage stimulation factor, CstF, both of which are important for maturation of mRNA 3′ ends (Rozenblatt-
Rosen et al., 2009). The ability of yeast Paf1C to promote transcript cleavage and polyadenylation is further 
supported by in vitro experiments (Nagaike et al., 2011). Another study in mouse myoblasts reports that 
loss of Paf1C leads to a global increase in the use of alternative polyA sites in introns and internal exons, 
thus extending the role of Paf1C in mRNA 3′ formation to mammalian cells (Yang et al., 2016).  
Although Paf1C is highly conserved, some important characteristics distinguish the yeast complex from its 
homologs in higher eukaryotes and could potentially underlie additional roles of Paf1C in more complex 
organisms. For instance, as mentioned above, although loss of Ctr9 and Paf1 in S. cerevisiae is associated 
with growth defects, none of the five subunits are essential for viability (Betz et al., 2002). In contrast, some 
Paf1C components in higher organisms are linked to more severe phenotypes (Bahrampour and Thor, 2016; 
Mosimann et al., 2006). Furthermore, while S. cerevisiae Paf1C is highly enriched shortly after the 
transcription start site of genes and seems to dissociate from chromatin just upstream of the polyA site , in 
mouse cells Paf1C binding extends beyond the polyA site (Yang et al., 2016). Finally, the complex 
composition in higher eukaryotes has some intriguing differences. Rtf1 does not seem to be a core Paf1C 
component in organisms other than S. cerevisiae, including fission yeast, and in higher eukaryotes, Paf1C 
also contains an additional subunit, Ski8/Wdr61 (Figure 1) (Zhu et al., 2005a). Together with Ski3 and the 
RNA helicase Ski2, Ski8/Wdr61 is part of the conserved Ski complex, which functions as a general co-
factor of the cytoplasmic exosome and assists with 3′-to-5′ RNA degradation (Halbach et al., 2013). It has 
been previously shown that in addition to the cytoplasm, the mammalian Ski complex localizes to actively 
transcribed genes in the nucleus in a Paf1C-dependent manner (Zhu et al., 2005a). Thus, Ski8/Wdr61 was 
suggested to link the two complexes, leading to speculation that mammalian Paf1C might orchestrate events 
downstream of RNA synthesis, such as RNA processing and quality control (Zhu et al., 2005a). However, 
so far these claims have not been substantiated by direct experimental evidence. Thus, the first goal of my 
thesis was to revisit these observations using mouse embryonic stem cells (mESC) and elucidate the 
functional role of the interaction between the Paf1 and Ski complexes in mammalian nuclei. 
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Figure 1. Subunit composition of the Paf1 complex in S. cerevisiae and higher eukaryotes. 
In S. cerevisiae, the Paf1 complex is composed of Ctr9, Paf1, Cdc73, Leo1 and Rtf1. In higher 
eukaryotes, Rtf1 is not stably associated with Paf1C and instead, the complex contains an 
additional subunit, Ski8/Wdr61, which is also part of the RNA helicase Ski complex functioning 
in cytoplasmic RNA decay. 
 
 
2. The Paf1 complex is a repressor of RNAi-mediated transcriptional silencing  
A novel role of Paf1C as a negative regulator of RNAi-mediated transcriptional repression was recently 
identified in a forward genetic screen in S. pombe (Kowalik et al., 2015). RNA interference (RNAi) is a 
gene silencing mechanism conserved in most eukaryotes and is broadly characterized by the ability of small 
double stranded RNAs to specifically repress the expression of complementary sequences (Meister and 
Tuschl, 2004). In the canonical RNAi pathway, Dicer processes double-stranded RNA into small interfering 
RNAs, which then guide Argonaute-containing effector complexes to specific targets by complementary 
base pairing (Meister and Tuschl, 2004). In mammalian somatic cells this process triggers post-
transcriptional gene silencing through degradation of target mRNAs in the cytoplasm, without interfering 
with transcription. However, in organisms such as plants, C. elegans, ciliates and fungi, small RNAs also 
mediate transcriptional silencing of their targets by inducing DNA methylation or chromatin modifications 
in the nucleus (Grewal, 2010; Holoch and Moazed, 2015). This mechanism of small RNA-directed 
chromatin silencing is best understood in the fission yeast S. pombe, where constitutive heterochromatin at 
the pericentromeric regions of chromosomes is established and maintained by the RNAi machinery (Holoch 
and Moazed, 2015). In this organism endogenous small RNAs originating from centromeric repeat 
sequences are loaded into the RNA-induced Transcriptional Silencing complex (RITS), containing an 
argonaute protein (Verdel et al., 2004). RITS is then targeted to centromeric repeats via complementary 
base pairing between the Ago-bound siRNAs and the nascent transcript, leading to recruitment of the Clr4 
histone methyltransferase (Bayne et al., 2010). Clr4 catalyzes methylation of histone H3 lysine 9 
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(H3K9me), which is a conserved feature of heterochromatin and serves as a binding site for the HP1 
homolog Swi6 (Hayashi et al., 2012). Furthermore, target recognition by RITS recruits the RNA-dependent 
RNA polymerase (RdRP) which initiates double-stranded RNA synthesis using the nascent transcript target 
as a template. This double-stranded RNA substrate is further processed into small RNAs by Dicer thus 
leading to amplification of siRNAs (Colmenares et al., 2007; Motamedi et al., 2004). This process 
establishes a self-reinforcing positive-feedback loop between siRNA production and H3K9 methylation 
(Figure 2).  
 
 
Figure 2. Positive feedback loop between siRNA production and H3K9 methylation in S. 
pombe.  
In S. pombe, endogenous siRNAs from centromeric repeat sequences are loaded onto the Ago-
containing RITS complex (RNA-induced Transcriptional Silencing complex). RITS targets 
centromeric repeats via complementary base-pairing with the nascent transcript, leading to 
recruitment of the CLRC complex, which catalyzes methylation of histone H3 on lysine 9 
(H3K9me), through the methyltransferase Clr4. Upon target recognition, RITS also recruits the 
RDRC complex, containing an RNA-dependent RNA polymerase (RdRP), which synthesizes 
double-stranded RNA using the nascent transcript as a template. These double-stranded RNA 
molecules are then processed by Dicer, leading to new production of siRNAs and further targeting 
of the RITS complex. Adapted with permission from (Holoch and Moazed, 2015). 
 
A controversial topic in the RNAi field is whether the ability of siRNAs to trigger epigenetic silencing is 
conserved in mammalian somatic cells. Although there are a few studies that describe transcriptional 
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silencing in human cells (Kim et al., 2006; Morris et al., 2004; Suzuki et al., 2005), convincing evidence 
for a direct role of the RNAi machinery in specifying stable chromatin modifications is missing. 
Interestingly, de novo heterochromatin formation using synthetic siRNAs has been difficult to achieve even 
in organisms where the RNAi pathway has a well-established role in epigenetic silencing (Iida et al., 2008; 
Simmer et al., 2010). Our lab recently identified the Paf1 complex as a negative regulator of this process 
and showed that in Paf1C mutant strains, a synthetic hairpin RNA targeting a euchromatic gene is capable 
of triggering stable and heritable heterochromatin formation at the corresponding locus even in the absence 
of the initial siRNA source (Kowalik et al., 2015). Proposed models suggest that Paf1C represses siRNA-
mediated heterochromatin formation by promoting efficient transcription termination and release of the 
nascent transcript. Altered transcription kinetics in Paf1C mutants leading to longer transcript retention on 
chromatin could potentially allow the RNAi machinery to establish more stable interactions with the target 
locus (Kowalik et al., 2015). Another model posits that Paf1C components oppose stable accumulation of 
the heterochromatic H3K9me mark by promoting rapid exchange of histone H3 (Sadeghi et al., 2015).  
Given the high conservation of Paf1C from yeast to humans, it is possible that the complex performs similar 
repressive functions in higher organisms. This would provide novel opportunities to investigate whether 
RNAi-mediated epigenetic silencing is conserved in mammalian somatic cells. Therefore, the second goal 
of my PhD project was to test if in the absence of the Paf1 complex, siRNAs can initiate de novo 
heterochromatin formation in mammalian cells, using mouse embryonic stem cells (mESCs) as a 
model system.
Chapter 1  Results 
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RESULTS 
1. Generating Paf1C conditional knock out cells expressing endogenous siRNAs 
To probe for a possible link between the Paf1 complex and RNAi-mediated chromatin modifications in 
mammalian cells, I used mouse embryonic stem cells (mESCs) as a model system. I took advantage of a 
previously generated Leo1fl/fl conditional knock out cell line expressing a CreERT2 recombinase fusion 
from the Rosa26 locus, where Leo1 could be depleted upon addition of 4-hydroxytamoxifen (4OHT) to the 
culture media. I focused on this particular Paf1C component as it is not essential for viability in mESCs, 
allowing us to minimize pleotropic effects that might arise from depletion of essential subunits. 
Furthermore, Leo1 has a well establish role as a repressor of siRNA-mediated epigenetic silencing in S. 
pombe (Kowalik et al., 2015), making it a good candidate to manipulate in order to test a possible 
conservation of this process in mammalian cells.  
My initial goal was to test if small RNAs originating from endogenous loci can direct heterochromatin 
formation at those regions (in cis) in the absence of a functional Paf1C. However, next generation 
sequencing experiments demonstrated that putative endogenous siRNAs (endo-siRNAs) are present at 
negligible amounts in mammalian somatic cells (Svoboda, 2014). Consistent with this, human Dicer cannot 
efficiently process long double-stranded RNA substrates, due to an auto-inhibitory function of its N-
terminal helicase domains (Ma et al., 2008). Therefore, to induce endo-siRNA production, I integrated a 
mouse oocyte-specific Dicer isoform (DicerO) in the Leo1fl/fl conditional knock out cells. In contrast to 
somatic Dicer, DicerO lacks the N-terminal DExD helicase domain (Figure 3A) and is able to efficiently 
process long duplex RNA substrates into small RNAs. Consequently, ectopic expression of DicerO in mESC 
leads to the production of endo-siRNAs mapping to several unique genomic loci (Flemr et al., 2013). Using 
a random stable integration strategy, I generated two Leo1fl/fl DicerO clones, expressing DicerO at high and 
low levels (Figure 3B). Small RNA sequencing in these two clones confirmed the presence of endo-siRNAs, 
whose levels correlated with the amount of DicerO expression (Figure 3C). I focused on endo-siRNAs 
originating from three unique genomic loci (Anks3, Optn and Rad23a/Gadd45gip), previously identified 
by Flemr and colleagues (Flemr et al., 2013) (Figure 3C). Small RNAs mapping to the Anks3 gene are 
derived from long intramolecular interactions forming an RNA stem in intron 4. Similarly, endo-siRNAs 
match the 3′ UTR of Optn, which is predicted to fold into a duplex RNA structure. At the 
Rad23a/Gadd45gip locus, siRNAs map to a site of convergent transcription defined by the overlap between 
the 3′ UTRs of the two genes (Flemr et al., 2013). All three endo-siRNA clusters displayed the characteristic 
length and bias for the U-base at the starting position (Figure 3C), suggesting they represent bona fide 
siRNAs that can be loaded onto Ago proteins.  
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Figure 3. Generating Paf1C conditional knock out cells expressing endo-siRNAs.  
A Schematic comparing the domain organization of somatic (DicerS) and oocyte Dicer (DicerO). B Left, outline of 
the strategy used to generate Leo1fl/fl cells with a stable integration of DicerO. Right, western blot analysis of DicerS 
and DicerO expression in the selected Leo1fl/fl DicerO clones. C Left, total RNA-seq tracks of WT cells and small 
RNA-seq tracks (rpm) of three endo-siRNA-producing loci in Leo1fl/fl DicerO clones A1 and F6. Right, length 
histograms of each endo-siRNA cluster. Clone A1 was used for all subsequent experiments. 
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2. Loss of Leo1 affects the mRNA levels and histone modifications of the endo-
siRNA-producing loci 
After establishing mES cell lines that express endogenous siRNAs, I next asked whether loss of Leo1 affects 
the expression and chromatin state of the three endo-siRNA-producing loci described above (Figure 3C). 
To induce Leo1 knock out, I treated the Leo1fl/fl DicerO cells (clone A1, Figure 3) with 4OHT for up to eight 
days. Leo1 mRNA levels were drastically reduced at day 2 and remained low throughout the time-course, 
confirming that Leo1 was efficiently downregulated (Figure 4A).  In the Leo1fl/fl DicerO cells, loss of Leo1 
led to 40-60% reduction of the mRNA levels of Optn, Rad23a and Gadd45gip, but not Anks3 (Figure 4A). 
These observations would be consistent with three different scenarios. First, since Paf1C is a PolII 
elongation factor, its function might be required for efficient PolII transcription of the Optn and 
Rad23a/Gadd45gip loci. Second, endo-siRNAs derived from Optn and Rad23a/Gadd45gip map to the 
3′UTR of these transcripts, thus potentially enabling post-transcriptional RNAi silencing in the cytoplasm. 
Third, if endo-siRNAs could indeed direct histone modifications, reduced mRNAs levels could potentially 
reflect formation of repressive chromatin environment at the target loci, leading to reduced transcriptional 
activity. To distinguish between these three scenarios, I next examined the mRNA expression levels of the 
above transcripts in Leo1fl/fl WT Dicer cells, where endo-siRNAs are not detectable by small-RNA 
sequencing. Similar to Leo1fl/fl DicerO cells, loss of Leo1 in the WT Dicer background led to reduction of 
the mRNAs levels of Optn, Rad23a and Gadd45gip albeit to a lesser extent (Figure 4B), suggesting that 
the decrease in mRNA expression cannot be fully explained by the presence of DicerO and endo-siRNAs.  
To further explore if loss of Leo1 affects the chromatin state of the endo-siRNA-producing loci, I treated 
the Leo1fl/fl DicerO cells with 4OHT for up to eight days to induce Leo1 knock out and performed H3K9me2 
ChIP-qPCR for each day of the 4OHT time course (Figure 4C). Methylation of histone H3 on lysine 9 is a 
hallmark of heterochromatin (Allis and Jenuwein, 2016) and in fission yeast, deletion of Paf1C subunits 
allows small RNA-mediated deposition of this repressive mark at homologous genes (Kowalik et al., 2015). 
Therefore, I speculated that in mammalian somatic cells, lack of Leo1 could similarly enable accumulation 
of H3K9me2 at target loci in the presence of endo-siRNAs. ChIP-qPCR following a 4OHT time-course in 
the Leo1fl/fl DicerO cells showed that H3K9me2 levels at the Anks3 and Optn loci (but not 
Rad23a/Gadd45gip) tend to increase throughout the time-course (Figure 4C). However, the same trend was 
observed after knocking out Leo1 in a Leo1fl/fl WT Dicer cell line (Figure 4D), suggesting that H3K9me2 
levels at the Anks3 and Optn genes increase independently of endo-siRNAs. 
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Figure 4. Loss of Leo1 affects the mRNA levels and histone modifications of the endo-siRNA-producing loci. 
A and B RT-qPCR measuring the mRNA expression levels of Leo1, Anks3, Optn, Radd23a and Gadd45gip in 
Leo1fl/fl DicerO clone A1 (A) and Leo1fl/fl WT Dicer (B) cells throughout a 4OHT time-course. X-axes indicate the 
duration of the 4OHT treatment in days. Y-axes indicate relative mRNA levels normalized to TBP. Two different 
primer pairs were used for each gene, except for Radd23a and Gadd45gip, where black and grey bars correspond 
to the mRNA levels of Radd23a and Gadd45gip, respectively (See also Materials and Methods). C and D ChIP-
qPCR measuring H3K9me2 levels at the Anks3, Optn and Radd23/Gadd45gip loci in Leo1fl/fl DicerO clone A1 (C) 
and Leo1fl/fl WT Dicer (D) cells throughout a 4OHT time-course. X-axes indicate the duration of the 4OHT 
treatment in days. Gapdh and MuERV loci were used as negative and positive controls for H3K9me2 enrichment, 
respectively. 
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3. WT Dicer is not required for deposition of repressive chromatin marks at the 
Anks3 endo-siRNA producing region. 
To exclude the possibility that WT Dicer produces very small amounts of endo-siRNAs, undetectable by 
sequencing but sufficient to induce the observed H3K9me2 changes upon Leo1 depletion, I next used 
previously generated Leo1fl/fl cells where Dicer was knocked out (Leo1fl/fl Dicer-/-) and re-introduced WT 
Dicer in that background by stable integration. I treated the Dicer knock out and Dicer rescue cell lines 
with 4OHT for six days to deplete Leo1 and performed ChIP-qPCR to measure the H3K9me2 levels at the 
Anks3 locus. However, in contrast to previous observations, loss of Leo1 did not correlate with 
accumulation of the H3K9me2 mark in the WT Dicer background (Figure 5B and Figure 4D). Similarly, 
H3K9me2 levels were not affected by the depletion of Leo1 in either Dicer-/- or the WT Dicer rescue 
background (Figure 5B). Although not fully conclusive, these results argue against a possible direct link 
between endo-siRNAs and heterochromatin formation in a WT Dicer background.  
4. Reporter silencing in the absence of Leo1 is independent of siRNAs 
The results obtained so far do not support a role for the mammalian Paf1C as an antagonist of RNAi-
mediated heterochromatin formation in mESCs. However, in my experimental set up, the effects of 
disrupting Paf1C function are tested on the population level rather than on individual cells. Importantly, in 
S. pombe Paf1C mutants, silencing of siRNA-targeted euchromatic loci is efficiently maintained through 
mitotic divisions even in the absence of the original siRNA source (Kowalik et al., 2015). However, the 
rate at which individual yeast mutant cells initiate de novo heterochromatin formation and gene silencing 
is low (Flury et al., 2017). Therefore, it was possible that if similar to fission yeast, only a small subset of 
the Leo1 knock-out mES cells could initiate heterochromatin formation, the effect will be largely masked 
at the population level. To address this, I engineered a fluorescent reporter, containing Neon Green fused 
to the Anks3 siRNA-producing intron 4, driven by the endogenous Anks3 promoter (Figure 6A). I chose 
Anks3 since endo-siRNAs from this gene are not complementary to the mature transcript and would not 
trigger post-transcriptional silencing of the reporter mRNA in the cytoplasm. I then used TALENs to 
integrate a single copy of this reporter construct into a defined genomic site at the β-globin locus in both 
Leo1fl/fl DicerO and Leo1fl/fl Dicer-/- cells (Figure 6A). I isolated seven Leo1fl/fl DicerO clones containing a 
homozygous integration of the Anks3 reporter, resulting in homogenous Neon Green expression as 
measured by FACS (Figure 6B). To assess how loss of Leo1 affects expression of the reporter in individual 
Leo1fl/fl DicerO cells, I performed a 4OHT time-course to induce Leo1 knock out in all seven clones and 
monitored Neon Green levels by FACS. Interestingly, the proportion of non-fluorescent cells in all clones 
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gradually increased throughout the 4OHT time-course, although it remained below 1% (Figure 6C, left). I 
also noticed an inverse correlation between the basal Neon Green levels and the amount of non-fluorescent 
cells in each clone at the end of the 4OHT treatment (Figure 6C, right). This suggests that lower expression 
levels render the cells more susceptible to reporter silencing in the absence of a functional Paf1C. 
 
 
Figure 5. WT Dicer is not required for deposition of repressive chromatin marks at the Anks3 endo-siRNA 
producing region. 
A Left, outline of the strategies used to generate Leo1fl/fl Dicer-/- and Leo1fl/fl WT Dicer rescue cell lines. Right, 
western blot analysis of WT DICER protein levels in the indicated cell lines. Leo1fl/fl WT Dicer rescue clone A2 
was used for subsequent ChIP experiments described in (B).  B ChIP-qPCR measuring H3K9me2 levels at the 
Anks3 endo-siRNA producing region in Leo1fl/fl (WT Dicer), Leo1fl/fl Dicer-/- (Dicer knock out) and Leo1fl/flDicer-/- 
WT Dicer rescue cell lines. X-axes indicate the duration of the 4OHT treatment in days. Dark- and light-red bars 
correspond to two different primer pairs that were used to measure H3K9me2 levels at the Anks3 endo-siRNA 
producing region.  Gapdh and MuERV loci were used as negative and positive controls for H3K9me2 enrichment, 
respectively. 
 
Chapter 1  Results 
19 
 
To test whether the silent reporter state can be maintained and propagated in the absence of Leo1, I focused 
on Leo1fl/fl DicerO reporter lines 2E, 3B and 7E (Figure 6C), as representatives of clones that exhibit low 
and high proportions of non-fluorescent cells upon depletion of Leo1. I isolated and expanded silent cells 
from the above clones which were either untreated (Leo1+/+) or treated with 4OHT for 6 days (Leo1 knock 
out) (Figure 6D). I then used this expanded population to assess the reporter expression status and chromatin 
state (Figure 6D). Interestingly, 4OHT-treated reporter lines 3B and 7E contained a much larger proportion 
of silent cells compared to their non-treated controls (Figure 6E). Western blot analysis of these cells 
confirmed that LEO1 was not expressed in the 4OHT-treated population (Figure 6F). However, compared 
to the parental cells, DicerO protein levels were drastically reduced or almost completely undetectable in 
the reporter lines, irrespective of 4OHT (Figure 6F), suggesting these cells would not produce (many) 
siRNAs. Thus, although I observed a higher proportion of silent cells in the Leo1 knock out reporter lines 
(Figure 6E), it is unclear whether this is due to siRNA-mediated transcriptional silencing. 
To test whether the increased frequency of non-fluorescent cells in clones 2E, 3B and 7E (Figure 6E) 
correlates with higher levels of heterochromatin marks, I performed both H3K9me2 and H3K9me3 ChIP-
qPCR using primers specific for the reporter locus (Figure 6G). Surprisingly, irrespective of 4OHT 
treatment, the Ct values of input samples containing more silent cells were 2-7 cycles higher compared to 
those with lower proportions of silencing (Figure 6G). Since qPCR Ct values should be very similar across 
all input samples, the above results could indicate the presence of micro-deletions in the reporter locus, that 
were selected for and propagated after FACS-sorting and expanding silent cells (Figure 6D). Therefore, in 
this case, downregulation of the fluorescent reporter could reflect impaired transcription, processing or 
translation. 
My previous results indicate that WT Dicer likely does not have a direct effect on the chromatin state of 
the endo-siRNA-producing loci (Figure 5). Nevertheless, I wanted to revisit these observations using my 
reporter system. For this, I generated five Leo1fl/fl Dicer-/- clones with a stable integration of the Anks3 
reporter, resulting in homogenous Neon Green expression as assessed by FACS (Figure 6H). I then treated 
five Leo1fl/fl DicerO and five Leo1fl/fl Dicer-/- reporter lines with 4OHT for up to 6 days to deplete Leo1, and 
monitored Neon Green expression levels by FACS (Figure 6I, left). In line with my previous observations, 
the proportion of non-fluorescent cells in almost all Leo1fl/fl DicerO clones increased throughout the 4OHT 
time-course. However, the number of silent cells in all five Leo1fl/fl Dicer-/- reporter lines remained 
unchanged (Figure 6I, left). Although these observations are intriguing, I again noticed an inverse 
correlation between the initial Neon Green levels and the amount of non-fluorescent cells in each clone at 
the end of the 4OHT treatment. Importantly, all five Leo1fl/fl Dicer-/- reporter lines had higher basal 
fluorescence than the Leo1fl/fl DicerO clones with the largest proportion of silent cells (Figure 6I, left). This 
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Figure 6. Reporter silencing in the absence of Leo1 is independent of siRNAs. 
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Figure 6. Reporter silencing in the absence of Leo1 is independent of siRNAs (continued) 
A Illustration of the Anks3 Neon Green reporter construct. B Flow cytometry analysis of Neon Green expression 
in seven Leo1fl/fl DicerO Anks3 reporter clones with a stable integration of the reporter described in (A). The parental 
Leo1fl/fl DicerO cell line from which all seven clones are derived is shown as an example of non-fluorescent cells. 
C Left, percent Neon Green negative cells determined by flow cytometry analysis of the seven Leo1fl/fl DicerO 
Anks3 reporter clones from (B) during a 6-day 4OHT time-course treatment. Right, average fluorescence intensity 
vs. percent Neon Green negative cells at 4OHT day 6 for the indicated Leo1fl/fl DicerO Anks3 reporter lines. D 
Outline of the experimental set up used to test the maintenance of reporter silencing upon deletion of Leo1. E Left, 
Flow cytometry analysis of Neon Green expression in the indicated Leo1fl/fl DicerO Anks3 reporter lines derived 
from previously FACS-sorted and expanded silent cells. Right, quantification of the percent Neon Green negative 
cells from the FACS profiles of the indicated clones. F Western blot analysis of LEO1 and myc-tagged DICERO 
protein levels in the Leo1fl/fl DicerO Anks3 reporter lines from (E). G Left, ChIP-qPCR primer binding sites along 
the Anks3 Neon Green reporter. Right, Ct values of input samples from H3K9me2 and H3K9me2 ChIP-qPCR of 
the Leo1fl/fl DicerO Anks3 reporter lines from (E). H Flow cytometry analysis of Neon Green expression in five 
Leo1fl/fl Dicer-/- Anks3 reporter clones with a stable integration of the reporter described in (A). A parental Leo1fl/fl 
Dicer-/- cell line is shown as an example of non-fluorescent cells. I Left, percent Neon Green negative cells 
determined by flow cytometry analysis of the indicated reporter cell lines during a 6-day 4OHT time-course 
treatment. Right, average fluorescence intensity vs. percent Neon Green negative cells at 4OHT day 6.  
 
 
makes it difficult to directly compare the WT Dicer and DicerO backgrounds, since variation in basal 
reporter expression could account for the observed differences in reporter silencing upon Leo1 knock out. 
Collectively, these data indicate that initiation and maintenance of reporter silencing is likely not dependent 
on siRNAs. 
5. Mammalian Paf1 complex does not interact with the Ski complex in mES cells 
It has been previously suggested that in addition to its function in transcription, the human Paf1 complex 
might also orchestrate RNA processing and quality control, based on its reported interaction with the RNA 
helicase Ski complex (Zhu et al., 2005a). The Ski complex is primarily cytoplasmic and has a well-
established role as a general co-factor of the cytoplasmic RNA exosome that assists with 3′-to-5′ RNA 
degradation (Halbach et al., 2013). However, a previous study suggested that in human cells, the Ski 
complex also localizes to the nucleus, where it interacts with Paf1C through the common subunit WDR61 
(Zhu et al., 2005a). Since it is still unclear whether the two complexes function together, I sought to address 
this question using mES cells. I created cell lines with endogenously tagged 3xFLAG-AviTag WDR61 and 
SKIV2L in a background expressing a promiscuous biotin ligase (BirA ligase). Western blot analysis 
showed that the two tagged proteins were properly expressed and biotinylated (Figure 7A). I then used our 
endogenously tagged cells and performed streptavidin pull downs followed by mass spectrometry. Using 
the common WDR61 subunit as a bait, I identified all Paf1C components (LEO1, CTR9, PAF1 and CDC73) 
as well as the Ski complex subunits TTC37 and SKIV2L (Figure 7B, left). However, streptavidin 
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purification of the Ski complex subunit SKIV2L, revealed interactions with the rest of the Ski complex 
components TTC37 and WDR61, but not with any Paf1C subunits (Figure 7B, right).  I next performed co-
IP experiments as a complementary approach to IP-MS. Using a FLAG immunoprecipitation of 
endogenously tagged SKIV2L, I did not detect any interaction with Paf1C subunits CTR9, LEO1 or PAF1 
(Figure 7C). Taken together these data indicate that the mammalian Ski complex and Paf1C do not form a 
stable interaction although they contain a common subunit.   
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Figure 7. The mammalian Paf1 complex does not interact with the Ski complex. 
A Western blots showing expression and biotinylation of endogenously tagged 3xFLAG-AviTag WDR61 and 
SKIV2L. B Mass spectrometry analysis of single step streptavidin purification of endogenously tagged WDR61 
(clone 1G) and SKIV2L using 150mM KCl. All experiments included three technical replicates and an untagged 
mESC as a control. FDR, false discovery rate. C Western blot analysis of endogenously tagged 3xFLAG-AviTag 
SKIV2L co-IP experiments.  
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DISCUSSION  
Although initially identified as a posttranscriptional silencing mechanism (Fire et al., 1998), RNAi 
pathways also play important roles in epigenetic gene regulation in fungi, ciliates, plants and C. elegans 
(Grewal, 2010; Holoch and Moazed, 2015). Whether siRNAs can specify histone and DNA modifications 
in mammalian cells however, remains somewhat controversial. In fact, initiating silent histone 
modifications at euchromatic loci using synthetic siRNAs has been difficult to achieve even in organisms 
where RNAi has a well-established role in epigenetic phenomena (Buhler et al., 2006b; Iida et al., 2008; 
Simmer et al., 2010). The recent discovery of the Paf1 complex as a repressor of siRNA-mediated 
heterochromatin formation in S. pombe (Kowalik et al., 2015) has opened exciting new avenues to explore 
a possible conservation of this process in mammalian cells. To test this hypothesis, I asked whether 
endogenous siRNAs produced by ectopic expression of oocyte DicerO in mES cells (Figure 3) can induce 
epigenetic silencing of their cognate loci (in cis) upon conditional ablation of the Paf1C subunit Leo1. 
Although the mRNA expression of some siRNA-producing loci decreased while the H3K9me2 levels 
showed a tendency to increase upon loss of Leo1, this trend was not correlated with the presence of DicerO 
(Figure 4). These findings suggest that the observed changes were not mediated by RNAi since endo-
siRNAs were not detected in cells expressing only WT Dicer (Figure 3). Furthermore, I ruled out the 
possibility that WT DICER generates low levels endo-siRNAs that could account for the accumulation of 
the H3K9me2 (Figure 5). I also note that H3K9me2 levels were measured by ChIP-qPCR specifically along 
the DNA sequences where endo-siRNAs map. Thus, regardless of the underlying trigger, it is possible that 
the observed increase in H3K9me2 levels upon Leo1 knock out is more localized and thus insufficient to 
confer transcriptional repression. Furthermore, in the case of Anks3 and Optn, H3K9me2 levels increased 
only up to two or three fold above basal levels (Figure 4), which is unlikely to result in robust transcriptional 
changes.  
As a complementary approach to my experiments on the population level, I designed a fluorescent reporter 
based on the Anks3 endo-siRNA producing sequence, allowing me to monitor initiation and maintenance 
of silencing in individual cells using FACS. This allowed me to assess whether similar to S. pombe, only a 
subset of mES cells were able initiate RNAi-mediated transcriptional silencing in the absence of a 
functional Paf1C. Furthermore, unlike the endogenous Anks3 locus, the siRNA-generating intron was 
positioned in close proximity to the promoter of the reporter construct (Figure 5A). I reasoned that this 
feature might render the promoter more susceptible to silencing even if the endo-siRNAs were able to 
induce only limited and localized chromatin changes. I initially found that the proportion of non-fluorescent 
cells in the Leo1fl/fl DicerO background increased in the absence of Leo1 (Figure 6C). However, further 
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experiments testing the maintenance of silencing, revealed that DicerO protein levels were significantly 
reduced or completely undetectable in cultured non-fluorescent cells (Figure 6E and F). This argues against 
a direct link between siRNAs and reporter silencing. Furthermore, ChIP-qPCR experiments hint at the 
presence of genomic abnormalities at the reporter locus of cell populations which maintain a higher 
frequency of silencing (Figure 6G). This suggests that reporter repression is more likely a consequence of 
abnormal transcription, processing and/or translation, rather than a direct result of RNAi-induced 
transcriptional silencing.  I also note that although the reporter was expressed from a defined genomic locus, 
there were clonal variations in basal fluorescence levels (Figure 6C and Figure 6I), which made it difficult 
to directly compare silencing in different backgrounds (e.g. Dicer-/- vs. DicerO). Therefore, a reporter cell 
line with an inducible DicerO and/or siRNA-source might be a more suitable approach to address this 
question.  
Overall, I did not find convincing evidence that siRNAs can direct heterochromatin formation and 
transcriptional silencing in mES cells lacking a functional Paf1 complex. However, further experiments are 
necessary to definitively rule out the presence of such mechanism in mammalian cells. For instance, my 
experimental set up relies on small amounts of endogenous siRNAs (Figure 3C), which might not be 
sufficient to trigger robust chromatin changes leading to transcriptional silencing. To address this, it might 
be necessary to provide a more potent siRNA source such as a synthetic hairpin or other long double-
stranded RNA substrates in combination with DicerO. This approach should be feasible, especially in stem 
cells, where attenuated interferon responses to double-stranded RNA (Chen et al., 2010b; Pare and Sullivan, 
2014; Wang et al., 2013) should minimize the toxicity that is usually associated with such exogenous 
substrates. Similarly, it is possible that certain features of our Anks3 reporter construct might be 
incompatible with robust siRNA-mediated transcriptional silencing. For instance, I purposefully positioned 
the Anks3 endo-siRNA intron close to the reporter promoter. However, while recent mechanistic studies in 
S. pombe revealed that intronic siRNA targets are compatible with RNAi-directed heterochromatin 
formation, it was also shown that targeting promoter-proximal introns can compromise the initiation and 
maintenance of silencing (Shimada et al., 2016). Likewise, it is possible that my reporter construct was less 
susceptible to repression, due to the close proximity of the promoter and the endo-siRNA-producing intron 
(Figure 6). Furthermore, several studies describing RNAi-mediated epigenetic silencing in human cells 
have used siRNAs specifically targeting promotor sequences (Kim et al., 2006; Morris et al., 2004; Suzuki 
et al., 2005) and it would be important to test if these results can be reproduced in my experimental system 
using promoter siRNAs.  
Since mammalian cells lack an RNA-dependent RNA polymerase (de Farias et al., 2017; Zong et al., 2009) 
which is required to amplify production of the siRNAs, it might be interesting to test whether ectopic 
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expression of an RdRP in combination with DicerO and an siRNA source could induce transcriptional 
silencing in Paf1C deficient mES cells. However, if RNAi-mediated epigenetic silencing can be achieved 
only under such artificial conditions, it is highly unlikely that normal biological processes in mammalian 
somatic cells would also depend on this mechanism. Murine Dicer is essential for embryonic development 
(Bernstein et al., 2003) and it has been previously reported that centromeric repeat sequences are 
derepressed in Dicer-deficient mES cells due to defects in centromeric heterochromatin formation, leading 
to suggestions that the RNAi machinery might be directly involved in this process (Kanellopoulou et al., 
2005). However, these results could reflect secondary effects caused by global changes in gene expression, 
especially since miRNA biogenesis is also perturbed in the absence of Dicer.  
Conflicting evidence about the cellular localization of RNAi components has further fueled the controversy 
surrounding siRNA-mediated epigenetic silencing in mammalian cells. While some studies report that the 
RNAi factors are confined to the cytoplasm (Much et al., 2016; Stalder et al., 2013; Zeng and Cullen, 2002), 
others suggest that the RNAi machinery has both cytoplasmic and nuclear localization (Burger and 
Gullerova, 2018; Doyle et al., 2013; Ohrt et al., 2012; Robb et al., 2005; White et al., 2014). Another study 
reports that the nuclei of human somatic cells contain active RNAi factors, but no RISC loading 
components, suggesting that siRNAs cannot be loaded in the nucleus (Gagnon et al., 2014). Thus, questions 
about the presence and significance of a nuclear RNAi pathway in mammalian cells remain subject of 
debate. In the present study, I also found no supporting evidence that siRNA-mediated epigenetic silencing 
in mammalian cells can occur in the absence of Paf1C. 
Differences in Paf1 complex composition in yeast versus higher eukaryotes prompted us to investigate 
whether mammalian Paf1C activity extends beyond transcription. In mammalian cells, Paf1C contains a 
novel subunit, Wdr61, which is also part of the conserved RNA helicase Ski complex, functioning in RNA 
decay (Zhu et al., 2005a). This has led to suggestions that in the nucleus, the two complexes interact through 
this common subunit, although so far no specific function has been ascribed to that interaction. To address 
this, I first sought to confirm that WDR61 links the Paf1 and Ski complexes in mES cells. However, in 
contrast to observations by Zhu et al., my IP-MS data clearly indicate that the two complexes do not interact 
stably. Although I cannot exclude a more transient association or discrepancy due to differences in cell 
lines (human vs. mouse), my results are consistent with the fact that Paf1C and the Ski complex perform 
their canonical functions in transcription and cytoplasmic RNA decay in different cellular compartments. 
Moreover, the yeast Ski complex was recently reported to bind directly to a translating 80S ribosome during 
RNA degradation (Schmidt et al., 2016), thus providing further support for the cytoplasmic localization of 
the Ski complex. Although I found no evidence that the two complexes can function together, further 
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investigation of the mammalian Ski complex revealed novel interaction partners and interesting insights 
into translation-coupled RNA decay, which are the focus of the second chapter of this thesis. 
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MATERIALS AND METHODS 
Experimental model  
Male 129×C57BL/6 mouse embryonic stem cells (mESC) (Mohn et al., 2008) were grown in serum/LIF 
media (DMEM (Gibco 21969-035) supplemented with 15% fetal bovine serum (Gibco 10270106), 2 mM 
L-glutamine (Gibco 25030024), 1x non-essential amino acids (Gibco 11140035), 1 mM sodium pyruvate 
(Gibco 11360070), 0.1 mM 2-mercaptoethanol (Sigma M-7522), 50 mg ml−1 penicillin, 80 mg ml−1 
streptomycin and homemade LIF) at 37 °C in 5% CO2. Cells were cultured on dishes coated with 0.1% 
gelatin (Sigma G1890). 
 
Generation of endogenously tagged cell lines  
Endogenous gene tagging with a 3xFLAG-AviTag was performed using TALEN homology-directed repair 
with single-stranded oligodeoxynucleotide (ssODN) donor templates encoding the tag, flanked by 5′ and 3′ 
homology arms. The ssODNs donors were synthetized as ultramers by Integrated DNA Technologies. N-
terminally tagged Skiv2l3xFLAG-Avi/3xFLAG-Avi clone 8F (cMB331) and Wdr613xFLAG-Avi/3xFLAG-Avi clone 1G (AR90) 
were generated using TALENs cutting near the start codon. Skiv2l3xFLAG-Avi/3xFLAG-Avi clone 8F (cMB331) was 
generated in a mES 129×C57BL/6 cells expressing BirA ligase and CreERT2 from the Rosa26 locus 
(cMB063) (Ostapcuk et al., 2018). Wdr613xFLAG-Avi/3xFLAG-Avi clone 1G (AR90) was generated in mES 
29×C57BL/6 cells expressing only BirA ligase from the Rosa26 locus (cMB053) (Ostapcuk et al., 2018). 
All clones were screened for homozygous integration of the tag by PCR and Sanger sequencing and 
expression of the fusion proteins was confirmed by western blot with a FLAG antibody. Biotinylation of 
the tag was verified by western blot using streptavidin-HRP. See also “List of cell lines” table at the end of 
the Materials and Methods section. 
 
Generation of cell lines with stable integrations 
Leo1fl/fl DicerO clones A1 and F6 were generated by random integration of DicerO-MycHis cDNA construct 
(Flemr et al., 2013) in a Leo1fl/fl background expressing CreERT2 from the Rosa26 locus (Clone 5C, 
cMB068). DicerO expression is driven by the human EF1α promoter. The cells were selected with 10µg/mL 
blasticidin for 5 days. Clones A1 and F6 were used for initial small RNA-seq experiment. Clone A1 was 
used for all subsequent experiments. Leo1fl/fl Dicer-/- WT Dicer rescue cell lines were generated by random 
integration of Dicer-MycHis cDNA construct (Flemr et al., 2013) in a Leo1fl/fl Dicer-/- background 
(cMB081) using the same random integration strategy as for DicerO. Only Leo1fl/fl Dicer-/- WT Dicer rescue 
clone A2 was used for subsequent ChIP experiments. To induce Leo1 knock out, the cells were treated with 
0.1 µM 4-hydroxytamoxifen (4-OHT) (Sigma) for 0, 1, 2, 4, 6, or 8 days (see Figure 4A for Leo1 mRNA 
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expression levels during the time course). See also “List of cell lines” table at the end of the Materials and 
Methods section. 
 
Generation of Anks3-Neon-Green reporter cell lines  
The Anks3-Neon-Green reporter, driven by the endogenous mouse Anks3 promoter was integrated into a 
defined site at the β-globin locus in both Leo1fl/fl DicerO (Clone A1) and Leo1fl/fl Dicer-/- (cMB079 and 
cMB081) cells. The reporter and its promoter were cloned into a pBlu-Neon-Green plasmid between the 5′ 
and 3′ β-globin locus homology arms. The resulting reporter plasmid was then used as donor for homology-
directed repair of a dsDNA cut at the β-globin locus induced by TALENs. For specific primer and TALEN 
sequences and a list of cell lines, see the tables at the end of the Materials and Methods section. 
 
Transfections  
For endogenous tagging of Skiv2l (cMB331) and Wdr61 (AR90) with TALENs, cells were transfected with 
400 ng of each TALEN, 1000 ng ssODN donor and 100 ng of pRRP puromycin recombination reporter 
(Flemr and Buhler, 2015). 24 hours post-transfection, the cells were selected with 2µg/ml puromycin for 
28 hours and surviving cells were plated at clonal densities as described above. For integration of the Anks3-
Non-Green reporter into the β-globin locus, cells were transfected with TALEN 400 ng of each TALEN, 
1000 ng on the pBlu-Anks3-Neon-Green plasmid donor and 100 ng of pRRP puromycin recombination 
reporter. For genome editing with TALENs, 24 hours post-transfection, the cells were selected with 2µg/ml 
puromycin for 28 hours and surviving cells were seeded sparsely on 10 cm plates for clonal expansion. 
After 5-7 days, colonies were individually picked into 96-well plates, expanded and genotyped by PCR. 
Cells with proper in-frame homozygous insertions of the 3xFLAG-Avi tag were further confirmed by 
Sanger sequencing and western blot and Anks3-Neon-Green reporter lines were analyzed by FACS for 
homogenous Neon Green expression. For WT Dicer and DicerO random integrations, cells were transfected 
with 2µg of cDNA plasmids. 24-hours post-transfection, the cells were selected with 10µg/mL blasticidin 
for 24 hours and surviving cells were seeded sparsely on 10 cm plates for clonal expansion for 5-7 days in 
the presence of 10µg/mL blasticidin. Individual clones were then picked picked into 96-well plates, 
expanded and screened by western blot with an anti-Myc antibody for DicerO integration and an anti-dicer 
for WT Dicer integration. All transfections were carried out with Lipofectamine 3000 reagent (Invitrogen 
L3000015) at 3 µl per 1 µg of total DNA in OptiMem media (Gibco, 31985062). Approximately 500,000 
cells were used for each transfection. 
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Cloning 
The Anks3-Neon-Green reporter contains the Promoter region of Anks3 (approximately 1000bp upstream 
of the annotated transcription start site) and portion of Exon1, fused to the siRNA-producing Intron 4, 
flanked by portions of Exon4 and Exon5. The Promoter-Exon fragment was amplified from mESC gDNA 
with a forward primer containing SpeI site and a reverse primer containing AatII site from, and the Exon4-
Intron4-Exon5 sequence was amplified with a forward primer containing an AatII site and a reverse primer 
containing AscI site. The resulting fragments were cloned into a NheI/AscI-digested pBlu-HB-Neon-Green 
plasmid containing 5′ and 3′ homology arms for targeted integration into the β-globin locus (plasmid 
pMB2032).  For specific primer sequences, see the “List of primers” table at the end of the Materials and 
Methods section. 
 
Small RNA sequencing  
Approximately 500,000 cells were seeded in a 6-well plate and cultured for 48 hours. The cells were 
trypsinized, collected in media, pelleted and washed with PBS. Small RNAs were isolated with mirPremier 
microRNA Isolation Kit from Sigma (SNC50). Libraries were prepared from 500ng small RNAs using the 
Illumina TruSeq Small RNA kit and sequenced on an Illumina HiSeq2500 platform (50 nt single-end reads). 
 
Total RNA sequencing 
Total RNA from a nearly confluent 6-well plate of Leo1fl/fl cells was isolated using the Agilent Absolutely 
RNA Miniprep Kit with on-column DNase digestion. After ribosomal RNA depletion with the Illumina 
Ribozero kit, libraries were constructed using ScriptSeq v2 (Epicentre; SSV21106) and sequenced on an 
Illumina HiSeq2500 platform (50 nt single-end reads). 
 
RT-qPCR  
Total RNA was extracted from mES cells with the Agilent Absolutely RNA Miniprep Kit and 500ng of 
RNA was reverse-transcribed using the PrimeScript RT-PCR Kit (Takara Bio RR036A-1). qPCR was 
performed with SsoAdvanced SYBR Green Supermix (Bio-Rad 172-5274) on a CFX96 Real-Time PCR 
System (Bio-Rad) and relative RNA levels were calculated using the ΔCt method and normalization to TBP 
mRNA abundance). See also “List of cell lines” table at the end of the Materials and Methods section. 
 
Chromatin immunoprecipitation (ChIP) 
H3K9me2 chromatin immunoprecipitations described in Figure 4 and Figure 5 were carried out as follows: 
One 10cm dish of confluent cells per sample was fixed in media supplemented with 1% Formaldehyde for 
10 min at room temperature, quenched with glycine for 8 min at room temperature and washed with PBS. 
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The cells were harvested in PBS supplemented with 0.5% BSA and 1X protease inhibitor cocktail (Roche) 
by scraping and cell pellets were flash-frozen in liquid nitrogen and stored at -80 °C. To prepare nuclear 
fractions, the cells were resuspended in 8mL buffer NP-Rinse1 (50mM Hepes, pH 8.0, 150mM NaCl, 1mM 
EDTA, 10% Glycerol, 0.5% NP-40, 0.25% Triton-X100) and incubated on a rotating wheel at 4 °C. The 
cells were spun down for 5 min at 1,2000g at 4 °C and the pellet was resuspended in in 10mL buffer NP-
Rinse2 (10mM Tris, pH 8.0, 1mM EDTA, 200mM NaCl) and spun down at 1,2000g for 5 min at 4 °C. The 
supernatant was removed, and the pellet was washed two times with 5mL shearing buffer (10mM Tris, pH 
8.0, 1mM EDTA, 0.1% SDS) and resuspended in 900 µl shearing buffer, supplemented with 1X protease 
inhibitor cocktail (Roche). The samples were then transferred to 12x12 AFA Covaris tubes, topped with 
shearing buffer to the rim and sonicated in Covaris S220 with a water bath filled with 1.52L of ddH2O, 
using the following sonication conditions: 5% Duty cycle, 200 cycles per burst, continuous degassing mode, 
140W peak incident power, 4 °C bath temperature.  
 
After sonication, the samples were transferred to 1.5mL tubes and clarified by centrigugation at 16,000 xg 
for 10 min at 4 °C. Protein concentrations was measured using the BioRad protein assay and for each sample 
approximately 500µg of total protein in 500µl was added to 125µl 5X IP buffer (250mM Hepes, pH 7.5, 
750mM NaCl, 1mM EDTA, 0.1% SDS, 0.5% Na-Deoxycholate, 5% triton) for a final concentration of 1X 
IP buffer (50mM Hepes, pH 7.5, 150mM NaCl, 1mM EDTA, 0.1% SDS, 0.1% Na-Deoxycholate, 1% 
triton). The samples were then incubated with 2µg of H3K9me2 antibody (Active Motif) overnight at 4 °C. 
Before addition of the antibody, approximately 5% of the sample volume was set aside as an input sample. 
On the following day, the IP samples were clarified by centrifugation at 16,000g for 5 min and transferred 
to 25µl M-280 Sheep Anti-Mouse IgG Dynabeads (Invitrogen) prewashed with 1X IP buffer, and incubated 
for 3 hours at 4 °C on a rotating wheel. The beads were then washed twice with 1X IP buffer, once with 
DoC wash buffer (10mM Tris, pH 8.0, 1mM EDTA, 0.25M LiCl, 0.5% NP-40, 0.5% Na-Deoxycholates) 
and once with 1X TE. Samples were eluted twice by resuspending the beads in 50µl elution buffer (1% 
SDS, 0.1M NaHCO3), following an incubation at 65°C for 20 min at 1000 rpm. Input samples were adjusted 
to the same volume (100µl) with elution buffer and processed together with the IPs. All samples were 
incubated with 2µg RNase A and incubated for 30 min at 37°C. After that the samples were treated with 
20µg Proteinase K for 2.5 hours at 55°C and de-crosslinked for 7 hours at 65°C. DNA was isolated by 
phenol/chlorophorm, precipitated with ethanol and dissolved in 50µl H2O. The purified DNA was then 
subjected to qPCR analysis using ChIP primers. 
 
H3K9me2 and H3K9me3 chromatin immunoprecipitations described in Figure 6 was carried out without 
crosslinking as follows: Approximately 1x106 cells for each sample were trypsinized, collected in media 
Chapter 1  Materials and Methods 
32 
 
and washed once with cold PBS. To isolate the nuclei, the cells were resuspended in 1ml ice cold PBS 
containing 0.1% NP-40 and incubated 5 min on ice. The nuclei were briefly spun down and washed once 
with 500µl cold MNase buffer (10mM Tris-HCl, pH 7.5, 4mM MgCl2, 1mM CaCl2) and resuspended in in 
250µl cold MNase buffer supplemented with 1X protease inhibitor complex (Roche). The chromatin was 
digested with 0.25µl MNase (NEB, 2000U/ul) for 7 min at 37ºC, 1200rpm. The reaction was stopped by 
adding 25ul of STOP solution (166mM EDTA, 333mM EGTA) and incubating the samples on ice for 5 
min.  The nuclei were lysed in 1ml Hypotonic lysis buffer (0.2mM EDTA, 1.5mM DTT, 20mM EGTA) , 
supplemented with 1X protease inhibitor cocktail (Roche) for 1 hour on ice with occasional vortexing. 
Insoluble debris were pelleted by centrifugation at 13,000g for 5 min at 4ºC and 125µl of 10X N-ChIP 
buffer (100mM Tris-HCl, pH 8.0, 20mM EDTA pH8.0, 200mM NaCl, 10% Triton-X100, 1% SDS, 10X 
protease inhibitor cocktail, Roche). The samples were split in half and incubated with either 3µg of mouse 
anti-H3K9me2 antibody (Wako, 302-32369) or 3µg of rabbit anti-H3K9me2 (Abcam ab8889) overnight at  
4ºC on a rotating wheel. Prior to addition of the antibodies, 5% of each sample was set aside as an input. 
On the following day, H3K9me2 IPs were incubated with 40µl of Protein G Dynabeads (Invitrogen) and 
H3K9me3 IPs were incubated with a 1:1 mix of Protein A or G Dynabeads (Invitrogen) for 2 hours at 4ºC 
on a rotating wheel. The beads were washed twice in RIPA buffer (10mM Tris-HCl pH 8.0, 1mM EDTA 
pH 8.0, 140mM NaCl, 1% Triton-X100, 0.1% SDS, 0.1% Sodium Deoxycholate), twice in RIPA500 buffer 
(10mM Tris-HCl pH 8.0, 1mM EDTA pH 8.0, 500mM NaCl, 1% Triton-X100, 0.1% SDS, 0.1% Sodium 
Deoxycholate), twice with LiCl, 1X TE. DNA was eluted twice in 50µl Elution buffer (10mM Tris-HCl pH 
8.0, 5mM EDTA pH 8.0, 150mM NaCl, 1% SDS) supplemented with 20µg Proteinase K, for 30 min at 
55ºC, 1400rpm. Input samples were adjusted to 150µl with elution buffer and 20µg Proteinase K, and 
incubated for 1 hour at 55ºC, 1400rpm (in parallel with elution). DNA was purified with 150ul 
phenol/chloroform mix, precipitated with ethanol and resuspended in 50 µl 10mM Tris pH8.5. The purified 
DNA was then subjected to qPCR analysis using ChIP primers). See also “List of cell lines” table at the 
end of the Materials and Methods section.  
 
Flow cytometry  
Cells grown on 6-well plates were harvested by trypsinization, collected in media and washed two times 
with PBS. Neon Green expression was analyzed (20,000 cells per sample) on BD LSRII SORP Analyser 
(Becton Dickinson). For experiments testing the maintenance of reporter silencing, Neon-green negative 
cells harvested from 10cm dishes as described above were sorted on BD FACSAria cell sorter (Becton 
Dickinson). After expanding the sorted Neon-Green negative population, the Neon-Green expression levels 
were analyzed on BD LSRII SORP Analyser (Becton Dickinson) as described above.
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Western Blotting 
Cells were lysed for 30 min on ice in 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 % Triton-X, 0.5 mM 
EDTA, 5 % glycerol, 1x protease inhibitor cocktail (Roche) and 1 mM DTT. Lysates were clarified by 
centrifugation at 16,000 xg for 10 min at 4 °C and protein concentration was measured using the BioRad 
protein assay. Approximately 20 µg of total protein extract was resolved on NuPAGE-Novex Bis-Tris 4–
12 % gradient gels (Thermo Fisher), transferred semi-dry to a polyvinylidene fluoride (PVDF) membrane, 
blocked in 5 % non-fat milk in TBS+0.05 % Tween (TBST) for 30 min at room temperature and incubated 
with primary antibodies at 4 °C overnight. The following primary antibodies were used for western blotting: 
mouse anti-Flag (1:1,000, Sigma clone M2), rat anti-tubulin (1:5,000, Abcam clone YL1/2), mouse anti-
Myc Tag (1:1,000, Cell Signaling 2276), anti-dicer (1:1,000) (Sinkkonen et al., 2010), rabbit anti-leo1 
(1:1,000, Abgent AP1978A). Following incubation with corresponding HRP-conjugated secondary 
antibodies, signal was visualized using Immobilon Western Chemiluminiscent HRP Substrate (Merck 
Millipore). To detect biotinylated proteins, after transfer, membranes were blocked in 2 % bovine serum 
albumin (BSA) in TBST for 30 min and incubated with HRP-conjugated streptavidin (Strep-HRP) (Sigma 
S2438) diluted 1:10,000 in 2 % BSA-TBST for 30 min at room temperature.  
 
Co-immunoprecipitation experiments  
Skiv2l3xFLAG-Avi/3xFLAG-Avi clone 12E (AR50) or the corresponding parental cell line (cMB063) from one 10cm 
confluent dish were trypsinized, collected in media, washed in PBS and lysed for 30 min at 4°C in 500µl 
whole cell lysis buffer (10 mM Tris-HCl pH 7.4, 150 mM KCl. 1.5 mM MgCl2, 0.5% NP-40) supplemented 
with 1X protease inhibitor cocktail (Roche), 50 units benzonase and 10 µg RNase A. Lysates were clarified 
by centrifugation at 16,000g for 15 min and incubated with 30 µl M-280 Streptavidin Dynabeads 
(Invitrogen 11206D) for 3 hours at 4°C. The beads were washed 3 times in wash buffer (10 mM Tris-HCl 
pH 7.4, 150 mM KCl. 1.5 mM MgCl2, 0.5% NP-40), resuspended in SDS loading buffer, boiled for 5min 
at 4°C and resolved by SDS-PAGE together with 5% of the input samples. Proteins were transferred semi-
dry to a polyvinylidene fluoride (PVDF) membrane, blocked in 5 % non-fat milk in TBS+0.05 % Tween 
(TBST) for 30 min at room temperature and incubated with primary antibodies at 4 °C overnight. The 
following primary antibodies were used for western blotting: mouse anti-Flag (1:1,000, Sigma clone M2), 
rabbit anti-Paf1 (1:1,000, Abcam ab181120), rabbit anti-leo1 (1:1,000, Abgent AP1978A), rabbit anti-Ctr9 
(1:1,1000, Abcam ab84487). Following incubation with corresponding HRP-conjugated secondary 
antibodies, signal was visualized using Immobilon Western Chemiluminiscent HRP Substrate (Merck 
Millipore). 
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Affinity purification for LC–MS/MS 
For Skiv2l3xFLAG-Avi/3xFLAG-Avi single step streptavidin purification, two confluent 10cm dishes seeded with 
equal number cells of the tagged line or the corresponding parental cell line were harvested by 
trypsinization, washed twice in PBS and lysed for 1 hour at 4°C in 500µl whole cell lysis buffer (10 mM 
Tris-HCl pH 7.4, 150 mM KCl. 2.5 mM MgCl2, 0.5% NP-40) supplemented with 1X protease inhibitor 
cocktail (Roche), 50 units benzonase and 10 µg RNase A. Lysates were clarified by centrifugation at 
16,000g for 10 min and incubated with 20 µl M-280 Streptavidin Dynabeads (Invitrogen 11206D) for 3 
hours at 4°C. After that, the beads were washed four times in wash buffer (10 mM Tris-HCl pH 7.4, 150 
mM KCl. 2.5 mM MgCl2, 0.1% NP-40) and two times in wash buffer without NP-40. For mass spectrometry 
analysis, captured proteins were digested with trypsin directly on the streptavidin beads. Wdr613xFLAG-
Avi/3xFLAG-Avi single step streptavidin purification was essentially carried out in the same way with the 
following exceptions: the cells were lysed in the absence of RNase and benzonase, in  buffer containing 
10mM Hepes pH 7.5, 150 mM KCl. 1.5 mM MgCl2, 0.5% NP-40 supplemented with 1X PIC cocktail 
(Roche). Every affinity purification experiment contained three separate technical replicates for each cell 
line. 
 
Mass spectrometry analysis  
Peptides generated by trypsin digestion (see ‘Affinity purification for LC–MS/MS’) were analyzed by mass 
spectrometry as described in the “Methods” section of the manuscript related to Chapter 2 of this thesis. 
The full manuscript can be found in the Appendix. 
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List of primers  
Gene Primer sequence Orientation Target Application 
mb 
Number 
Leo1 
 
GACGGTGAGGAGGAGCAAGAC Forward Exon2 RT-qPCR 8094 
GTCTGCTTCGGAATCCGATGG Reverse Exon3 RT-qPCR 8095 
Leo1 
 
CTGCCCAACTTCCTCAGTGTAG Forward Exon5 RT-qPCR 8098 
CCTCTTCATCCAGCATCTCCTCATC Reverse Exon6 RT-qPCR 8099 
Tbp 
 
TGCTGTTGGTGATTGTTGGT Forward Exon8 RT-qPCR 4325 
AACTGGCTTGTGTGGGAAAG Reverse Exon8 RT-qPCR 4326 
Anks3 
 
GACTGCACTCTTCCACTGTAC Forward Exon4-Exon5 RT-qPCR 9270 
TGCTTCCATCAAAGGAGTGTATC Reverse Exon4-Exon5 RT-qPCR 9271 
Anks3 
 
GAACCTGAGGCCTTGCAA Forward Exon1-Exon2 RT-qPCR 9272 
GGACATCCAGCTCCTCTG Reverse Exon1-Exon2 RT-qPCR 9273 
Anks3 
 
GCAGCCAAATGTTCATAGGGG Forward Intron4 ChIP-qPCR 9139 
GTTCTGAGTGCATGAGAGCCT Reverse Intron4 ChIP-qPCR 9140 
Anks3 
 
GGTTAGCAGAGAGGAGTTAGGC Forward Intron4 ChIP-qPCR 9137 
TACCAACTGAACTGCCCAGC Reverse Intron4 ChIP-qPCR 9138 
Optn 
 
TCCGAAATCAAGATGGAGCAG Forward Exon9-Exon10 RT-qPCR 9266 
TCTGCCTGTTGCTTGGTTAG Reverse Exon9-Exon10 RT-qPCR 9267 
Optn 
 
GAAGGTGTGGGAAGAGTGAG Forward 3′ UTR RT-qPCR 9268 
GCAAGGTGTTTACTAAACTGGTG Reverse 3′ UTR RT-qPCR 9269 
Optn 
 
TTGACACACTGTACCCCTCCT Forward 3′ UTR ChIP-qPCR 9125 
CCATTCTGGCTGACTGCTCA Reverse 3′ UTR ChIP-qPCR 9126 
Radd23a 
 
GGCAAGTGATTCAACAGAACC Forward Exon7-Exon8 RT-qPCR 9274 
GGAGGCTCATTCAACATCTGG Reverse Exon7-Exon8 RT-qPCR 9275 
Radd23a/ 
Gadd45gip 
 
GAGGAAGGAGGGTTGTCCTTG Forward 3′ UTR qPCR 9147 
CTTAACAGCCCAGCCTACTCA Reverse 3′ UTR qPCR 9148 
Gadd45gip 
 
CAAGAATGGTACCCGAGCTTAG Forward Exon1-Exon2 RT-qPCR 9276 
AATCATTTGTGGCATCTTGGC Reverse Exon1-Exon2 RT-qPCR 9276 
MuERV 
 
CAGAGTGATGAGAGACAGATGGA Forward 
Upstream of 
MuERV on 
chr1:114 
ChIP-qPCR 8738 
MuERV 
 
GTTGACAACCAGGAATAGCCAC Reverse 
5′end of MuERVL 
LTR (MT2) 
ChIP-qPCR 8740 
Gapdh CTCTGCTCCTCCCTGTTCC Forward Promoter ChIP-qPCR 9674 
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Gapdh TCCCTAGACCCGTACAGTGC Reverse Promoter ChIP-qPCR 9674 
Anks3 
 
ACCAACACTAGTCATACCCACCTTC
ACACCCA 
Forward 
Promoter, contains 
SpeI site 
Cloning 9444 
ACCAACGACGTCCTTGCAAGGCCT
CAGGTTCC 
Reverse 
Exon1, contains 
AatII site 
Cloning 9445 
Anks3 
 
ACCAACGACGTCCTTCTGGAGAGTGG
AGCCA 
Forward 
Exon4, contains 
AatII site 
Cloning 9446 
ACCAACGGCGCGCCGGAGTGTATCCA
TATACAGGCTCC 
Reverse 
Exon5, contains 
AscI site 
Cloning 9447 
Anks3 
reporter 
 
GTCACCTTCCCGGGATGCTC Forward Promoter-Exon1 ChIP-qPCR 12357 
CAATCACCTCACGTTGGCATT Reverse Exon4 ChIP-qPCR 9264 
Anks3 
reporter 
 
GAACCTGAGGCCTTGCAA Forward Exon1 ChIP-qPCR 9272 
GCCCACCCCTATGAACATTTG Reverse Intron4 ChIP-qPCR 12353 
Wdr61 
CTGTCTGGCCTTTAGCGCTTCATCC
TTGGTTAAGGAAATGgactataaggaccac
gacggagactacaaggatcatgatattgattacaaagac
gatgacgataaggctGGCCTGAACGACATC
TTCGAGGCTCAGAAAATCGAATGG
CACGAAggtcctACCAACCAGGTAAG
GTCTGCAGTGAGAGGGAAAGCTTC
AG 
ssDNA 
ultramer  
encodes a 3xFLAG-
AviTag, flanked by 
5′ and 3′ Wdr61 
homology arms 
N-terminal 
endogenous 
gene 
tagging 
9656 
Skiv2l 
AGTTTCCGGGCTGCTCGGGAGCTG
CCGCGGCTCCAGGATGgactataaggacc
acgacggagactacaaggatcatgatattgattacaaag
acgatgacgataaggctGGCCTGAACGACA
TCTTCGAGGCTCAGAAAATCGAAT
GGCACGAAggtcctATGGAGACGGAG
CGACTCGGTGAGGGGGAGGGGAG
GAGAG 
ssDNA 
ultramer 
encodes a 3xFLAG-
AviTag, flanked by 
5′ and 3′ Skiv2l 
homology arms 
N-terminal 
endogenous 
gene 
tagging 
10000 
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List of TALENs 
TALEN Sequence TALEN units Source 
HB-SBE 
Β-globin 
locus 
CCAGATTTGGTCACAGTT HD1 HD2 NI3 NN4 NI5 NG6 NG7 NG8 
NN9 NN10 NG1 HD2 NI3 HD4 NI5 NN6 
NG7 LR-NG 
Matyas Flemr,  
Bühler Lab 
HB-SBK 
Β-globin 
locus 
GGAGGACAACTTTCCT NN1 NN2 NI3 NN4 NN5 NI6 HD7 NI8 NI9 
HD10 NG1 NG2 NG3 HD4 HD5 LR-NG 
Matyas Flemr,  
Bühler Lab 
SBE 
WDR61 
AGCGCTTCATCCTTGGTT NI1 NN2 N*3 NN4 HD5 NG6 NG7 HD8 
NI9 NG10 HD1 HD2 NG3 NG4 NN5 NN6 
NG7 LR-NG 
This work 
SBK 
WDR61 
CTCACTGCAGACCTTACCT 
 
HD1 NG2 HD3 NI4 HD5 NG6 NN7 HD8 
NI9 NN10 NI1 HD2 HD3 NG4 NG5 NI6 
HD7 HD8 LR-NG 
This work 
SBE 
SKIV2L 
GCTCGGGAGCTGCCGCGG NN1 HD2 NG3 N*4 NN5 NN6 NN7 NI8 
NN9 HD10 NG1 NN2 HD3 N*4 NN5 N*6 
NN7 LR-NN 
This work 
SBK 
SKIV2L 
CTCACCGAGTCGCTCCGT HD1 NG2 HD3 NI4 HD5 N*6 NN7 NI8 
NN9 NG10 N*1 NN2 HD3 NG4 HD5 N*6 
NN7 LR-NG 
This work 
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List of cell lines   
Identifier Genotype Clone Source Stable Integration 
cMB053 Rosa26 BirA-V52/-  Ostapcuk et al., 2018  
cMB063 Rosa26Cre-ERT2/BirA-V5  Ostapcuk et al., 2018  
cMB068 Rosa26Cre-ERT2-5/- Leo1fl/fl Clone 5C 
Alex Tuck, 
Bühler Lab 
 
cMB536 Rosa26 Cre-ERT2/- Leo1fl/fl DicerO Clone A1 This work DicerO 
cMB537 Rosa26 Cre-ERT2/- Leo1fl/fl DicerO Clone 6F This work DicerO 
cMB079 Rosa26Cre-ERT2/- Leo1fl/fl Dicer-/- Clone 3D 
Alice Wenger, 
Bühler Lab 
 
cMB081 Rosa26Cre-ERT2/- Leo1fl/fl Dicer-/- Clone 6D 
Alice Wenger, 
Bühler Lab 
 
cMB538 Rosa26 BirA-V52/ BirA-V5 Wdr613xFLAG-Avi/3xFLAG-Avi Clone 1G This work  
cMB539 Rosa26 BirA-V52/ BirA-V5 Wdr613xFLAG-Avi/3xFLAG-Avi Clone 2G This work  
cMB540 Rosa26 BirA-V52/ BirA-V5 Wdr613xFLAG-Avi/3xFLAG-Avi Clone 10H This work  
cMB331 Rosa26Cre-ERT2/BirA-V5 Skiv2l3xFLAG-Avi/3xFLAG-Avi Clone 8F This work  
cMB541 Rosa26Cre-ERT2/BirA-V5 Skiv2l3xFLAG-Avi/3xFLAG-Avi Clone 12E This work  
cMB542 
Rosa26Cre-ERT2/- Leo1fl/fl Dicer-/- WT Dicer 
 
Clone A2 This work WT Dicer 
cMB543 
Rosa26 Cre-ERT2/- Leo1fl/fl DicerO Anks3-
NeonGreen 
Clone 2E This work 
DicerO; 
Anks3-Neon-Green 
reporter 
cMB544 
Rosa26 Cre-ERT2/- Leo1fl/fl DicerO Anks3-
NeonGreen 
Clone 3B This work 
DicerO; 
Anks3-Neon-Green 
reporter 
cMB545 
Rosa26 Cre-ERT2/- Leo1fl/fl DicerO Anks3-
NeonGreen 
Clone 7E This work 
DicerO; 
Anks3-Neon-Green 
reporter 
cMB546 
Rosa26 Cre-ERT2/- Leo1fl/fl DicerO Anks3-
NeonGreen 
Clone 8F This work 
DicerO; 
Anks3-Neon-Green 
reporter 
cMB547 
Rosa26 Cre-ERT2/- Leo1fl/fl DicerO Anks3-
NeonGreen 
Clone 9H This work 
DicerO; 
Anks3-Neon-Green 
reporter 
cMB548 
Rosa26 Cre-ERT2/- Leo1fl/fl DicerO Anks3-
NeonGreen 
Clone 11G This work 
DicerO; 
Anks3-Neon-Green 
reporter 
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cMB549 
Rosa26 Cre-ERT2/- Leo1fl/fl DicerO Anks3-
NeonGreen 
Clone 12A This work 
DicerO; 
Anks3-Neon-Green 
reporter 
cMB550 
Rosa26Cre-ERT2/- Leo1fl/fl Dicer-/- Anks3-
NeonGreen 
Clone 3A This work 
Anks3-Neon-Green 
reporter 
cMB551 
Rosa26Cre-ERT2/- Leo1fl/fl Dicer-/- Anks3-
NeonGreen 
Clone 11F This work 
Anks3-Neon-Green 
reporter 
cMB552 
Rosa26Cre-ERT2/- Leo1fl/fl Dicer-/- Anks3-
NeonGreen 
Clone 4D This work 
Anks3-Neon-Green 
reporter 
cMB553 
Rosa26Cre-ERT2/- Leo1fl/fl Dicer-/- Anks3-
NeonGreen 
Clone 4F This work 
Anks3-Neon-Green 
reporter 
cMB554 
Rosa26Cre-ERT2/- Leo1fl/fl Dicer-/- Anks3-
NeonGreen 
Clone 8A This work 
Anks3-Neon-Green 
reporter 
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Chapter 2  
INTRODUCTION 
1. Cytoplasmic mRNA degradation  
Eukaryotic mRNAs begin their life cycle in the nucleus where they are transcribed, capped, polyadenylated 
and spliced and then exported to the cytoplasm to serve as templates for translation into protein before they 
are finally degraded. Although regulation of gene expression is often mainly associated with the control of 
transcriptional events, RNA decay plays a key role in shaping the cellular proteome during normal 
conditions and in response to changing environmental cues (Bresson et al., 2017; Garneau et al., 2007; 
Pérez-Ortín et al., 2013). RNA degradation also supports the fidelity of gene expression through specialized 
cytoplasmic mRNA quality control pathways, which eliminate aberrant mRNAs that can generate 
potentially toxic protein products (Shoemaker and Green, 2012). The 5′ cap structure and 3′ poly(A) tail of 
eukaryotic mRNAs are two key features that confer stability by shielding the transcript ends from the 
cytoplasmic exonucleases. With the exception of non-polyadenylated histone mRNAs, transcript decay in 
the cytoplasm is typically initiated by gradual shortening of the poly-A tail and removal of the 5′ m7G cap 
(Figure 8) (Łabno et al., 2016a; Parker, 2012). At this point transcripts can become subject to degradation 
in the 5′-3′ direction by Xrn1, a conserved, highly processive exoribonuclease with a strong affinity towards 
substrates with 5′ monophosphates (Łabno et al., 2016a; Parker, 2012). Alternatively, mRNAs can be 
degraded in the 3′-5′ direction by the cytoplasmic exosome and its cofactor, the RNA helicase Ski complex 
(Łabno et al., 2016a; Parker, 2012). Dysregulation of RNA decay is implicated in several pathological 
conditions, underscoring the importance of this process in maintaining cellular homeostasis. For instance, 
reduced expression of Xrn1 is associated with osteosarcoma (Pashler et al., 2016), and mutations in 
exosome subunits have been linked to cancer and severe neurological disorders (Morton et al., 2018; 
Robinson et al., 2015). Furthermore, loss of function of the Ski complex causes tricho-hepato-enteric 
syndrome, a congenital bowl disorder that also affects multiple other organs (Fabre et al., 2012; Hartley et 
al., 2010). 
RNA decay has been extensively studied in S. cerevisiae and several pioneering studies in this organism 
have been crucial in elucidating key mechanistic details of this process (Parker, 2012). The current model 
for RNA decay suggests that Xrn1 is the major cytoplasmic exonuclease, while the Ski-exosome complex 
is thought to operate redundantly with the 5′-3′ degradation pathway and make a more significant 
contribution in eliminating aberrant mRNAs (Łabno et al., 2016a; Parker, 2012). However, the precise 
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endogenous substrates of the cytoplasmic Ski-exosome pathway and its global function in RNA decay 
remain poorly defined particularly in mammalian cells. Thus, it is still an open question whether on a global 
scale, the two cytoplasmic pathways preferentially target certain transcripts, for instance based on specific 
RNA features. Furthermore, the presence of additional decay factors and pathways in higher eukaryotes 
(Łabno et al., 2016a) suggests an added level of complexity and highlights the importance of examining the 
process in other organisms. 
 
Figure 8. General mRNA degradation pathways in the cytoplasm 
Degradation of cytoplasmic mRNA is typically initiated by shortening of the 3′ poly(A) tail 
catalyzed by the major deadenylase complexes Ccr4-NOT and Pan2/Pan3, followed by removal 
of the 5′ cap structure. At this point transcripts can be degraded in the 5′-3′ direction by the 
exoribonuclease Xrn1, or in the 3′-5′ direction by exosome and its co-factor the helicase Ski 
complex. Adapted with permission from (Garneau et al., 2007). 
 
 
It is becoming increasingly clear that RNA decay is extensively coupled to other stages of the transcript 
life-cycle. In the cytoplasm in particular, a significant crosstalk exists between the translation and RNA 
degradation machineries. This is particularly evident for the cytoplasmic RNA surveillance pathways, 
which selectively degrade mRNAs containing aberrantly terminating ribosomes or stalled translation 
elongation complexes (Shoemaker and Green, 2012). However, accumulating evidence over the past decade 
suggests that the overlap between translation and RNA degradation is more widespread and not simply 
limited to RNA surveillance. In support of this idea, Xrn1 has been suggested to degrade mRNAs co-
translationally (Hu et al., 2009; Pelechano et al., 2015), and recent structures of the yeast Ski complex and 
Xrn1 bound to the ribosome have established a direct physical link between the translation and RNA 
degradation machineries (Schmidt et al., 2016; Tesina et al., 2019). These observations raise interesting 
questions. First, is the physical association between the two processes conserved in higher eukaryotes? 
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Second, to what extent does each decay pathway interact with translation and what is the functional 
relevance of this interaction? This introduction focuses on several key aspects of yeast and mammalian 
cytoplasmic mRNA decay pathways and their links to translation. 
1.1. mRNA Deadenylation  
The poly(A) tails of eukaryotic mRNAs range in size from about 90 nucleotides in yeast to 200-250 in 
mammals and are coated by poly(A) binding protein (Pab1/PABPC1) (Eckmann et al., 2011). The poly(A) 
RNP is one of the most dynamic features of mature transcripts and plays a key role in controlling the 
stability of an mRNA (Jalkanen et al., 2014). Deadenylation of the poly(A) tail is considered the first and 
rate-limiting step in mRNA decay and is important for stimulating decapping and subsequent degradation 
in both 5′-3′ and 3′-5′ directions (Chen and Shyu, 2011; Parker, 2012).  
Two conserved complexes, Ccr4-Not and Pan2-Pan3, are the major deadenylases that catalyze shortening 
of the poly(A) RNP (Wahle and Winkler, 2013). The predominant route for cytoplasmic deadenylation is 
thought to be through the Ccr4-Not complex which contains two catalytic subunits, Ccr4 and Caf1/Pop2 
that act as 3′-5′ poly(A)-specific exoribonucleases (Tucker et al., 2002; Tucker et al., 2001). The catalytic 
activity of the Pan2-Pan3 complex lies in Pan2, which belongs to the RNaseD exoribonuclease family 
(Boeck et al., 1996; Uchida et al., 2004). Early studies in yeast have demonstrated that the two deadenylase 
complexes are differentially regulated by Pab1. While Pab1 appears to stimulate the activity of Pan2-Pan3 
(Boeck et al., 1996), it has an inhibitory effect on the Ccr4-Not complex (Tucker et al., 2002). Thus, poly(A) 
tails bound by Pab1 would be protected from the activity of Ccr4-Not, but susceptible to degradation by 
Pan2-Pan3. This has become the basis of the widely-accepted bi-phasic model of mRNA deadenylation in 
both yeast and mammalian cells, which suggests that the two complexes act in a temporal manner. In the 
first phase, Pan2-Pan3 catalyzes initial trimming of the poly(A) tail, while subsequent deadenylation is 
carried out by the Ccr4-Not complex (Tucker et al., 2001; Yamashita et al., 2005).  
Recent mechanistic studies in yeast and human cells have provided further details that clarify certain aspects 
of deadenylation. Contrary to previous observations, in vitro studies using components from fission yeast, 
demonstrate that Pab1 actually accelerates deadenylation through Ccr4-Not, by stimulating Ccr4, while 
inhibiting Caf1 (Webster et al., 2018). Consequently, the two catalytic subunits are proposed to have 
complementary roles, with Ccr4 displacing bound Pab1 and allowing the exposed poly(A) tail to be 
degraded by Caf1 (Webster et al., 2018). These findings are consistent with results obtained from 
reconstituted systems using human components (Yi et al., 2018), indicating that the mechanism of 
deadenylation by Ccr4-Not is conserved from yeast to humans.  
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Re-examining the role of the Pan2-Pan3 complex in human cells also suggests that certain aspects of the 
bi-phasic model need to be reevaluated. Unlike Ccr4-Not, perturbation of Pan2-Pan3 had only a minor 
impact on transcript abundance in HeLa cells, suggesting that the initial trimming of the poly(A) tail by 
Pan2-Pan3 is not essential or rate-limiting for deadenylation and decay (Yi et al., 2018). Thus, while Ccr4-
Not seems to be the major deadenylase acting during bulk cytoplasmic decay of polyadenylated mRNAs, 
the functional role of initial poly(A) shortening by Pan2-Pan3 remains unclear (Yi et al., 2018).  
1.2. mRNA Decapping  
Deadenylated mRNAs are subject to decapping, which renders the transcripts susceptible to degradation in 
the 5′-3′ direction by the exoribonuclease Xrn1. Removal of the 5′ cap structure is mainly carried out by a 
conserved Nudix family hydrolase, Dcp2, which cleaves between the α ‐ and β ‐phosphate of the cap to 
release m7GDP and 5′‐end monophosphate RNA (Grudzien-Nogalska and Kiledjian, 2017). Dcp2 forms a 
complex with Dcp1, which enhances the intrinsic catalytic activity of the hydrolase and is required for 
decapping in vivo (Beelman et al., 1996; Chang et al., 2014a). Structural data from S. pombe indicate that 
Dcp1 stimulates the activity of Dcp2, by locking it in a particular closed, more active conformation. 
Interestingly, in mammalian cells this interaction surface is not well conserved, explaining why an 
additional factor, the scaffold protein EDC4, is required to bridge the Dcp1-Dcp2 interaction in higher 
eukaryotes (Chang et al., 2014a; She et al., 2008).  
Multiple other activators known as enhancers of decapping (EDCs) function to stimulate the decapping 
machinery. Pat1, Lsm1-7, Dhh1 and Edc3 are among the factors conserved from yeast to human that 
promote decapping during general mRNA turnover (Grudzien-Nogalska and Kiledjian, 2017). Pat1 
associates with Lsm1-7 to form a complex which preferentially binds to deadenylated mRNAs and 
enhances the interaction of Dcp2 with the transcript (Chowdhury et al., 2007; Chowdhury and Tharun, 
2008; Nissan et al., 2010; Tharun and Parker, 2001). Pat1 has also been shown to interact with the 5′-3′ 
exoribonuclease Xrn1, thus establishing the Lsm1-7/Pat1 complex as an important link between 
deadenylation, decapping and mRNA degradation (Nissan et al., 2010).  
Apart from Dcp2, recent studies in mammalian cells suggest that additional enzymes are capable of 
removing the cap structure of mRNAs. Dcp2 is not ubiquitously expressed in all mouse tissues and appears 
to be developmentally regulated (Song et al., 2010). Furthermore, exogenous RNA substrates could still be 
decapped in Dcp2-deficinet MEF cells, suggesting the presence of other enzymes that could act redundantly 
(Song et al., 2010). In fact, besides Dcp2, at least one other yeast and two mammalian proteins have also 
been shown to catalyze decapping (Grudzien-Nogalska et al., 2016; Jiao et al., 2010; Song et al., 2013; 
Song et al., 2010). Since the human genome encodes 22 Nudix proteins, future research is likely to reveal 
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additional decapping enzymes functioning in vivo (McLennan, 2006). This is another example of 
redundancy associated with RNA decay and highlights the complexity of this process particularly in higher 
eukaryotes. 
1.3. Uridylation and its role in mRNA degradation 
Although poly(A) tails of mature mRNAs are probably the best studied modification with respect to 
transcript stability, non-templated addition of other nucleotides has also been reported to affect the fate of 
RNA molecules. Much attention has been given to the extension of mRNA 3′-ends with short stretches of 
uridine residues, as research over the past fifteen years has established an important role for this 
modification in promoting cytoplasmic decay (De Almeida et al., 2018; Łabno et al., 2016a). Uridylation 
was first described in mouse and plants, where miRNA-directed cleavage products were found to contain 
short stretches of non-templated uridine residues at their 3′ ends, which was correlated with decapping and 
shortening of the 5′ cleavage product (Shen and Goodman, 2004). Subsequently, U-tails were also shown 
to be important for the turnover of non-polyadenylated histone mRNAs (Mullen and Marzluff, 2008). 
Uridylation is catalyzed by terminal uridylyl transferases (TUTases) or poly(U) polymerases (PUPs) and it 
is now clear that this modification is pervasive and conserved among all eukaryotes with the notable 
exception of S. cerevisiae (De Almeida et al., 2018). 
Initial evidence that uridylation plays an important role in regulating the stability of cytoplasmic RNAs 
came from studies of the non-canonical nucleotidyltransferase Cid1 in S. pombe. Cid1 exhibits a robust 
poly(U) polymerase activity in vitro and was shown to catalyze the addition of U-tails to several 
polyadenylated mRNAs in vivo (Rissland et al., 2007; Rissland and Norbury, 2009). Cid1-dependent 
uridylation further promotes decapping of these poly(A)+ mRNAs through the Lsm1–7 complex (Rissland 
and Norbury, 2009). These observations are consistent with earlier findings that describe the ability of the 
Lsm1–7/Pat1 complex to preferentially bind not only 3′ oligo(A) tails, but also 3′ oligo(U) stretches 
(Chowdhury et al., 2007). Interestingly, loss of Cid1 caused an accumulation of decay intermediates lacking 
5′ cap structures, but with seemingly intact poly(A) tails (Rissland and Norbury, 2009). This suggests that 
in S. pombe, deadenylation was not a prerequisite for decapping, as this step could be bypassed by tagging 
the poly(A) tail with a stretch of uridines (Rissland and Norbury, 2009). Thus, deadenylation and 
uridylation were shown to have overlapping functions, suggesting that in S. pombe the two pathways 
operate in parallel, rather than sequentially (Rissland and Norbury, 2009).  
The human ortholog of Cid1, ZCCHC6/TUT7, was also shown to exhibit poly(U) polymerase activity in 
vitro (Rissland et al., 2007) and an independent study demonstrated that in mammalian cell extracts, short 
3′-end oligo(U) tracts added to a particular RNA promoted decapping through the Lsm1–7/Pat1 complex 
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(Song and Kiledjian, 2007), which is in line with observations from fission yeast. Although these early 
findings from S. pombe and mammalian cells demonstrated the conservation of uridylation and its impact 
on RNA degradation, it was unclear whether this process targets mRNAs on a global scale. The 
development of deep-sequencing approaches such as TAIL-seq, which provides information about poly(A) 
tail length and simultaneously detects 3′ end modifications (Chang et al., 2014b), were crucial for 
identifying the transcriptome-wide effects of uridylation. Recent applications of this technique in human 
cells revealed that approximately 85% of mRNAs contained 3′ U-tails at a frequency of higher than 1% 
suggesting that uridylation is pervasive (Chang et al., 2014b). Another study showed that human TUT4 and 
TUT7 act redundantly to catalyze mRNAs’ uridylation both in vitro and in vivo, and loss of these factors 
resulted in a global increase in mRNA half-lives (Lim et al., 2014). Conversely, depletion of major 
cytoplasmic decay factors such as Xrn1 or the exosome caused an accumulation of U-tailed transcripts, 
suggesting that uridylation has a general role in facilitating RNA degradation (Figure 9) (Lim et al., 2014). 
Interestingly, unlike S. pombe, where uridylation seems to be independent of deadenylation, in human cells, 
U-tails were specifically added to deadenylated transcripts (Lim et al., 2014).  
 
Figure 9. Uridylation promotes mRNA degradation. 
TUT4 and TUT7 function redundantly to uridylate deadenylated mRNAs. U-tails can be 
recognized by the exosome or the exoribonuclease Dis3l2 to initiate 3′-5′ degradation of the 
transcript. The Lsm1-7 complex also binds U-tails and promotes decapping to allow degradation 
in the 5′-3′ direction by the exoribonuclease Xrn1. Adapted with permission from (Lim et al., 
2014). 
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The same study also detected TUT4/7-dependent terminal oligo(U) stretches on histone mRNAs as well as 
other truncated decay intermediates lacking poly(A) tails (Lim et al., 2014). This suggests that besides its 
important role in bulk RNA turnover, uridylation may also facilitate the decay of RNA fragments generated 
by an internal endonucleolytic cleavage, which is often associated with RNA surveillance.  
1.4. Cytoplasmic mRNA degradation by the 5′-3′ exoribonuclease Xrn1 
Degradation of RNAs in the 5′-3′ direction by the processive exoribonuclease Xrn1 constitutes the major 
route for cytoplasmic mRNA decay (Parker, 2012). Besides targeting mRNAs that have been decapped 
after deadenylation, Xrn1 also degrades the byproducts of endonucleolytic cleavage such as those generated 
during cytoplasmic RNA surveillance (Jones et al., 2012). Initial evidence that Xrn1 is the predominant 
pathway for degradation of cytoplasmic mRNAs came from studies in S. cerevisiae, showing that blocking 
decay in the 5′-3′ direction caused perturbation in the normal rates of RNA turnover and was associated 
with more severe growth phenotypes compared to inactivation of the 3′-5′ pathway (Parker, 2012).  
Consistent with its central role in cytoplasmic RNA decay, Xrn1 is highly conserved in all eukaryotes (Jones 
et al., 2012). The catalytic core of the enzyme is formed by two conserved N-terminal regions, CR1 and 
CR2, which coordinate a Mg2 + ion, necessary for catalysis (Chang et al., 2011; Jinek et al., 2011). 
Structural and biochemical studies have provided further explanation for the affinity of Xrn1 towards 
single-stranded substrates bearing a 5′ monophosphate (Jinek et al., 2011). The catalytic core of the 
exonuclease contains a conserved pocket of four basic residues which recognize a 5′ monophosphate, but 
exclude larger groups through steric hindrance (Jinek et al., 2011). This explains why Xrn1 cannot degrade 
the 5′ cap structure, thus perhaps ensuring that only transcripts that have already been committed to 
degradation after decapping or cleavage are targeted by the enzyme (Jinek et al., 2011). The high 
processivity of Xrn1 is achieved by recognition of the 5′ nucleotide of the RNA, which stimulates substrate 
translocation after each round of hydrolysis (Jinek et al., 2011). As the active channel is wide enough to 
accommodate only single stranded RNA, substrate translocation allows Xrn1 to combine hydrolysis with 
ATP-independent melting of more structured RNAs (Jinek et al., 2011). 
Xrn1-mediated RNA decay has also been linked to other stages of the transcript life cycle. For instance, 
two studies implicate Xrn1 in a transcript buffering mechanism that couples RNA synthesis to degradation 
(Haimovich et al., 2013; Sun et al., 2013). More recently, Xrn1 has also been shown to associate with the 
ribosome during translation-coupled RNA decay (Tesina et al., 2019). These studies suggest that a 
significant crosstalk exists between RNA decay and other stages of gene expression. 
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1.5. Cytoplasmic 3′-5′ mRNA degradation by the exosome and the Ski complex 
Cytoplasmic mRNAs can also be targeted for degradation in the 3′-5′ direction by the multi-subunit 
exosome complex and its cofactors (Parker, 2012). The exosome was discovered about 20 years ago in S. 
cerevisiae and since then orthologs have been found in a range of eukaryotes (Mitchell et al., 1997). This 
ribonuclease complex localizes to both the cytoplasm and nucleus where it targets various RNA species for 
degradation, processing, and surveillance, thus making a major contribution to RNA metabolism. The 
nuclear exosome is involved in the quality control of mRNAs, the maturation of stable non-coding RNAs, 
such as rRNA, snRNA and snoRNAs, and degrades the by-products of pervasive transcription, including 
cryptic unstable transcripts (CUTs) in yeast and promoter upstream transcripts (PROMPTS) in humans 
(Chlebowski et al., 2013; Kilchert et al., 2016). The cytoplasmic exosome functions during general mRNA 
turnover and has also been shown to degrade some highly unstable mRNAs containing AU-rich elements 
in their 3′ UTRs (Chen et al., 2001; Chlebowski et al., 2013). Transcripts targeted by the cytoplasmic RNA 
quality control pathways and RNAi are also exosome substrates (Chlebowski et al., 2013; Orban and 
Izaurralde, 2005).  
The core exosome complex contains 9 catalytically inactive subunits, arranged in a two-layer, ring-like 
structure around a central channel which is wide enough to accommodate single-stranded RNA 
(Chlebowski et al., 2013). The first layer of the ring contains 6 proteins (Rrp41, Rrp42, Rrp43, Rrp45, 
Rrp46 and Mtr3) homologous to the RNase PH nucleases found in bacteria (Liu et al., 2006; Mitchell et al., 
1997). The second layer, referred to as the ‘cap’, is formed by three RNA binding proteins, Rrp4, Rrp40 
and Csl4 (Liu et al., 2006). The 9-subunit core serves as a binding platform for the ribonucleases Rrp6 and 
Dis3 (Rrp44), which provide enzymatic activity to the complex (Chlebowski et al., 2013). Rrp6 is a 
distributive 3′-5′ exonuclease of the DEDD family of nucleases and is restricted to the nucleus in both yeast 
and mammalian cells (Burkard and Butler, 2000; Januszyk et al., 2011). Dis3 is homologous to the bacterial 
RNase II/R and has both endonuclease and processive 3′-5′ exonuclease activities (Dziembowski et al., 
2007; Lebreton et al., 2008; Schaeffer et al., 2009; Schneider et al., 2009). In S. cerevisiae, Dis3 functions 
both in the cytoplasm and the nucleus. Human genomes encode two additional homologs of Dis3, Dis3L 
and Dis3L2 (Staals et al., 2010; Tomecki et al., 2010). Unlike S. cerevisiae, human Dis3 is mainly localized 
to the nucleus and Dis3L is restricted to the cytoplasmic exosome (Staals et al., 2010; Tomecki et al., 2010). 
Interestingly, while all human Dis3 homologs are processive 3′-5′ exonucleases, only the nuclear Dis3 has 
retained its endonuclease activity (Staals et al., 2010; Tomecki et al., 2010). Dis3L2 does not seem to 
associate with the exosome and instead functions separately as an alternative 3′-5′ degradation pathway in 
the cytoplasm (Lubas et al., 2013; Malecki et al., 2013). Biochemical and structural data indicate that RNA 
substrates can thread through the central channel of the catalytically inert core to access Dis3 (Bonneau et 
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al., 2009), which sits on the bottom of the channel. Alternatively, RNAs can be directly degraded by Rrp6 
(Makino et al., 2015), which interacts with the top (‘cap’) of the core ring.  
Multiple auxiliary factors and protein complexes associate with the exosome to regulate its access and 
recruitment to a wide range of substrates (Zinder and Lima, 2017). In mammalian cells, the nuclear exosome 
functions in the context of at least three different adapter complexes that facilitate RNA targeting (Fasken 
et al., 2011; Lubas et al., 2011; Meola et al., 2016). A central component of these complexes is the DEVH-
box RNA helicase Mtr4/SKIV2L2, which unwinds substrates and funnels them into the narrow central 
channel of the exosome core (Weick et al., 2018). Similarly, the activity of the cytoplasmic exosome is 
coupled to its co-factor, the Ski complex, containing the DEVH-box RNA helicase Ski2/SKIV2L 
(Anderson and Parker, 1998; Halbach et al., 2013; Halbach et al., 2012). In S. cerevisiase, a separate protein 
Ski7, bridges the interaction between the cytoplasmic exosome and the Ski complex (Araki et al., 2001). 
The N-terminal portion of yeast Ski7 is required for binding to the Ski complex and exosome (Araki et al., 
2001), while the C-terminal region has sequence similarity to translational GTPase domains (Guydosh and 
Green, 2014; Kowalinski et al., 2015), such as the one found in its closest paralog, Hbs1, functioning to 
release stalled ribosomes (Shoemaker et al., 2010). However, it was shown that whereas Ski7 is able to bind 
GTP, it is not a GTP-hydrolyzing enzyme (Kowalinski et al., 2015). Recent structural and biochemical 
studies in yeast also suggest that Ski7 is a constitutive component of the cytoplasmic exosome, which 
occupies similar surfaces on the core complex as Rrp6 (Kowalinski et al., 2016). 
Until recently, it was unclear how the mammalian Ski co-factor interacts with the exosome, since Ski7 has 
no apparent orthologs outside fungi (Marshall et al., 2013). However, its closest paralog, Hbs1 is conserved 
across eukaryotes and two independent groups recently reported that a short splice variant of human HBS1L 
(HBS1L3) is the Ski7-like mammalian protein that can interact with both the exosome and the Ski complex, 
thus confirming the evolutionary conservation of this co-factor (Kalisiak et al., 2017; Kowalinski et al., 
2016). Since yeast Ski7 and human HBS1L3 share only a sparse sequence similarity, it would be interesting 
to examine how each of these factors recruits the Ski complex to the exosome (Kowalinski et al., 2016).  
The Ski complex is the only known cytoplasmic co-factor of the exosome. It is evolutionary conserved and 
assists all exosome-mediated RNA degradation pathways, including general RNA turnover and surveillance 
(Anderson and Parker, 1998; Araki et al., 2001; Mitchell and Tollervey, 2003; van Hoof et al., 2002; van 
Hoof et al., 2000). Recently, the yeast Ski complex has also been shown to physically interact with the 80S 
ribosome (Schmidt et al., 2016), suggesting that it is involved in translation-coupled decay, similar to yeast 
Xrn1.The Ski complex consists of the tetratricopeptide protein Ski3/TTC37, the RNA-dependent RNA 
helicase Ski2/SKIV2L, and two copies of the beta-propeller Ski8/WDR61 (Halbach et al., 2013; Synowsky 
and Heck, 2008). Ski2 is structurally and functionally related to its nuclear counterpart Mtr4, although 
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biochemically Ski2 seems to have a broader substrate specificity than Mtr4 and has affinity for both single-
stranded and double-stranded RNAs (Halbach et al., 2012). The N-terminal portion of Ski2 interacts with 
Ski3 and Ski8, while the C-terminal region harbors the helicase activity (Halbach et al., 2013; Halbach et 
al., 2012). The catalytic core of Ski2 is formed by two RecA domains (RecA1 and RecA2), which fold into 
a globular structure that mediate substrate binding and ATP hydrolysis (Halbach et al., 2012). RecA2 has 
a conserved unwinding β-hairpin region, which is a typical feature of the DExH-box helicases (Halbach et 
al., 2012). The C-terminal region also contains an RNA-binding ‘insertion’ domain which forms an 
elongated structure protruding from the globular core (Halbach et al., 2012).  
 
 
Figure 10. Model for RNA channeling into the exosome-Ski complex. 
Substrate access into the ATPase core of the Ski complex is controlled by interactions between the 
N-terminal arm of Ski3 and the insertion domain of Ski2 which restrict the RNA binding and 
ATPase activities of the complex. Upon activation, RNA is threaded through the Ski2 helicase and 
into the core exosome (Exo9) channel where it reaches the catalytic exoribonuclease Rrp44 (Dis3). 
Ski7 is proposed to bridge the interaction between the two complexes. Adapted with permission 
from (Halbach et al., 2013). 
  
 
Although the catalytic activity of the complex is provided entirely through the helicase Ski2, structural and 
biochemical studies of the yeast Ski complex have revealed important functions for Ski3 and Ski8 (Halbach 
et al., 2013). In addition to the N-terminal region of Ski2, Ski3 and both copies of Ski8 make contacts with 
the globular helicase core as well, which stabilizes RNA binding to Ski2 and extends its RNA binding 
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surface (Halbach et al., 2013). More importantly, the N-terminal arm of Ski3 and the insertion domain of 
Ski2 form a lid-like structure, which controls the ATPase activity of the complex, possibly by regulating 
substrate access to the catalytic core (Figure 10) (Halbach et al., 2013). Consistent with this, the ATPase 
rate of Ski2 in isolation increases about 5-fold compared to the activity of the whole complex, while the 
ATP binding properties remain unchanged (Halbach et al., 2013). Thus, besides contributing to the overall 
structural integrity of the complex, Ski3 and Ski8 also modulate its RNA binding and ATPase properties 
(Halbach et al., 2013). Furthermore, Ski3 and Ski8 are important for linking the complex to the exosome, 
since Ski7 does not interact directly with Ski2 (Wang et al., 2005). Biochemical experiments suggest that 
the Ski complex can directly thread single-stranded RNA substrates into the exosome channel, combining 
the helicase and nuclease activities of the two machineries (Figure 10) (Halbach et al., 2013).  
Our understanding of Ski-exosome-mediated RNA degradation in the cytoplasm comes primarily from 
studies in S. cerevisiae. Details about the regulation and function of the Ski complex in higher eukaryotes 
are limited, although abnormalities of the exosome and its cytoplasmic co-factor have been implicated in 
human Mendelian diseases (Fabre and Badens, 2014). Current models for cytoplasmic decay suggest that 
the yeast Ski complex operates redundantly with Xrn1. However, loss of function of Xrn1 has been 
associated with specific phenotypes in Drosophila and C. elegans  (Grima et al., 2008; Newbury and 
Woollard, 2004; Zabolotskaya et al., 2008) and similarly, perturbation of the Ski complex causes the rare 
congenital disorder trico-hepato-enteric syndrome (Fabre et al., 2012), suggesting that at least in vivo, the 
two decay pathways are not completely redundant in multicellular organisms.  
1.6. Degradation of non-polyadenylated histone mRNAs 
Replication-dependent histone mRNAs are the only known examples of metazoan mature coding transcripts 
which are not polyadenylated. Consequently, regulation of histone mRNA turnover differs significantly 
from the canonical degradation pathways of poly(A)+ transcripts. Instead of a poly(A) tail, histone mRNAs 
contain a conserved 26-bp stem-loop (SL) structure within their 3′ UTRs, which is bound by a stem loop 
binding protein (SLBP) (Battle and Doudna, 2001; Williams and Marzluff, 1995). This feature regulates all 
aspects of histone mRNA metabolism, including processing, export, translation and RNA turnover 
(Marzluff and Koreski, 2017). The expression of histones is regulated at multiple levels and is tightly 
coupled to the cell cycle to ensure proper packaging of DNA into chromatin. While histone mRNAs 
accumulate at the onset of DNA synthesis, they are rapidly degraded at the end of S-phase (Harris et al., 
1991; Whitfield et al., 2000). This balance between the amount of histones and DNA synthesis is important, 
since artificially elevated levels of histones have been linked to chromosome loss and genome instability 
(Meeks-Wagner and Hartwell, 1986).  
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The conserved stem loop structure at the 3′end of histone transcripts acts as a cis regulatory sequence 
element that is both necessary and sufficient to induce histone mRNA decay at the end of S-phase (Pandey 
and Marzluff, 1987). The stem loop forms a tight ternary complex with the SLBP and the 3′-5′ exonuclease 
Eri1 (Tan et al., 2013), which has been shown to be important for degradation of the SL structure (Hoefig 
et al., 2013). Eri1 is conserved from fission yeast to humans and has an N-terminal SAP domain important 
for RNA binding, followed by a DEDD family nuclease domain (Dominski et al., 2003; Yang et al., 2006). 
The SLBP occupies the 5′ side of the SL, while Eri1 interacts with the loop, the 3′ arm and the 3′ flanking 
sequence of the SL (Tan et al., 2013). SLBP and Eri1 do not contact each other directly in the ternary 
complex and have been shown to recognize the overall structure of the stem loop, rather than specific 
sequences (Tan et al., 2013).  
The initial trigger of histone mRNA degradation is thought to be uridylation of their 3′ ends (Mullen and 
Marzluff, 2008). Several TUTases have been implicated in this process, including TUT1, TUT3, TUT4 and 
more recently TUT7 (Lackey et al., 2016; Mullen and Marzluff, 2008; Schmidt et al., 2011). Addition of 
oligo(U) tails has been suggested to promote degradation of the stem loop by Eri1, consistent with the 
observed accumulation of uridylated full length histone mRNAs in Eri1 knock down cells (Hoefig et al., 
2013). The removal of the stem loop by Eri1 would then allow the transcripts to be degraded in the 3′-5′ 
direction by the exosome (Slevin et al., 2014). Furthermore, U-tailed histone mRNAs are also bound by the 
Lsm1-7 complex, which has been suggested to repress translation and mediate decapping, allowing the 
transcript to be degraded in the 5′-3′ direction (Hoefig et al., 2013; Lyons et al., 2014; Mullen and Marzluff, 
2008). Consistent with this, knock down of Lsm1, Dcp2, or Xrn1 reduces the rates of histone mRNA 
degradation in HeLa cells (Mullen and Marzluff, 2008). Interestingly, in vitro experiments demonstrated 
that Eri1 can efficiently degrade single-stranded RNA and overhangs, but is strongly inhibited by double-
stranded RNA structures (Yang et al., 2006), which raises the question as to how Eri1 degrades through the 
stem loop in vivo. Several observations suggest that the RNA helicase Ufp1 might be involved in this 
process. In addition to its essential role in NMD, Upf1 is also important for histone mRNA degradation 
(Kaygun and Marzluff, 2005a; Mullen and Marzluff, 2008) and has been shown to interact with the SLBP, 
in an RNA-independent manner (Hoefig et al., 2013). Upf1 was also found to co-immunoprecipitate with 
Eri1 and proteins of the Lsm1-7 complex (Hoefig et al., 2013). It is therefore possible that melting of the 
stem-loop structure by Upf1 facilitates Eri1-mediated degradation. However, a precise molecular 
mechanism underlying the proposed role for Upf1 is still missing. Furthermore, since Eri1 has been shown 
to associate with the Lsm1-7 complex in an RNA-independent manner (Hoefig et al., 2013), it remains 
unclear if and how these factors cooperate during histone mRNA degradation. The initial events that trigger 
biochemical changes at the 3′ stem loop RNP, recruitment of TUTases and subsequent uridylation are also 
not very well understood. It has also been suggested that Eri1 may function to oppose the constant addition 
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of uridines by TUTases, thus facilitating efficient translation, since stretches of only five uridines have been 
shown to significantly interfere with histone translation (Hoefig and Heissmeyer, 2014). In this scenario, 
the continuous removal of histone U-tails by Eri1 would be counteracted at the end of S-phase, for instance 
by an unknown factor.  
Although histone mRNAs can be degraded both in the 5′-3′ and 3′-5′ direction (Mullen and Marzluff, 2008), 
the relative contribution of each pathway is unclear. When introduced into S-phase HeLa cells, luciferase 
reporter constructs containing histone 3′ stem loops and Dcp2-resistant caps were degraded much slower 
than reporters with normal caps (Su et al., 2013). Similarly, knock down of Dcp2 delayed degradation of 
reporters with normal cleavable caps, suggesting that 5′-3′ degradation preceded by decapping is the 
predominant pathway for histone degradation (Su et al., 2013). Other studies, however, report that knock 
down of exosome subunits has a larger stabilizing effect on histone mRNAs, arguing for a more significant 
contribution of the 3′-5′ decay pathway (Mullen and Marzluff, 2008; Slevin et al., 2014). Consistent with 
this, many histone mRNA decay intermediates with partially degraded stem loops or ORFs were found to 
be capped (Slevin et al., 2014). Interestingly, the same study also reports that knock down of the exosome-
independent 3′-5′ exonuclease Dis3L2 does not affect histone mRNA degradation, although Dis3L2 has 
been implicated in this pathway in another study (Łabno et al., 2016b).  
2. Cytoplasmic mRNA quality control pathways 
In addition to the general decay pathways initiated by deadenylation and decapping, cells have evolved 
specialized mechanisms that monitor the quality of cytoplasmic mRNAs and selectively eliminate aberrant 
transcripts. These mechanisms comprise three mRNA surveillance pathways: nonsense-mediated decay 
(NMD), no-stop decay (NSD) and no-go decay (NGD), which target transcripts with premature stop codons, 
no in-frame stop codons, and mRNAs containing stalled ribosomes, respectively (Shoemaker and Green, 
2012). A unifying feature of these pathways is their close link to the ribosome, whereby detection of an 
aberrant translation event is required to trigger mRNA degradation (Shoemaker and Green, 2012).   
2.1. Nonsense-mediated decay (NMD) 
Translation of mRNAs containing premature stop codons (PTCs) could produce truncated protein products 
with potentially toxic or dominant-negative properties. Therefore, timely detection and elimination of such 
transcripts through the NMD pathway is important for cellular homeostasis. PTC-containing mRNAs could 
arise from random nonsense or frameshift DNA mutations, or pre-mRNA processing events, which could 
produce spliced isoforms containing additional stop codons within the main ORF (Lykke-Andersen and 
Chapter 2  Introduction 
53 
 
Jensen, 2015). NMD can also result from the translation of alternative PTC-containing ORFs within the 
full-length mature transcript. For instance, it has been estimated that approximately 35-50% of upstream 
ORFs (uORFs) can trigger degradation of the host mRNA through NMD (Somers et al., 2013).  
The initial step in the NMD pathway requires detection of a prematurely terminating ribosome, which leads 
to the assembly of a multi-protein complex that promotes accelerated mRNA degradation (Lykke-Andersen 
and Jensen, 2015). Central to the formation of this complex is the helicase Upf1, which is a conserved 
primary NMD factor important for both substrate recognition and degradation (Kim and Maquat, 2019; 
Lykke-Andersen and Jensen, 2015). Key to the function of Upf1 in NMD are its RNA-dependent ATPase 
and 3′-5′ helicase activities (Franks et al., 2010; Kurosaki et al., 2014; Weng et al., 1996) as well as 
phosphorylation of its N- and C-terminus (Ohnishi et al., 2003; Yamashita et al., 2001). Upf1 has several 
distinct domains including a disordered N-terminal region, followed by a cysteine- and histidine-rich (CH) 
sequence and helicase domain, and a C-terminal region containing serines and glutamines (SQ) (Kim and 
Maquat, 2019). The CH region of Upf1 represses its ATPase activity by folding onto the helicase domain 
(Chamieh et al., 2008; Fiorini et al., 2013). Interaction between Upf1 and two other core NMD factors, 
Upf2 and Upf3, induces a large conformational change in the CH domain, which stimulates the ATPase 
and helicase activity of Upf1 (Chakrabarti et al., 2011; Chamieh et al., 2008). In addition, the kinase Smg1 
phosphorylates the [S/T]Q motifs in the N- and C-terminal regions of Upf1 which triggers recruitment of 
downstream NMD factors such as the endonuclease Smg6 or the Smg5–Smg7 complex (Chakrabarti et al., 
2014; Okada-Katsuhata et al., 2012). Smg6 catalyzes endonucleolytic cleavage close to the aberrantly-
terminating ribosome, producing RNA fragments that can be degraded by the major cytoplasmic 
exonucleases (Eberle et al., 2009; Huntzinger et al., 2008; Lykke-Andersen et al., 2014; Schmidt et al., 
2015). Furthermore, the Smg5–Smg7 dimer promotes substrate deadenylation and subsequent decapping 
through recruitment of the Ccr4-Not deadenylase complex (Loh et al., 2013; Unterholzner and Izaurralde, 
2004). NMD can also promote cap removal more directly, via recruitment of the general decapping complex 
or the decapping enhancer Pnrc2 (Cho et al., 2013; Cho et al., 2009; Lai et al., 2012). 
The precise mechanism of target recognition that allows the NMD machinery to distinguish premature stop 
codons from normal translation termination events is not fully understood. Upf1 has been shown to 
associate with the 3′ UTRs of actively translated mRNAs and was also observed within the coding sequence 
after translation inhibition (Hogg and Goff, 2010; Hurt et al., 2013; Kurosaki and Maquat, 2013; Zund et 
al., 2013). How Upf1 can specifically target aberrantly terminating ribosomes is unclear, but it is generally 
thought that its direct interaction with the canonical translation termination factors eRF1 and eRF3 is the 
initial event triggering an NMD (Lykke-Andersen and Jensen, 2015). Stop codons within the A-site of the 
ribosome are recognized by the eRF1-eRF3 complex and subsequent GTP hydrolysis by eRF3 promotes 
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the release of the nascent polypeptide chain and dissociation of the ribosomal subunits (Dever and Green, 
2012). Several studies have suggested that stop codons in close proximity to the poly(A) binding protein 
are less prone to NMD, possibly due to the ability of PABP to promote efficient termination and prevent 
the interaction between eRF3 and Upf1 (Eberle et al., 2008; Silva et al., 2008; Singh et al., 2008). According 
to this model short 3′UTRs would correlate with more efficient translation termination, which would 
counteract NMD. Conversely, longer 3′UTRs seem to predispose some mRNAs to NMD, possibly due to 
the increased distance between the stop codon and the poly(A) tail (Figure 11) (Buhler et al., 2006a; Eberle 
et al., 2008; Singh et al., 2008). An additional consequence of a longer 3′UTR might be higher non-specific 
Upf1 occupancy, which could increase the probability of forming an interaction between eRF3 and Upf1.  
 
Figure 11. Models for NMD substrate recognition 
In the EJC model, the presence of a premature stop codon (PTC) upstream of an exon-junction 
complex facilitates NMD. Upf1 interacts with eRF3 engaged with the terminating ribosome as 
well as Upf2 and Upf3 which are associated with the EJC. Upf2 and Upf3 cooperatively stimulate 
the ATPase and helicase activities of Upf1. 
In the 3′ UTR model, due to the extended distance between the PTC and PABP, translation 
termination is inefficient which facilitates interaction between eRF3 and Upf1. In this model, 
longer 3′ UTRs would predispose transcripts to NMD, also possibly due to increased non-specific 
binding of Upf1. Adapted with permission from (Shoemaker and Green, 2012). 
 
Multiple other studies support a role for the exon-junction complex (EJC) in NMD. EJCs are deposited 20-
24 nucleotides upstream of each exon-exon junction during pre-mRNA splicing in the nucleus (Le Hir et 
al., 2000). Since authentic stop codons are expected to be located in the last exon, the presence of an EJC 
downstream of a stop codon represents an aberrant event favoring NMD (Figure 11) (Lykke-Andersen and 
Jensen, 2015). However, not all NMD events are dependent on EJCs, as illustrated by the ability of some 
non-spliced transcripts to undergo NMD (LeBlanc and Beemon, 2004; Rajavel and Neufeld, 2001) and the 
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fact that PTCs can trigger degradation even after the pioneer round of translation, when EJCs would no 
longer be present along the ORF (Rufener and Muhlemann, 2013). 
2.2. Non-stop (NSD) and no-go decay (NGD) 
Non-stop decay (NSD) and no-go decay (NGD) are cytoplasmic quality control mechanisms that target 
messages lacking an in-frame stop codon or mRNAs containing stalled translation elongation complexes, 
respectively (Doma and Parker, 2006; Frischmeyer et al., 2002; van Hoof et al., 2002). Non-stop substrates 
could potentially arise from truncated or cleaved mRNAs, where the translating ribosome would stall upon 
reaching the end of the template (Shoemaker and Green, 2012). Another class of non-stop targets includes 
transcripts lacking a termination codon, but containing a poly(A) tail (Shoemaker and Green, 2012). Such 
mRNAs could be formed for example by alternative polyadenylation which has been shown to be 
widespread and can occur within the ORF (Frischmeyer et al., 2002; Ozsolak et al., 2010). Translation of 
the poly(A) sequence in this case would also result in translational arrest (Arthur et al., 2015; Garzia et al., 
2017; Guydosh and Green, 2017; Ikeuchi and Inada, 2016; Juszkiewicz and Hegde, 2017; Sundaramoorthy 
et al., 2017). The no-go pathway elicits degradation of transcripts containing ribosomes stalled at stable 
RNA structures, stretches of poly-basic codons or chemically damaged residues among others (Doma and 
Parker, 2006; Guydosh and Green, 2017; Ikeuchi et al., 2019; Simms et al., 2014; Winz et al., 2019). 
Although often referred to as two separate pathways, both NSD and NGD involve arrested translation 
elongation complexes that are resolved through the same mechanism (Figure 12). Another characteristic 
feature of the combined NSD/NGD pathway is an endonycleolytic cleavage upstream of the stalling 
sequence (D’Orazio et al., 2019; Doma and Parker, 2006; Guydosh and Green, 2017; Ikeuchi et al., 2019; 
Simms et al., 2017; Tsuboi et al., 2012). The resulting 5′ and 3′ RNA fragments can then be degraded by 
Xrn1 and the exosome. Subsequent rounds of surveillance-coupled endonycleolytic cleavage can also occur 
if an upstream translating ribosome stalls upon reaching the end of the cleaved 5′ RNA fragment. In support 
of this model, several studies report the presence of regularly-spaced cleavage events upstream of the 
stalling sequence (Guydosh and Green, 2017; Simms et al., 2017).  
Two conserved factors, Dom34 (Pelota in mammals) and Hbs1, recognize and resolve stalled ribosome 
complexes during NSD/NGD (Guydosh and Green, 2014; Pisareva et al., 2011; Shoemaker et al., 2010; 
Shoemaker and Green, 2011; Tsuboi et al., 2012). Dom34 and Hbs1 are structural and functional homologs 
of the canonical translation termination factors, eRF1 and eRF3, and similarly form a heterodimer that can 
interact with the A-site of the ribosome (Becker et al., 2011; Chen et al., 2010a; Graille et al., 2008; Lee et 
al., 2007). Hbs1 is a GTPase with substantial sequence similarity to eRF3, and Dom34 is structurally related 
to eRF1 with two important distinguishing features. Unlike eRF1, Dom34 does not contain the conserved 
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GGQ motif that is necessary to catalyze peptide hydrolysis, and its N-terminal domain lacks the NIKS 
sequence motif involved in stop codon recognition (Chen et al., 2010a; Graille et al., 2008; Lee et al., 2007). 
As a result, the presence of a specific A-site codon is not a prerequisite for Dom34:Hbs1 binding, allowing 
the complex to function more broadly as a general rescue factor for a variety of translational stalls.  
The Dom34:Hbs1:GTP complex can supposedly sense a vacant A-site on the ribosome during a prolonged 
translational arrest (Figure 12). Upon binding to Hbs1, Dom34 adopts a conformation more closely 
resembling a tRNA, which supposedly facilitates interaction with the A-site (Chen et al., 2010a). After GTP 
hydrolysis and Hbs1 release, the concerted action of Dom34/PELOTA and the recycling factor 
Rli1/ABCE1 dissociates the ribosomal subunits (Pisareva et al., 2011; Shoemaker and Green, 2011). Unlike 
eRF1 which also promotes peptide-tRNA hydrolysis, Dom34 releases a peptide-tRNA conjugate, which 
remains associated with the 60S subunit (Pisareva et al., 2011; Shoemaker et al., 2010; Shoemaker and 
Green, 2011). This unusual nascent polypeptide-tRNA-60S complex is recognized and processed by the 
ribosome quality control (RQC) pathway, which leads to nascent chain proteasomal degradation after 
ubiquitination by the E3 ubiquitin ligase Listerin (Joazeiro, 2019). Thus, mRNA surveillance is coupled to 
nascent chain quality control to eliminate all defective components of an aberrant translation event.  
 
Although Dom34:Hbs1 does not exhibit preference for a specific A-site codon, the recycling activity of the 
yeast and mammalian complex has been shown to depend on the length of the mRNA downstream of the 
P-site (Pisareva et al., 2011; Shoemaker and Green, 2011). While the S. cerevisiae Dom34:Hbs1 complex 
seems more permissive to various 3′ mRNA lengths (Shoemaker and Green, 2011), the mammalian 
Pelota:Hbs1 has been shown to efficiently recycle stalled ribosomes if they contained only up to 9 mRNA 
nucleotides downstream of the P-site, while the recycling activity was completely inhibited by the presence 
of more than 12 nucleotides (Pisareva et al., 2011). This suggests that the two rescue factors would primarily 
function on stalled ribosome complexes containing very short or no mRNA overhangs. Consistent with this, 
Dom34/Pelota:Hbs1 has been shown to split empty 80S ribosomes (Pisareva et al., 2011; Shoemaker and 
Green, 2011; van den Elzen et al., 2014). Furthermore, studies in yeast have demonstrated that Dom34 
primarily targets ribosomes that stall either on the edge of truncated mRNAs or close to the end of the 3′ 
UTR (Guydosh and Green, 2014). In contrast, Dom34 did not seem to act on various classes of stall-
inducing sequences, such as poly-prolines that were located within the ORF (Guydosh and Green, 2014). 
Structural data suggest that this preference for arrested ribosomes with short 3′ mRNA overhangs might be 
due to Hbs1 whose N-terminus contacts the mRNA entry site and may survey the 3′ mRNA length (Becker 
et al., 2011). Consistent with this, ribosome splitting by Dom34 and the recycling factor Rli1 in yeast is not 
dependent on the 3′ mRNA length in the absence of Hbs1 (Shoemaker and Green, 2011). This preference 
for short 3′ mRNA overhangs raises the question of how/if Dom34:Hbs1 is able to act on the primary 
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stalling event, since an endonucleolytic cleavage that can generate a short 3′ mRNA end has been shown to 
occur upstream of the stall-inducing sequence. Regardless of the mechanism, Dom34/Pelota and Hbs1 can 
become important for ribosome rescue after secondary cleavage events upstream of the initial stall site 
(Guydosh and Green, 2017).  
 
Figure 12. Triggers of NGD and NSD 
Although NGD and NSD are commonly referred to as separate processes, both events converge 
on stalled translation elongation complexes and involve an endonucleolytic cleavage at the vicinity 
of the stalled ribosome. An empty ribosome A-site during translational arrest is recognized by the 
rescue factors Dom34 (Pelota in mammals) and Hbs1, which facilitate dissociation of the ribosome 
subunits. Potential triggers of ribosome stalling include secondary mRNA structures, translation 
of truncated messages or sequences that encode inhibitory peptides. Ribosomes translating 
mRNAs lacking an in-frame stop codon also arrest at the poly(A) tail and become substrates for 
Dom34:Hbs1. Adapted with permission from (Shoemaker and Green, 2012). 
 
 
Recognition of arrested elongation complexes by Dom34:Hbs1 does not seem to be a prerequisite for 
mRNA cleavage, since ribosome stalls seem to trigger endonucleolysis even in the absence of Dom34:Hbs1 
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(Chen et al., 2010a; Guydosh and Green, 2017; Kuroha et al., 2010). As the identity of the endonuclease 
has remained obscure for a long time, a recent study in yeast provides strong evidence that Cue2 is the 
conserved enzyme that cleaves mRNAs during NGD/NSD (D’Orazio et al., 2019). Distinguishing features 
of Cue2 include two N-terminal CUE ubiquitin-binding domains and a C-terminal SMR (small MutS-
related) hydrolase domain (D’Orazio et al., 2019). Although DNA nicking has been described as the 
canonical function of MutS-related SMR enzymes (Fukui and Kuramitsu, 2011), some proteins with SMR 
domains have been shown to function as endoribonucleases (Bhandari et al., 2011; Zhou et al., 2017), 
consistent with the SMR structural similarity to the bacterial RNase E (Fukui and Kuramitsu, 2011). NGD 
reporter cleavage was completely abolished by removal of the C-terminal SMR domain of Cue2 or by 
mutations in its catalytic residues (D’Orazio et al., 2019). Further analysis revealed that Cue2 cleaves 
mRNAs at the A-site of the trailing ribosome within a collided ribosome pair, in line with structural 
homology modelling, which places the catalytic domain of Cue2 at the A-site of the 40S subunit (D’Orazio 
et al., 2019). It was subsequently shown that ribosomes accumulating at cleaved sites were Dom34 
substrates, further supporting a role for Cue2 in the NGD pathway (D’Orazio et al., 2019).  
Putative Cue2 homologs exist in multiple organisms (D’Orazio et al., 2019), and another study in C. elegans 
identified the SMR-domain containing protein Nonu-1 as the endonuclease involved in NSD (Glover et al., 
2019). Interestingly, the mammalian Cue2 homolog, N4BP2 contains a PNK domain (D’Orazio et al., 
2019). Since an endonucleolytic cleavage event can generate a 3′ RNA fragment carrying a 5′ hydroxyl 
group, the kinase activity of N4BP2 could potentially phosphorylate the 3′ cleavage product to facilitate 
subsequent Xrn1-mediated degradation (D’Orazio et al., 2019). 
3. Ribosome collisions as a platform for mRNA and protein quality control  
As stalled translation elongation complexes are the underlying trigger of mRNA surveillance, an important 
question is how the cells initially recognize terminally arrested ribosomes to elicit degradation of the mRNA 
and the arrested nascent polypeptide chain. Genetic studies in S. cerevisiae identified the 40S ribosomal 
protein Asc1 (Rack1 in mammals) and the ubiquitin ligase Hel2 (Znf598 in mammals) as two important 
factors involved in the early events of ribosome-associated quality control pathways (Brandman et al., 2012; 
Kuroha et al., 2010). Deletion of Asc1 or Hel2 in yeast results in increased read-through of stall-inducing 
poly-basic sequences and production of full length reporter proteins, suggesting that these factors might be 
necessary for initial recognition of ribosome stalls (Brandman et al., 2012; Kuroha et al., 2010). The WD-
repeat β-propeller protein Asc1/Rack1 is an integral component of the 40S ribosomal subunit located near 
the mRNA exit channel (Gerbasi et al., 2004; Nielsen et al., 2017). Besides its ribosome-associated 
functions, Asc1/Rack1 is also involved in different cell signaling pathways (Nielsen et al., 2017). 
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Hel2/Znf598 is a RING-type E3 ubiquitin ligase that has been shown to directly associate with translating 
ribosomes (Garzia et al., 2017; Singh et al., 2012; Winz et al., 2019). 
Subsequent studies have demonstrated that regulatory ubiquitination of 40S ribosomal subunits mediated 
by Hel2/Znf598 and Asc1/Rack1 is the initial event that marks arrested ribosomes for surveillance (Garzia 
et al., 2017; Juszkiewicz and Hegde, 2017; Matsuo et al., 2017; Sitron et al., 2017; Sundaramoorthy et al., 
2017; Winz et al., 2019). Translational stalling on a poly-arginine reporter in yeast has been shown to 
require Hel2-mediated ubiquitination of the 40S subunit uS10 (Rps20) at Lysine 6 and 8 (Matsuo et al., 
2017). Subsequent ribosome splitting and degradation of the arrested nascent chain were also dependent on 
this modification (Matsuo et al., 2017). Conversely, deletion of Hel2 or disruption of its interaction with 
the 40S subunit, allowed translational read-through of the stall-inducing sequence, effectively abolishing 
induction of the ribosome quality control pathway (Matsuo et al., 2017; Sitron et al., 2017; Winz et al., 
2019).  
The mammalian ortholog of Hel2, Znf598, has also been shown to mediate site-specific ubiquitination of 
40S subunits. More specifically, several studies demonstrated that ribosome stalling on poly-lysine 
reporters encoded by consecutive AAA-codons, was dependent on eS10 (Rps10) and uS10 (Rps20) 
ubiquitination by Znf598 (Garzia et al., 2017; Juszkiewicz and Hegde, 2017; Sundaramoorthy et al., 2017). 
Similar to the Hel2∆ phenotype, loss of Znf598 or mutations that render its 40S targets resistant to 
ubiquitination, promote increased read-through of the poly-lysine reporters and suppress induction of the 
ribosome quality control pathway (Garzia et al., 2017; Juszkiewicz and Hegde, 2017; Sundaramoorthy et 
al., 2017). Although Rack1 does not possess an enzymatic activity, it has been implicated in regulating 
ubiquitination of uS3 (Rps3), uS5 (Rps2) and uS10 (Rps20) (Sundaramoorthy et al., 2017). However, lack 
of Rack1 resulted in a less pronounced read-through phenotype compared to knockdown of Znf598, and 
the combined loss of both proteins did not have an additive effect, suggesting that Rack1 and Znf598 might 
have partially overlapping functions within the same pathway (Sundaramoorthy et al., 2017). A recent study 
suggests that yeast Asc1 helps recruit and retain Hel2 on the ribosome, providing a possible explanation for 
the observed Asc1/Rack1 role in ribosome stalling and ubiquitination (Winz et al., 2019).  
Although 40S ubiquitination by Hel2/Znf598 and Asc1/Rack1 has been primarily studied in the context of 
ribosome stalling, subunit dissociation and degradation of the nascent polypeptide chain, these two proteins 
also facilitate endonucleolytic cleavage and degradation of NSD and NGD substrates (Ikeuchi and Inada, 
2016; Ikeuchi et al., 2019; Winz et al., 2019). This suggests that Hel2/Znf598 and Asc1/Rack1 are early-
acting factors that function prior to ribosome splitting and RNA decay. Given that the recently discovered 
NGD endonuclease Cue2 in yeast has ubiquitin binding domains, it is possible that Hel2-ubiquitinated sites 
might help recruit Cue2 to arrested ribosomes to initiate RNA decay (D’Orazio et al., 2019).  
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Since Hel2/Znf598 and Asc1/Rack1 have been shown to specifically target stalled translation complexes, 
it is unclear how they distinguish between temporary or programmed translational pauses versus pathologic 
terminally arrested ribosomes. Some forms of permanently stalled ribosomes such as those arriving at the 
end of a truncated template would contain an empty A-site, making them an optimal substrate for the 
ribosome rescue factors Dom34/Pelota-Hbs1 (Guydosh and Green, 2014). However, subjecting other forms 
of more temporary pauses to surveillance might be inappropriate, as they could represent normal events 
that facilitate proper folding of the nascent chain, recruitment of chaperones or localization of the mRNP 
(Collart and Weiss, 2019). A recent study suggests that individually paused 80S ribosomes can evade 
surveillance since they are not optimal targets for 40S ubiquitination (Juszkiewicz et al., 2018). Instead, 
Znf598 has been shown to specifically recognize and ubiquitinate a di-ribosome or disome structure, which 
arises when an elongating trailing ribosome collides with a slower or stalled leading ribosome (Juszkiewicz 
et al., 2018). This disome structure is defined by extensive 40S-40S interactions between the stalled and 
collided ribosomes which positions the mRNA channels of the two ribosomes in close proximity, forming 
a nuclease-resistant unit (Figure 13) (Juszkiewicz et al., 2018). Structural data indicate that the inter-
ribosomal 40S-40S interactions form two distinct interfaces (Juszkiewicz et al., 2018). Interface 1 includes 
ribosomal subunits eS1 (Rps3A), uS11 (Rps14), eS26 (Rps26), and eS28 (Rps28), which surround the 
mRNA exit channel of the stalled ribosome (Figure 13) (Juszkiewicz et al., 2018). Interestingly, interface 
2 juxtaposes Rack1 of the leading ribosome and uS3 (Rps3), uS10 (Rps20), and eS10 (Rps10) of the trailing 
ribosome, which were previously shown to be targeted for ubiquitination (Figure 13) (Juszkiewicz et al., 
2018). This is consistent with a model where Znf598 specifically recognizes interface 2, which would 
explain why it preferentially associates with and ubiquitinates eS10 (Rps10) within disomes as well as 
higher order collided ribosome structures in vitro (Juszkiewicz et al., 2018). Similarly, inducing global 
ribosome collisions in vivo by subjecting HEK293 cells to sub-inhibitory concentrations of various 
translation elongation inhibitors coincided with Znf598 localization to polysomes and elevated levels of 
ubiquitinated eS10 (Rps10) (Juszkiewicz et al., 2018).  
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Figure 13. Structure of the collided di-ribosome 
A The collided di-ribosome or disome structure is primarily formed by interactions between the 
40S subunits of the stalled and collided ribosomes. The ubiquitination sites of uS10 (Rps20) and 
eS10 (Rps10) are indicated with cyan and red dots, respectively. B and C Closer view of the two 
interfaces formed by the 40S-40S interactions. Interface 1 shown in B is formed by eS1 (Rps1), 
uS11 (Rps14), eS26 (Rps26) and eS28 (Rps28) of the stalled ribosome and uS4 (Rps9) and h16 of 
the 18S rRNA of the collided ribosome. Interface 2 shown in C is formed by Rack1 of the stalled 
ribosome and uS3 (Rps3), uS10 (Rps20) and eS10 (Rps10) of the collided ribosome. Adapted with 
permission from (Juszkiewicz et al., 2018). 
 
The collided di-ribosome conformation has also been shown to facilitate Hel2-mediated quality control 
pathways in yeast (Ikeuchi et al., 2019). Consistent with studies in mammalian cells, cryo-EM analysis of 
disomes isolated from S. cerevisiae, confirmed that this structure is formed primarily by interactions 
between the 40S subunits of the stalled and collided ribosomes, which bring Asc1 and all Hel2 substrates 
in close proximity (Ikeuchi et al., 2019). Furthermore, similar to Znf598, Hel2 was also shown to 
preferentially ubiquitinate disomes over monosomes (Ikeuchi et al., 2019). This was important not only for 
degradation of the nascent polypeptide chain, but also for mRNA cleavage within the disome unit during 
NGD, suggesting that the two events are coupled by Hel2-mediated disome ubiquitination (Ikeuchi et al., 
2019). Another recent study using NGD reporters in yeast also suggests that ribosome collisions are 
essential for endonucleolytic cleavage and mRNA degradation during NGD (Simms et al., 2017). In this 
study, ribosome stalling stem-loop structures or poly-basic repeat sequences initiated robust NGD only 
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when they were located further than 105nt from the start codon (Simms et al., 2017). Polysome analysis 
subsequently showed that NGD-incompetent reporters harboring stalling sequences near the AUG codon 
were translated by only a few ribosomes, which reduces the likelihood of collisions and suggests that higher 
ribosome occupancy on the translated mRNA promotes endonucleolytic cleavage and robust NGD (Simms 
et al., 2017). Furthermore, consistent with previous observations, inducing global ribosome collisions in 
vivo triggered Hel2-mediated ubiquitination of the 40S subunit (Simms et al., 2017). Collectively, findings 
from studies in yeast and mammalian cells suggest that aberrant translation events are often defined by 
collided ribosomes which serve as platforms for recruitment of downstream quality control factors. 
4. Co-translational mRNA degradation 
RNA decay is coupled to other stages and events of the transcript lifecycle and a growing body of evidence 
points to a significant crosstalk between translation and mRNA degradation. For instance, efficient 
translation initiation and elongation have been generally associated with increased transcript stability. More 
recently, the differential decoding efficiency of the 61 codons, referred to as ‘codon optimality’ has also 
been shown to affect mRNA half-lives (Presnyak et al., 2015; Radhakrishnan et al., 2016). A transcriptome-
wide study of mRNA decay rates in S. cerevisiae found a striking correlation between non-optimal codons 
and shorter mRNA half-lives (Presnyak et al., 2015). The same study also showed that altering codon 
optimality was sufficient to change transcript stability (Presnyak et al., 2015). Since decoding non-optimal 
codons slows down ribosome translocation, elongation rates dictated by codon usage emerge as a key 
determinant of transcript stability (Presnyak et al., 2015).   
The extensive crosstalk between RNA decay and translation is best illustrated by the cytoplasmic mRNA 
surveillance pathways, which dispose of faulty transcripts co-translationally. Since substrate recognition 
depends on detection of aberrant translation termination or elongation events, inhibition of translation 
results in stabilization of surveillance targets (Shoemaker and Green, 2012). However, accumulating 
evidence suggests that co-translational degradation might be more widespread and not simply limited to the 
mRNA quality control pathways.  Consistent with this model early studies in yeast and human cells found 
that the general decay factors Xrn1 and Dcp2 co-sediment with polysomal fractions (Mangus and Jacobson, 
1999; Wang et al., 2002). Components of the decapping and deadenylation machinery were also shown to 
co-purify with ribosome complexes in Drosophila cells (Antic et al., 2015). Furthermore, decapped and 
deadenylated mRNA decay intermediates were associated with polysomes in yeast and Drosophila cells, 
suggesting that dissociation of ribosomes from the mRNA is not a prerequisite for RNA degradation (Antic 
et al., 2015; Hu et al., 2009).  
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Further evidence supporting pervasive co-translational decay during bulk mRNA degradation comes from 
systematic profiling of yeast polyadenylated mRNAs bearing a 5′ monophosphate (5P-seq), which mainly 
represent decapped degradation intermediates generated by the enzymatic activity of Xrn1 (Pelechano et 
al., 2015). Interestingly, the distribution of these 5′P molecules within the coding mRNA sequence was not 
random but instead displayed a pronounced, frame-specific 3-nucleotide periodicity reminiscent of the 
codon-wise translocation of the ribosome (Pelechano et al., 2015). This pattern was dependent on Xrn1 and 
was shown to be weaker around the beginning of the ORF, which is consistent with a model where after 
decapping, Xrn1 chases, catches up and closely follows the last translating ribosome (Pelechano et al., 
2015).  
Another recent study in human cells surveyed global mRNA degradation by sequencing the 3′ and 5′ ends 
of capped and polyadenylated decay intermediates, respectively (Ibrahim et al., 2018). Similar to previous 
findings in yeast, the authors observed a striking 3-nucleotide periodicity for both ends of decay 
intermediates mapping to coding sequences (Ibrahim et al., 2018). However, this ribosome-phased pattern 
was not affected by the knockdown of Xrn1 or certain exosome subunits (Ibrahim et al., 2018). Instead, by 
further examining the distribution of degradation fragments relative to ribosome protected footprints, the 
authors concluded that the 3-nucleotide periodicity must have been produced by repeated ribosome-
associated endonucleolytic cleavage events (Ibrahim et al., 2018). Although the general cytoplasmic 
exonucleases did not seem directly involved in generating the 3-nucleotide pattern, Xrn1 and the exosome 
were suggested to trim and clear the ribosome-associated fragments downstream of the endonuclease 
(Ibrahim et al., 2018). Approximately two-thirds of the 50% most highly expressed mRNAs were estimated 
to be degraded through such co-translational process, suggesting that this is not a quality control pathway 
for aberrant transcripts, but a more general mechanism that targets canonical mRNAs engaged by ribosomes 
(Ibrahim et al., 2018). 
Consistent with the co-translational mRNA decay model, S. cerevisiae Xrn1 was recently reported to 
directly and specifically associate with translating ribosomes (Tesina et al., 2019). The cryo-EM structure 
of the Xrn1-ribosome complex shows that the exonuclease interacts predominantly with the small 40S 
subunit, making direct contacts with the mRNA and ribosomal proteins surrounding the mRNA exit channel 
(Tesina et al., 2019). These interactions suggest that mRNA exiting the ribosome decoding center is 
funneled directly into the catalytic core of Xrn1 (Tesina et al., 2019). This tight coupling between translation 
and decay is proposed to further contribute to the processivity of the exonuclease, by facilitating substrate 
channeling and stimulating Xrn1 conformational changes throughout the catalytic cycle (Tesina et al., 
2019). However, S. cerevisiae strains carrying an endogenous mutation that completely abolished the 
association of Xrn1 with polysomes were indistinguishable from WT strains, unlike xrn1∆ mutants which 
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exhibited a significant growth phenotype (Tesina et al., 2019). Perturbing the interaction between the 
exonuclease and the ribosome also had little effect on the degradation of a known Xrn1 substrate, although 
it is not clear how this mutation affects mRNA decay on a global scale (Tesina et al., 2019).  
The 3′-5′ RNA degradation pathway was also shown to be physically linked to translation in a recent cryo-
EM structure capturing the S. cerevisiae Ski complex associated with a translating 80S ribosome (Schmidt 
et al., 2016). The Ski complex was bound near the 40S mRNA entry tunnel presenting a short 3′ mRNA 
overhang that was threaded directly into the Ski2 helicase core (Schmidt et al., 2016). The lid-like structure 
formed by Ski3 and the insertion domain of Ski2, which autoinhibits the ATPase properties of the helicase, 
adopts a more open conformation upon binding to the 40S subunit, suggesting that direct coupling to the 
ribosome might stimulate the enzymatic activity of the Ski complex (Schmidt et al., 2016). The interaction 
between the two complexes was increased when the 80S ribosome contained 3′ mRNA overhangs between 
10 and 20 nucleotides and was weakened with shorter or longer mRNA stretches (Schmidt et al., 2016), 
suggesting that the Ski complex might preferentially target ribosomes presenting certain RNA lengths 
downstream of the A-site. One potential source of such substrates could be co-translational endonucleolytic 
cleavage events (Schmidt et al., 2016). Targeted ribosomal profiling revealed that the Ski-ribosome 
complex was enriched over non-optimal codons suggested to promote decay through translational stalling 
and it is conceivable that an endonuclease acting on such transcripts could create an ‘access point’ for the 
Ski complex (Schmidt et al., 2016). Interestingly, contrary to previous models, the Ski complex was found 
to associate with 80S ribosomes stalled on a non-stop reporter even in the absence of Ski7 and Dom34, 
suggesting that the helicase complex functions upstream of these factors and likely recruits a preassembled 
Ski7-exosome complex to its substrates to initiate degradation (Schmidt et al., 2016). It is currently unclear 
whether the direct interaction between the ribosome and the main cytoplasmic decay factors is conserved 
in higher eukaryotes and what fraction of transcripts would be targeted for degradation co-translationally. 
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RESULTS   
1. Mammalian RNA decay pathways are highly specialized and widely linked to 
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1.1. Summary  
The prevailing model for cytoplasmic mRNA degradation, largely based on studies in S. cerevisiae, 
suggests that the 5′-3′ exonuclease Xrn1 is the predominant route for mRNA degradation, whereas the 3′-
5′ Ski-exosome pathway is thought to function redundantly with Xrn1, and contribute more significantly to 
RNA surveillance (Parker, 2012). However, the precise endogenous targets of the two pathways are poorly 
defined in higher eukaryotes, including mammals. Thus, it is still an open question whether on a global 
scale, certain mRNAs are preferentially degraded via one pathway, and if so, what factors might 
underlie such specificity. Furthermore, cytoplasmic RNA decay is influenced by translation and studies 
over the past decade suggest that mRNAs are widely targeted for degradation while still engaged with 
actively translating ribosomes (Hu et al., 2009; Pelechano et al., 2015). Consistent with this, recent cryo-
EM structures of the yeast Ski complex and Xrn1 bound to the ribosome have now established a direct 
physical link between the translation and RNA degradation machineries (Schmidt et al., 2016; Tesina et al., 
2019). However, it is currently unknown whether the physical association between the two processes 
is conserved in higher eukaryotes. It also remains unclear to what extent each decay pathway 
interacts with translation, and what factors might influence this. Here, we set out to address these 
questions by examining the two major cytoplasmic decay pathways and their links to translation in 
mouse embryonic stem cells.  
We first performed crosslinking and analysis of cDNAs (CRAC) to identify the transcriptome-wide targets 
of Xrn1 and the Ski complex helicase Skiv2l in unperturbed cells (Figure 14A and 14B). Although some 
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transcripts were similarly occupied by Xrn1 and Skiv2l, for others binding of one factor seemed to 
dominate, suggesting that under normal conditions certain transcripts might be primarily degraded via one 
route (Figure 14C). Further focusing on 3′-5′ decay, we found that substrates highly bound by Skiv2l, were 
also upregulated upon Skiv2l knock out, indicating that the 3′-5′ degradation pathway is important for 
regulating the steady-state levels of this subset of mRNAs. Our CRAC data further revealed that both Xrn1 
and Skiv2l crosslink to the small subunit of the ribosome, in a manner closely resembling the recent yeast 
cryo-EM structures, confirming that the physical coupling between translation and RNA degradation is 
conserved in mammals (Figure 14D). Interestingly, we observed major differences in the binding patterns 
of Xrn1 and Skiv2l along mRNAs. While Xrn1 was enriched in the 3′ UTRs, Skiv2l was exclusively bound 
to ribosome-occupied regions and was largely absent from 3′ UTRs (Figure 14E). These findings are 
surprising given that the activity of the yeast Ski complex is required for efficient degradation of 3′UTRs 
(Anderson and Parker, 1998) and previous studies have shown that Ski2 is bound to 3′ UTRs in yeast  
(Sohrabi-Jahromi et al., 2019; Tuck and Tollervey, 2013). Our data suggest that the mammalian 3′-5′ Ski-
exosome pathway does not normally degrade full-length transcripts, and its activity is instead tightly 
coupled to co-translational RNA decay. Consistent with this, we show that Skiv2l is enriched at sites of 
abnormal translation, known to trigger mRNA surveillance, such as NMD substrates, upstream ORFs 
(uORFs) and other sequences encoding amino acid stretches that can cause ribosome stalling.  
Given the preference of Skiv2l for certain substrates as revealed by our CRAC data, in combination with 
the striking correlation between Skiv2l mRNA binding and ribosome occupancy, we next wondered 
whether the Ski complex associates with specific adapter proteins that regulate its recruitment to ribosome-
bound sequences. Using IP-MS experiments, we identified two factors, Focadhesin and the RNA binding 
protein Aven, as interaction partners of the mammalian Ski complex (Figure 15A and 15B). Interestingly, 
Aven and Skiv2l shared similar ribosome and mRNA binding sites, suggesting that they might function in 
the same pathway (Figure 15C and 15D). Loss of Aven led to marked accumulation of Skiv2l on most of 
its substrates (Figure 15E) and a substantial increase in Skiv2l CRAC reads containing non-templated 3′-
end U-tails, indicating an increase in 3′-5′ decay.  
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Figure 14. mRNA binding profiles of Xrn1 and Skiv2l in mESC. 
A Major decay pathways in the nucleus and cytoplasm. B Schematic of the CRAC method. C CRAC coverage of 
Mtr4, Xrn1 and Skiv2l along individual mRNAs. D Xrn1 and Skiv2l CRAC signal on the ribosomal 40S subunit, 
based on the mouse 18S rRNA sequence and human structure. Significantly bound regions are colored by χ2 p-value. 
E Cumulative distribution of Skiv2l and Xrn1 CRAC reads around the start and stop codons of mRNAs. Adapted 
from (Tuck et al., 2020). 
 
Since the distribution of Skiv2l across transcripts is tightly coupled to ribosomes, we hypothesized that the 
changes in Skiv2l binding in the absence of Aven could reflect altered ribosome occupancy. Indeed, global 
profiling of disomes, or collided di-ribosome pairs that arise at translation stall sites, revealed that in the 
absence of Aven, disome occupancy was significantly increased in transcripts gaining Skiv2l binding 
(Figure 16). These data suggest that Aven could act to facilitate translation and prevent sustained ribosome 
stalls that would otherwise trigger mRNA surveillance and Skiv2l recruitment. This is in line with a 
previously reported role for Aven in promoting efficient translation of highly structured mRNAs 
(Thandapani et al., 2015), and is further supported by our own data showing that Aven binding is enriched 
at sequences with high structural propensity.  
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Figure 15. The mammalian Ski complex interacts with Focadhesin (Focad) and Aven.  
A Mass spectrometry analysis (MS) of tandem FLAG-streptavidin purification of endogenously tagged 3xFLAG-
Avi-Skiv2l. B MS of single strep streptavidin purification of endogenously tagged 3xFLAG-Avi-AVE. C Aven 
CRAC signal on the ribosome 40S subunit and D around the start and stop codons of mRNAs. E Example of an 
mRNA that gains Skiv2l binding (measured by CRAC) in the absence of Aven. Adapted from (Tuck et al., 2020). 
 
Collectively, our findings are consistent with a model where Aven and Skv2l act in concert to limit aberrant 
translation, whereby Aven counteracts prolonged ribosome stalls and Skiv2l helps eliminate the mRNA if 
the stalls accumulate and cannot be resolved. Intriguingly, the Aven-Skiv2l pathway acts on a wide range 
of substrates, including mRNAs, uORFs and most surprisingly on small-ORF-containing RNAs derived 
from transcription of non-coding regions. Since Aven is conserved from Drosophila to humans, our work 
reveals a higher-eukaryote-specific mechanism that coordinates cytoplasmic 3′-5′ RNA decay. 
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Figure 16. Skiv2l binding and disome occupancy along mRNAs increase in the absence of Aven.  
A Schematic highlighting the differences between conventional monosome foot-printing and disome profiling which 
maps sites of collided ribosome pairs. B Example of an mRNA that gains substantial Skiv2l binding (measured by 
CRAC) and disome density upon Aven knock out. Adapted from (Tuck et al., 2020). 
 
1.2. Contributions 
This was a shared project between me and Alex Tuck, a postdoctoral researcher in the Bühler Lab. Both 
Alex and I created cell lines and performed CRAC and RNA-seq experiments. Genome-wide data analyses 
were done by Alex Tuck. I performed IP-MS experiments discovering the interaction between the 
mammalian Ski complex and Aven/Focadhesin. The IP-MS data were analyzed by Daniel Hess and 
Vytautas Iesmantavicius from the Protein Analysis Facility at the FMI. In addition, we had an excellent 
collaboration with the Gatfield Lab from the University of Lausanne who performed all ribosome profiling 
experiments. More specifically, monosome and disome profiling was done by Luz Liechti, and related 
analyses were performed by Alaaddin Arpat and Violeta Castelo-Szekely from the Gatfield Lab. 
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DISCUSSION 
1. Cytoplasmic RNA degradation is widely linked to translation  
It is well established that cytoplasmic RNA decay can be influenced by translation. Although mRNA 
surveillance, which depends on ongoing translation, is one of the best examples demonstrating the close 
links between the ribosome and the decay machinery, accumulating evidence suggests that co-translational 
decay may be more widespread (Antic et al., 2015; Hu et al., 2009; Ibrahim et al., 2018; Pelechano et al., 
2015). Recent cryo-EM structures of yeast Xrn1 and the Ski complex bound to the translating ribosome 
have further established a direct link between the two processes (Schmidt et al., 2016; Tesina et al., 2019). 
This raises the question of whether the physical interaction between translation and mRNA decay is 
conserved in higher eukaryotes and to what extent RNA degradation occurs co-translationally. Although 
cryo-EM data was collected on endogenous ribosome-Ski complexes isolated from wild-type S. cerevisiae 
(Schmidt et al., 2016), the structure of yeast Xrn1 bound to the ribosome was specifically obtained from 
ski2∆ cells, by trapping the complex on a reporter construct containing ribosome stalling sequences (Tesina 
et al., 2019). Thus, while Xrn1 was shown to co-sediment with polysomes (Tesina et al., 2019), it was 
unclear if direct interaction between the exonuclease and the ribosome would also occur on canonical 
mRNAs and under normal conditions. Furthermore, another study in Drosophila S2 cells suggests that the 
association between Xrn1 and ribosomes is not direct, as it was sensitive to treatment with micrococcal 
nuclease (Antic et al., 2015). However, ribosomal RNA hits from our Xrn1 and Skiv2l CRAC data clearly 
show that the two decay factors crosslink to the 40S subunit, indicating that they can directly interact with 
the ribosome. Moreover, the crosslinking sites on the small ribosomal subunit that we identified for Xrn1 
and Skiv2l are in good agreement the cryo-EM structures from S. cerevisiae. Thus, we demonstrate that the 
direct association between the two decay factors and the ribosome is conserved in mammalian cells and 
more importantly, that it can occur under wild-type conditions. 
When examining the global mRNA binding patterns of Xrn1 and Skiv2l, we noticed prominent differences 
in the distribution of these two factors along transcripts. Consistent with previous transcriptome-wide 
studies in yeast (Sohrabi-Jahromi et al., 2019; Tuck and Tollervey, 2013), our data indicate that Xrn1 is 
enriched in the 3′ UTR. Since the interaction between the ribosome and Xrn1 has been suggested to 
contribute to the processivity of the exonuclease (Tesina et al., 2019), it is possible that increased binding 
to the 3′ UTR reflects slower progression though this ribosome-free region, where the presence of secondary 
structures or bound proteins may negatively affect the processivity of Xrn1. Interestingly, Skiv2l binding 
along mRNAs displayed the opposite pattern. While the helicase was enriched at 5′ UTRs and along the 
coding sequence, it was almost completely excluded from the 3′ UTRs, closely mirroring the ribosome 
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distribution along a transcript. This binding pattern was rather surprising, as previous studies have shown 
that the Ski complex is required for efficient degradation of 3′ UTRs in yeast (Anderson and Parker, 1998). 
Further supporting this notion, transcriptome-wide data sets examining Ski2 binding along mRNAs in S. 
cerevisiae, clearly indicate that the helicase accumulates in the 3′ end of transcripts, including 3′ UTRs, 
which is at odds with our CRAC data (Sohrabi-Jahromi et al., 2019; Tuck and Tollervey, 2013). These 
differences can be reconciled by the recent discovery of a novel Ski-complex interacting factor, Ska1, which 
associates with a subpopulation of the Ski complex in yeast (Zhang et al., 2019). Although Ska1 has no 
enzymatic activity, it was shown to be required for Ski complex-mediated degradation of ribosome-poor 
regions including long 3′ UTRs and coding sequences with low ribosome occupancy (Zhang et al., 2019). 
As direct association with the ribosome is important for disrupting the autoinhibitory conformation of the 
Ski complex and for stimulating the catalytic activity of the helicase (Schmidt et al., 2016), it is not 
surprising that the complex may require similar assistance from other factors in the absence of nearby 
ribosomes. This model however lacks direct experimental evidence and it is equally likely that the sole 
function of Ska1 is to antagonize the interaction between the ribosome and the Ski complex. Consistent 
with this, Ski3 is displaced from polysomes upon overexpression of Ska1 (Zhang et al., 2019). Intriguingly, 
no Ska1 homologs are predicted to exist outside of other Saccharomyces species (Zhang et al., 2019), which 
may explain why the mammalian Skiv2l is exclusively associated with ribosome-occupied regions. Thus, 
our findings highlight a previously undescribed difference between the mammalian and the yeast 3′-5′ decay 
pathway.  
The stark exclusion of Skiv2l form 3′UTRs suggests that the Ski complex is likely not involved in the 
degradation of full-length transcripts unlike Xrn1, which accumulates at the 3′ end of mRNAs. This would 
be consistent with a model where the 5′-3′ pathway also represents the main route for general mRNA 
turnover in mammalian cells, while the Ski complex and exosome are exclusively involved in more 
specialized decay triggered by translational events, including mRNA surveillance. In support of this, we 
found that compared to Xrn1, Skiv2l targets were characterized by higher ribosome occupancy and Skiv2l 
binding was diminished upon treatment with the translational inhibitors cycloheximide and harringtonine. 
These observations strongly suggest that the ribosome is a major determinant of Skiv2l recruitment in 
mammalian cells. On the other hand, Xrn1-mediated degradation in yeast was not strongly impacted by 
decoupling the exonuclease from the ribosome (Tesina et al., 2019), suggesting that the physical link with 
translation might be a byproduct, rather than a prerequisite for 5′-3′ decay. 
We cannot fully exclude the possibility that the exosome degrades full-length transcripts including 3′ UTRs 
independently of its helicase co-factor. This seems unlikely given that all reported functions of the 
cytoplasmic exosome require the Ski complex (Anderson and Parker, 1998; Araki et al., 2001; Mitchell and 
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Tollervey, 2003; Orban and Izaurralde, 2005; van Hoof et al., 2002; van Hoof et al., 2000). Furthermore, 
in the absence of Ski2, the exosome could only trim the 3′ ends of transcripts by about 50 nucleotides from 
the poly(A) site (Tesina et al., 2019), suggesting that at least in yeast, the function of the Ski complex is 
required for efficient exonucleolytic activity of the exosome. Of note, our CRAC data indicate that the 
mammalian Skiv2l can in fact bind along very short 3′UTRs, possibly because this length still allows it to 
engage nearby ribosomes in the ORF. Consistent with this, ribosomes with a short 3′ RNA overhang of 10-
20 and up to 50 nucleotides were shown to interact with the yeast Ski complex (Schmidt et al., 2016).  
Nevertheless, it could be interesting to examine whether similar to yeast, all functions of the mammalian 
cytoplasmic exosome are coupled to its co-factor. This could be achieved by initial comparison of Skiv2l 
CRAC data sets versus Dis3l, the catalytic subunit of cytoplasmic exosome. If the two complexes function 
together, their substrates as well as mRNA binding patterns should largely overlap. Conversely, if the 
exosome was involved in degradation of full-length transcripts independently of Skiv2l, Dis3l would be 
expected to crosslink along 3′ UTRs. These experiments could be complemented by examining transcript 
half-lives in in Skiv2l-/- versus Dis3l-/- cells, where any changes in the stability of direct targets should largely 
correlate between the two conditions. Similarly, performing Skiv2l CRAC in the absence of Dis3l could 
reveal whether coupling to the exonucleolytic activity of the exosome is required for the observed 
distribution of Skiv2l along mRNAs. It should be noted however, that binding of the yeast Ski complex to 
the ribosome is proposed to be the first step in initiating 3′-5 decay, as it can occur independently of the 
exosome (Schmidt et al., 2016). Therefore, the initial recruitment of the Ski complex to substrates is 
unlikely to be affected in Dis3l-/- cells, but depending on whether the helicase can move along the mRNA 
in the absence of an exonucleolytic activity, its binding pattern along the transcript might change.  
Unlike S. cerevisiae, S. pombe and higher eukaryotes possess an additional 3′-5′ cytoplasmic exonuclease, 
Dis3l2, which operates independently of the exosome. Although Dis3l2 has been implicated in general 
mRNA decay in human cells and S. pombe (Lubas et al., 2013; Malecki et al., 2013), other studies suggest 
that it primarily functions as a quality control pathway for cytoplasmic non-coding RNAs (Łabno et al., 
2016b; Pirouz et al., 2016; Ustianenko et al., 2016). Human Dis3l2 was found to co-sediment with 
polysomes, suggesting it might also degrade its mRNA targets co-translationally (Lubas et al., 2013). Thus, 
it would be interesting to test if the mammalian Dis3l2 complements the Ski-exosome 3′-5′ pathway by 
degrading full-length transcripts including their 3′UTRs under normal conditions. For this purpose, a 
systematic profiling of direct Dis3l2 mRNA targets by CRAC and RNA-seq analysis of Dis3l2-/- cells could 
useful in examining any distinct and overlapping functions with the other cytoplasmic pathways. 
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2. Skiv2l binding reveals triggers of translation-coupled RNA decay 
Consistent with its close links to the ribosome, we found that Skiv2l was enriched at sites that are known 
to trigger RNA degradation as a result of abnormal translation. For instance, uORFs known to induce NMD 
were occupied by Skiv2l (e.g. Ifrd1), and other endogenous NMD substrates (e.g. alternatively-spliced 
Dhx9) were bound by Skiv2l upstream of the premature stop codon, consistent with a role for the helicase 
in degrading the 5′ RNA fragment following an endonucleolytic cleavage. To examine if Skiv2l responds 
to other aberrant translation events, we combined our CRAC data with disome profiling, which we used as 
a proxy for prolonged translational stalls that are likely to trigger mRNA surveillance. We observed disome 
enrichment at regions encoding stretches of poly-lysine, -proline, -glutamate, -aspartate and -arginine which 
were previously reported to pause ribosomes (Ingolia et al., 2011). Skiv2l binding was elevated over the 
same regions, suggesting that these sequences are indeed more susceptible to surveillance. However, for 
some amino acid stretches, such as poly-prolines, the Skiv2l occupancy was much less pronounced than 
the disome peak, suggesting that certain pauses are resolved without triggering surveillance and decay of 
the message. This is consistent with the presence of specific factors such as eIF5A, which has been shown 
to alleviate translational stalls at poly-proline stretches by facilitating the reactivity of the amino acid during 
peptide bond formation (Gutierrez et al., 2013; Pelechano and Alepuz, 2017; Schuller et al., 2017). Of note, 
the 3′ ends of Skiv2l-bound RNA fragments at proline pairs were enriched in frame, indicating that the 
incorporation of this amino acid into the nascent peptide, and not the underlying mRNA sequence, is 
responsible for triggering surveillance. 
Translational arrest on poly-basic (lysine and arginine) encoding sequences has been proposed to occur as 
a result of electrostatic interactions between the positively charged polypeptide and the negatively charged 
ribosome exit tunnel (Lu and Deutsch, 2008). However, the degree to which poly-basic residues impede 
translation varies greatly between organisms. While consecutive stretches of arginines are potent inducers 
of surveillance due to translational arrest in yeast (Brandman et al., 2012; Ikeuchi et al., 2019; Letzring et 
al., 2013), poly-arginines have little effect in mammalian cells. Instead, the main triggers of ribosome stalls 
in human cells appear to be poly-lysines specifically encoded by consecutive AAA codons (Garzia et al., 
2017; Juszkiewicz et al., 2018; Lu and Deutsch, 2008; Sundaramoorthy et al., 2017). These findings suggest 
that elongation pausing at polybasic residues depends on the underlying mRNA sequence, rather than 
incorporation of the specific amino acid. This is consistent with previous work demonstrating that reporters 
with iterated AAA codons produced significantly less protein than those with equivalent number of AAGs, 
despite coding for the same poly-lysine peptide (Arthur et al., 2015; Koutmou et al., 2015). In line with 
these findings, we observed equivalent Skiv2l binding at lysine-rich versus lysine-poor A/G sequences, 
while Skiv2l and disomes were enriched at A-rich but not G-rich stretches. This suggest that adenine-rich 
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mRNA sequences are prone to translation-coupled surveillance involving Skiv2l, and that sequence, rather 
than the encoded amino acid, is key. 
Since ubiquitination of stalled elongation complexes has been shown to trigger mRNA surveillance and 
protein quality control, it is tempting to speculate that Skiv2l might recognize such ubiquitination events. 
Of note, the arch domain of Skiv2l contacts the 40S ribosomal subunits uS3 (Rps3) and uS10 (Rps20) 
(Schmidt et al., 2016), both of which are substrates for ubiquitination (Garzia et al., 2017; Ikeuchi et al., 
2019; Juszkiewicz and Hegde, 2017; Sundaramoorthy et al., 2017). However, no ubiquitin densities were 
detected in the cryo-EM structure of the ribosome bound by the Ski complex, suggesting that this 
modification is likely not essential for Skiv2l binding. Nevertheless, it is possible that ubiquitinated 
ribosomal subunits might be recognized by the recently discovered NGD/NSD endonuclease, Cue2, which 
has several ubiquitin binding domains (D’Orazio et al., 2019). The mammalian Cue2 ortholog, N4bp2, is 
also predicted to bind ubiquitin, and it would be interesting to test if N4bp2 is the endonuclease that acts 
upstream of the Ski complex to cleave mRNAs during aberrant translation and create ‘access points’ for 
Skiv2l within the ORF to initiate 3′-5 decay. This could be tested by performing Skiv2l CRAC in the 
absence of N4bp2. If this factor is indeed the primary endonuclease acting in response to stalled ribosomes, 
Skiv2l recruitment to mRNAs and especially at sites that trigger surveillance should be diminished. 
3. Skiv2l determines the steady-state level of a subset of mRNAs 
Although our data support a model where Xrn1 is the major exonuclease for general mRNA turnover, 
whereas the Ski complex specializes in translation-trigged decay and surveillance, we wondered whether 
there are certain transcripts which would be primarily degraded through the 3′-5′ pathway. Consistent with 
the idea that mRNAs can be targeted for decay both in the 5′-3′ and 3′-5′ direction, on many individual 
transcripts we detected similar Xrn1 and Skiv2l binding. However, a more global comparison of the 
mRNAs bound by Xrn1 and Skiv2l using PCA analysis revealed prominent and reproducible differences. 
This pattern could also be observed on many individual transcripts where binding of one decay factor 
seemed to dominate. This was particularly intriguing for the set of mRNAs highly bound by Skiv2l, but not 
Xrn1, as our CRAC data would suggest that they are primarily targeted by the Ski-exosome pathway. 
Consistent with this, many mRNAs highly bound by Skiv2l were also upregulated upon Skiv2l knock out, 
suggesting that the 3′-5′ pathway is important for determining their steady-state levels. This group includes 
the replication-dependent histones, which represent some of the most highly upregulated transcripts in the 
Skiv2l knock out cells. 
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Certain features of the replication-dependent histone mRNAs could make them optimal Ski complex 
substrates. For instance, their very short 3′ UTRs may allow Skiv2l to engage the 3′ end of the full-length 
transcript by enabling interactions with ribosomes from the nearby ORF. Indeed, we often observe Skiv2l 
CRAC signal along the whole length of the histone 3′UTR, including over the entire stem-loop structure. 
These observations suggest that 3′-5′ histone mRNA decay through the Ski complex may bypass the need 
for the 3′-5′ exonuclease Eri1, which was shown to be required for efficient degradation of the stem-loop, 
following uridylation (Hoefig et al., 2013). Consistent with this, some studies report that knock down of 
Eri1 has no discernible effect on histone mRNA stability (Mullen and Marzluff, 2008). In addition, it would 
be interesting to test if Upf1 is dispensable for Ski complex-mediated decay, since Skiv2l also has ATPase 
and helicase activities. Finally, it has been shown that active translation of histone mRNAs is required for 
their rapid degradation upon inhibition of DNA synthesis (Graves et al., 1987; Kaygun and Marzluff, 
2005b). This feature is likely to further contribute to the affinity of Skiv2l for histone mRNAs, as our data 
indicate that ribosome occupancy is a prerequisite for Skiv2l binding. 
Efficient histone mRNA degradation has been previously shown to require the activity of the exosome 
through its catalytic subunit Rrp6 (Mullen and Marzluff, 2008; Slevin et al., 2014). This is interesting given 
that Rrp6 primarily functions in the nucleus, although small amounts of it have also been detected in the 
cytoplasm (Burkard and Butler, 2000; Januszyk et al., 2011). Thus, it could be interesting to reevaluate the 
relative contribution of the exosome exonucleases, although it might not be surprising that multiple factors 
and pathways are involved in histone mRNA decay to confer robustness to the process. 
4. Aven and Focadhesin interact with the Ski complex  
In stark contrast to the variety of auxiliary proteins that associate with the nuclear exosome, the Ski complex 
is the only described co-factor that assists the exosome in the cytoplasm. In yeast, a novel Ski complex-
interacting factor, Ska1, was recently shown to associate with a subset of Ski-exosome complexes to 
facilitate degradation of ribosome-devoid RNAs (Zhang et al., 2019). Although Ska1 is not conserved 
outside of the fungal species, its discovery raises the question of whether additional unidentified factors 
may function with the Ski complex in other organisms as well. Our work identified two proteins, Aven and 
Focadhesin, which interact with the Ski complex in mES cells, thus expanding the set of factors that 
coordinate cytoplasmic 3′-5′ RNA decay in mammalian cells.  
Focadhesin is a large cytoplasmic protein initially identified as a focal adhesion component that functions 
as tumor suppressor in glioblastoma (Brockschmidt et al., 2012). Focadhesin was shown to interact and co-
localize with the focal adhesion protein vinculin and its re-expression in glioblastoma cells led to decreased 
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proliferation and cell invasion both in vitro and in vivo (Brockschmidt et al., 2012). Focadhesin deletions 
have also been associated with breast and colorectal cancer (Weren et al., 2015). Further characterization 
of the molecular functions of Focadhesin as a tumor suppressor revealed that it interacts with tubulin and 
impacts microtubule dynamics during the cell cycle consistent with its localization to the centrosome 
(Brand et al., 2019). Focadhesin knock down also led to accelerated progression through the G2/M phase 
of the cell cycle (Brand et al., 2019).  
Interestingly, a recent study showed that the plant Focadhesin homolog, Rst1, together with another protein 
of unknown function, Ripr, associate with the exosome and the Ski complex (Lange et al., 2019). More 
specifically, IP-MS analysis revealed that Rst1 mainly co-purifies with its binding partner Ripr, Ski7 and 
the core exosome, while the Ski complex components and Ski7 were most highly enriched in the Ripr co-
IPs (Lange et al., 2019). This suggests that Rst1 and its binding partner Ripr bridge the interaction between 
the Ski7-exosme complex and the Ski2-Sk3-Ski8 proteins. Ripr is a 356 amino acid protein without any 
apparent functional domains or resemblance to other proteins (Lange et al., 2019). The phenotypes 
associated with loss of function of either Rst1, Ripr or the exosome were largely overlapping, suggesting 
that all components might act in the same pathway (Lange et al., 2019). Furthermore, similar to exosome 
and Ski complex mutants, loss of Rst1 and Ripr led to production of secondary siRNAs from certain 
exosome substrates such as endogenous mRNAs or RISC-cleavage products (Lange et al., 2019). Therefore, 
these observations strongly support a role for Rst1 and Ripr as co-factors of the cytoplasmic exosome and 
the Ski complex in plants (Lange et al., 2019).  
Aven is a primarily cytoplasmic protein, which is expressed in a variety of tissues and cell lines (Chau et 
al., 2000). It was initially identified in a yeast two-hybrid screen as a protein that interacts with and stabilizes 
the pro-survival factor Bcl-xL (Chau et al., 2000).  The same study also showed that Aven binds to Apaf1 
(apoptotic protease activating factor 1) and prevents its oligomerization, which inhibits formation of the 
apoptosome, activation of Caspase-9 and subsequent cell death, thus establishing Aven as an apoptosis 
inhibitor (Chau et al., 2000). Subsequent studies showed that proteolytic cleavage of the N-terminus of 
Aven by Cathepsin-D is required to activate its pro-survival properties (Melzer et al., 2012). Consistent 
with its function as an apoptotic inhibitor, Aven overexpression has been linked to the development of acute 
leukemias and correlates with poor prognosis in childhood acute lymphoblastic leukemia (Choi et al., 2006; 
Eißmann et al., 2012). Aven was also implicated in cell cycle regulation in response to DNA damage. The 
addition of Aven mRNA to cycling Xenopus egg extracts caused activation of the ataxia telangiectasia-
mutated (ATM) kinase and inhibited progression through the G2/M phase (Guo et al., 2008). On the other 
hand, loss of Aven in osteosarcoma cells induced G2 cell cycle arrest and reduced activation of ataxia 
telangiectasia-related (ATR) kinase in response to DNA damage (Baranski et al., 2015). 
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A more recent study of the molecular functions of Aven showed that it co-fractionates with polysomes and 
binds RNAs through its N-terminal RGG/RG box, which is a known RNA-interaction motif, found in 
various RNA binders (Thandapani et al., 2013; Thandapani et al., 2015). Arginine residues within RGG/RG 
sequences can be methylated by protein arginine methyltransferases (PRMTs) to modulate the properties 
of the motif (Thandapani et al., 2013). Similarly, Aven association with polysomes is dependent on 
methylation of its RGG/RG box by Prmt1 (Thandapani et al., 2013). It was also shown that Aven recognizes 
G-quadruplex RNAs (Thandapani et al., 2015), which are higher-order RNA structures formed by stacks 
of guanine tetrads that are stabilized by potassium ions (Kwok and Merrick, 2017). In vivo, Aven was bound 
to the G-quadruplex motif within the ORFs of two mRNAs encoding for the mixed lineage leukemia family 
proteins (Thandapani et al., 2015). This increased the polysomal association of the mRNAs and facilitated 
their translation (Thandapani et al., 2015). Recruitment of the helicase Dhx36 implicated in resolving G-
quadruplex structures was suggested to mediate the positive effect of Aven on translation (Creacy et al., 
2008; Lattmann et al., 2010; Thandapani et al., 2015; Tippana et al., 2019; Yangyuoru et al., 2018). 
Interestingly, Aven IP-MS data sets from this study indicate interactions with Focadhesin as well as all Ski 
complex components (Thandapani et al., 2015), which is in line with our findings, although we did not 
detect any association between Aven and Dhx36 or Prmt1. Our data indicate that Aven and Focadhesin are 
stably bound and interact more weakly or transiently with the Ski complex.   
5. Aven and the Ski complex act in concert to oppose translational stalling 
The interaction of Aven and Focadhesin with the Ski complex raised the question of whether these two 
factors are involved in cytoplasmic 3′-5′ RNA decay. Since Focadhesin was challenging to work with due 
to its large size and low abundance, we mainly focused on characterizing the interaction between Aven and 
the Ski complex. Global profiling of Aven substrates by CRAC revealed that Skiv2l and Aven share similar 
mRNA and ribosome binding sites, supporting a role for these proteins in the same pathway. Perhaps our 
most striking finding is the pronounced global increase of Skiv2l binding to RNAs upon Aven knock out. 
We observed similar changes in the absence of Focadhesin, suggesting that Aven and Focadhesin have 
overlapping functions. As our previous results indicate that the distribution of Skiv2l across transcripts is 
tightly coupled to ribosomes, we predicted that the changes in Skiv2l binding in the absence of Aven could 
presumably reflect altered ribosome occupancy. Indeed, mRNAs that gained Skiv2l also displayed an 
increase in disome occupancy, suggesting that ribosomes were more prone to stalling in the absence of 
Aven. Collectively, these observations are consistent with a model where Aven and Skiv2l serve 
complementary roles as part of a translation-coupled RNA surveillance pathway, where Aven opposes 
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prolonged translational stalls and Skiv2l assists in eliminating transcripts where these aberrant events 
accumulate (Figure 17). 
 
Figure 17. Model for how the combined functions of Aven and the Ski complex could oppose translational 
stalling. 
In WT cells, Aven associates with polysomes by direct binding to the 40S ribosomal subunit and/or the mRNA. This 
facilitates ribosome translocation along difficult to translate sequences, including structured regions. In the absence 
of Aven, ribosomes are more susceptible to stalling which promotes the formation of collided ribosomes. The stalled 
mRNPs signal to the mRNA surveillance machinery which initiates an endonucleolytic cleavage of the message at the 
vicinity of the stalled ribosome. This event creates an ‘access point’ for Skiv2l which recognizes and binds the 80S 
ribosome presenting a short 3′ mRNA overhang. RNA degradation in the 3′-5′ direction is presumably initiated by 
subsequent recruitment of the RNA exosome to the Ski-ribosome complex.  
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Several lines of evidence further support this proposed model. Aven was enriched at RNA sequences 
predicted to have higher structural propensity, including G-quadruplexes and GC-rich sequences. Since 
structured RNA regions can negatively impact translation elongation, Aven could potentially facilitate 
ribosome translocation along the mRNA by helping to resolve such structural elements. This would be 
consistent with a reported role for Aven in promoting the optimal translation of mRNAs containing G-
quadruplexes, through recruitment of the helicase Dhx36 (Thandapani et al., 2015). However, besides 
Skiv2l, we did not detect any other significantly enriched helicases in our Aven IPs. Nevertheless, it might 
be possible that the RGG/RG domain of Aven directly contributes to the remodeling of the structured region 
as previously suggested for other RGG/RG motifs (Loughlin et al., 2019; Meyer et al., 2019). Of note, in 
the Aven knock out, Skiv2l binding was elevated at predicted structural sequences, indicating that they are 
indeed more susceptible to surveillance. On a more global scale, elevated Skiv2l binding in the absence of 
Aven was paralleled by an increase in Skiv2l CRAC reads containing non-templated U-tails, which are 
thought to be added to RNA 3′ ends to help initiate decay. This further supports the notion that lack of Aven 
leads to increased surveillance and 3′-5′ RNA decay.  
One prediction from our model is that the combined absence of Aven and Skiv2l should have an additive 
effect on transcript levels, as Skiv2l would not be available to clear stalled mRNPs forming due to lack of 
Aven. Consistent with this, we observed a more significant upregulation of Aven-Skiv2l substrates in the 
double knock compared to a single Skiv2l deletion. This trend was best illustrated by the histone mRNAs 
and small-ORF (smORF) containing RNAs originating from intergenic, upstream or antisense loci. A 
common feature of these two sets of transcripts is their high GC content. In addition, the smORF RNA 
sequences were predicted to form secondary structures. These characteristics might explain why histone 
mRNAs and smORF RNAs are particularly dependent on the Aven-Skiv2l pathway.  
According to our model, Aven functions upstream of Skiv2l to oppose prolonged translational pausing, 
while Skiv2l acts at a later step to clear stalled mRNPs. Since this scenario would not necessarily require 
direct association between Aven and the Ski complex, it is perhaps somewhat puzzling that they interact, 
although they do not seem to form a stable complex. In light of these observations, it is important to consider 
alternative models that could also explain our data. For instance, since Aven and Skiv2l seem to occupy a 
similar site on the ribosome, near the mRNA entry channel, could it be possible that Aven competes with 
Skiv2l for binding to the 40S subunit? In this case, Aven could act to limit the association of the Ski complex 
with polysomes, by masking its binding site on the ribosome (Figure 18). This could also explain why 
Skiv2l binding to mRNAs is increased in the absence of Aven. However, if the sole purpose of Aven was 
to exclude Skiv2l from polysomes, it is unlikely that its loss would also affect monosome and disome 
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distribution. Nevertheless, this question could be addressed biochemically by testing Ski complex binding 
to the ribosome in the presence and absence of Aven.  
 
Figure 18. Model for competition between Aven and the Ski complex 
Aven could potentially mask the Skiv2l binding site on the 40S ribosomal subunit to prevent or minimize the 
association of the Ski complex with polysomes. The absence of Aven could therefore expose the Skiv2l binding site 
on the 40S subunit and potentially facilitate recruitment of the Ski complex to the translating ribosome.  
 
In an alternative scenario, Aven could modulate the enzymatic properties of the Ski complex. For instance, 
Aven might act to stabilize the closed conformation of the Ski complex and further limit its catalytic 
activity, even when the Ski complex is in contact with the ribosome (Figure 19). Conversely, in the absence 
of Aven, the autoinhibitory interactions within the Ski complex might be easier to remodel upon binding to 
the ribosome, leading to stabilization of Skiv2l on the mRNA and promoting its catalytic activity. This 
model would reconcile the interaction between Aven and the Ski complex as well as the increase in Skiv2l 
binding and 3′-5′ RNA decay in the absence of Aven, although it still does not explain the observed changes 
in ribosome occupancy. To examine if Aven directly affects the catalytic activity of Skiv2l, we could test 
the RNA binding, helicase and ATPase properties of the Ski complex in isolation and in combination with 
Aven.  
 
Figure 19. Model for how Aven might affect the enzymatic activity of the Ski complex  
The interaction between Aven and the Ski complex could potentially stabilize the autoinhibitory conformation of the 
Ski complex and thus limit its RNA binding and ATPase and helicase activities. In this case, the absence of Aven 
could facilitate activation of the Ski complex and promote it catalytic activity. 
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Finally, Aven might affect the association between the Ski complex and the exosome, for instance by 
promoting or restricting exosome recruitment (Figure 20). The interaction between the Ski complex and 
the exosome is typically more transient and its detection in co-IP experiments often relies on prior 
crosslinking of the sample (Kalisiak et al., 2017). Therefore, to test if Aven controls the association of the 
two complexes, we could perform Skiv2l IP-MS experiments under crosslinking conditions, in the presence 
and absence of Aven. Given that the plant homolog of Focadhesin, Rst1, was recently shown to bridge 
interactions between the exosome and the Ski complex, it would also be important to test if the mammalian 
Focadhesin performs a similar function. Again, this could be addressed by Skiv2l IP-MS analysis in wild 
type versus Focadhesin knock out cells. Depending on the outcome of these experiments, it might also be 
important to test if the combined loss of both proteins affects the interaction between the Ski complex and 
the exosome, since our data suggest that Aven and Focadhesin have overlapping functions. 
 
Figure 20. Model for how Aven could influence the interaction between the Ski complex and the RNA exosome. 
Binding of Aven (shown in light blue) to the Ski complex could potentially facilitate or limit the recruitment of the 
RNA exosome to either promote or oppose 3′-5′ RNA degradation of Skiv2l substrates.    
 
In conclusion, we found that the two major cytoplasmic decay pathways in mammalian cells have physical 
links to translation. Our data suggest that general mRNA turnover mostly occurs via the Xrn1 5′-3′ pathway, 
but also reveal a subset of transcripts whose steady-state levels depend on the 3′-5′ pathway. We present 
evidence that the mammalian Ski complex helicase Skiv2l is exclusively recruited to ribosome-occupied 
regions, strongly suggesting that the Ski complex functions predominantly in translation-associated RNA 
degradation. We further identified Focadhesin and Aven as interaction partners of the Ski complex. 
Although additional biochemical and structural data would be necessary to elucidate the precise molecular 
functions of these interactions, our data are consistent with a model where Aven and the Ski complex have 
distinct but complementary roles in a translation coupled-surveillance pathway. While Aven seems to 
oppose ribosome stalling possibly by facilitating translation through structured regions, the Ski complex 
helps clear the transcript in case the stall cannot be resolved. Interestingly, the Aven-Skiv2l pathway acts 
on a wide range of substrates, including mRNAs, uORFs and most surprisingly on small ORF-containing 
RNAs derived from transcription of non-coding regions. 
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RNA decay is crucial for mRNA turnover and surveil-
lance and misregulated in many diseases. This com-
plex system is challenging to study, particularly in
mammals, where it remains unclear whether decay
pathways perform specialized versus redundant
roles. Cytoplasmic pathways and links to translation
are particularly enigmatic. By directly profiling decay
factor targets and normal versus aberrant translation
in mouse embryonic stem cells (mESCs), we uncov-
ered extensive decay pathway specialization and
crosstalk with translation. XRN1 (50-30) mediates
cytoplasmic bulk mRNA turnover whereas SKIV2L
(30-50) is universally recruited by ribosomes, tackling
aberrant translation and sometimes modulating
mRNA abundance. Further exploring translation
surveillance revealed AVEN and FOCAD as SKIV2L
interactors. AVEN prevents ribosome stalls at struc-
tured regions, which otherwise require SKIV2L for
clearance. This pathway is crucial for histone transla-
tion, upstream open reading frame (uORF) regula-
tion, and counteracting ribosome arrest on small
ORFs. In summary, we uncovered key targets, com-
ponents, and functions of mammalian RNA decay
pathways and extensive coupling to translation.
INTRODUCTION
RNA decay ensures steady-state mRNA expression, eliminates
aberrant transcripts, and remodels the transcriptome upon
changing conditions (Bresson et al., 2017; Pe´rez-Ortı´n et al.,
2013; Sohrabi-Jahromi et al., 2019; Tuck and Tollervey, 2013).
In the nucleus, mRNAs are mainly degraded 30–50 by the exo-
some complex, assisted by factors including the helicase Mtr4
(MTR4) (Kilchert et al., 2016; LaCava et al., 2005; Mitchell
et al., 1997; Schmid and Jensen, 2018). Cytoplasmic mRNA
turnover is initiated by poly(A) tail removal and proceeds via
30–50 exoribonucleolysis by the exosome or decapping followed1222 Molecular Cell 77, 1222–1236, March 19, 2020 ª 2020 The Auth
This is an open access article under the CC BY license (http://creativeby 50–30 degradation by the exoribonuclease Xrn1 (XRN1) (Hsu
and Stevens, 1993; qabno et al., 2016; Parker, 2012; Zinder
and Lima, 2017). Cytoplasmic exosome activity requires the
Ski complex (Anderson and Parker, 1998), comprising the scaf-
fold Ski3 (TTC37), two copies of Ski8 (WDR61), and the helicase
Ski2 (SKIV2L). Ski2, like its homolog Mtr4, unwinds RNA and
channels it to the exosome (Halbach et al., 2013). Many pathol-
ogies are linked to dysregulation of these factors. For example,
XRN1 is downregulated in osteosarcoma (Pashler et al., 2016),
exosome mutations are linked to cancer (Robinson et al., 2015)
and neurological disorders (Morton et al., 2018), and Ski com-
plex impairment causes a congenital bowl disorder (Fabre
et al., 2012; Hartley et al., 2010).
The complexity of RNA decay makes it hard to study and
fundamental questions remain. For example, do decay path-
ways act redundantly or target specific transcripts? If the latter,
how is specificity achieved, and what advantage does it confer?
Analyses of S. cerevisiae mutants suggest that Xrn1 contributes
more than the exosome to cytoplasmic turnover (Parker, 2012).
However, compensation between decay pathways and second-
ary effects make it unclear whether this reflects the physiological
situation. Furthermore, higher eukaryotes have extra factors and
pathways, including 30 uridyltransferases acting in cytoplasmic
decay (qabno et al., 2016; Lim et al., 2014) and diverse MTR4-
containing nuclear exosome adaptor complexes (Lubas et al.,
2011; Meola et al., 2016).
A further challenge is that RNA decay is coupled to other RNA
life cycle events. For example, the nuclear exosome is recruited
during transcription to remove early termination products, in-
trons, or full-length mRNAs (Kilchert et al., 2016). In the cyto-
plasm, there is crosstalk between translation and RNA decay,
epitomized by surveillance pathways targeting mRNAs with pre-
mature termination codons (nonsense-mediated decay [NMD]),
translational roadblocks (no-go decay [NGD]), or no stop codon
(nonstop decay [NSD]) (Roy and Jacobson, 2013). A key event is
mRNA cleavage at stalled ribosomes, which generates 50 and 30
RNA fragments that are cleared by the exosome and Xrn1
(Gatfield and Izaurralde, 2004; Ghosh and Jacobson, 2010;
Guydosh and Green, 2017). Coupling between translation and
degradation could be widespread and extend beyond surveil-
lance (Ibrahim et al., 2018). In support of this, Xrn1 can act
co-translationally (Hu et al., 2009; Pelechano et al., 2015), andor(s). Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
structures capture the yeast Ski complex or Xrn1 bound to ribo-
somes (Schmidt et al., 2016; Tesina et al., 2019). There is intense
interest in understanding whether decay factor interactions with
the ribosome are conserved in higher eukaryotes, the functional
relevance, and whether this constitutes a major decay route.
Here, we address key questions about mammalian mRNA
decay. First, what are the physiological targets of major decay
pathways? Second, focusing on cytoplasmic decay, to what
extent is this coupled to translation, and what factors influence
this? To reveal direct, physiological targets of decay factors,
we used crosslinking and analysis of cDNAs (CRAC) to compare
the transcriptome-wide interactions of XRN1, SKIV2L, and
MTR4 in mouse embryonic stem cells (mESCs). Our data sug-
gest that most mRNA turnover occurs via the 50–30 pathway,
but some mRNAs (particularly those encoding histones) depend
on cytoplasmic 30–50 decay. We find that SKIV2L and XRN1
directly bind ribosomes, and translation appears to assist bulk
mRNA turnover by XRN1. Strikingly, SKIV2L is specifically and
pervasively recruited to ribosome-occupied regions, suggesting
it acts exclusively in translation-associated mRNA surveillance.
Our data reveal triggers of ribosome stalling and SKIV2L recruit-
ment, which we explore by globally mapping stalled ribosomes.
Proteomic analyses identify the RNA-binding factor AVEN and
uncharacterized protein FOCAD as Ski complex interactors.
We observe AVEN binding to GC-rich RNAs predicted to be
structured and increased SKIV2L binding, decay, and ribosome
stalling at these regions upon Aven knockout. We conclude that
AVEN and SKIV2L cooperate to counteract aberrant translation,
with AVEN preventing ribosome stalls at structured regions and
SKIV2L eliminating transcripts if these events accumulate. The
AVEN-SKIV2L pathway acts on diverse substrates, including
histone mRNAs, upstream open reading frames (uORFs), and
small ORF (sORF)-containing RNAs. In summary, we uncover
specialization between mammalian RNA decay pathways and
widespread crosstalk with translation and establish SKIV2L
and AVEN as components of a universal translation surveillance
program.
RESULTS
Mammalian RNA Decay Pathways Target Distinct
Transcripts
To examine the specificity of RNA decay pathways (Figure 1A),
we applied the CRAC approach to SKIV2L, XRN1, and MTR4
in mESCs (Granneman et al., 2009; Tuck et al., 2018). After
endogenously 3xFLAG-Avi tagging these proteins (Figure S1A;
Table S1) (Flemr and B€uhler, 2015), we crosslinked cells with
UV (254 nm) to fix protein-RNA interactions, purified ribonucleo-
proteins (RNPs) under denaturing conditions, performed a
limited RNase digestion, and sequenced the RNA fragments
(Figure 1B). We performed five or six technical replicates
(including three published MTR4 datasets; Table S2). Global
comparison of mRNAs bound by SKIV2L, MTR4, and XRN1 us-
ing principal-component analysis (PCA) or correlation coeffi-
cients revealed highly reproducible differences (Figures 1C,
1D, and S1B; Table S3). To explore the specificity of individual
transcripts, we used t-distributed stochastic neighbor embed-
ding (t-SNE) to arrange mRNAs by relative binding to the threeproteins (Figure 1E). Although some transcripts bound similarly
to SKIV2L, XRN1, and MTR4 (e.g., Trim28; Figure 1F), others
had a clear preference (e.g.,Sfpq orPim3; Figure 1F), suggesting
that for many transcripts, one decay route dominates. Further-
more, functionally related mRNAs shared binding preferences
(Figures 1E and S1D) (e.g., histone mRNAs bound abundantly
to SKIV2L).
As XRN1-dependent 50–30 decay is assumed to be the main
determinant of RNA half-life and steady-state abundance we
were intrigued by transcripts bound highly by SKIV2L (e.g., Fig-
ure 1G). SKIV2L assists the exosome in 30–50 decay, and a
co-immunoprecipitation confirmed that 3xFLAG-Avi-tagged
SKIV2L interacts with the cytoplasmic exosome component
DIS3L (Figure S1C). We therefore suspected that highly
SKIV2L-bound mRNAs are degraded in a 30–50 SKIV2L-depen-
dent manner. To test this, we generated Skiv2lfl/fl conditional
knockout cells by integrating loxP sites into introns 10 and 17
in CreERT2-expressing mESCs (Flemr and B€uhler, 2015) (Fig-
ure 1H). We treated these cells with 4-hydroxytamoxifen
(4OHT) to induce loxP recombination andproductionof truncated
SKIV2Lwithout a catalytic domain (Figures 1H and S1E) and pro-
filed gene expression by RNA sequencing (RNA-seq) (Table S3).
There were many changes after 6 days of 4OHT treatment, but
these did not correlate with SKIV2L CRAC (Figure 1I, right) so
are likely indirect effects. Conversely, after 4 days of 4OHT treat-
ment, transcript upregulation correlated with SKIV2L CRAC
(Figure 1I, left, and Figure S1F). Measuring transcriptome-wide
half-lives following transcription shut off by actinomycin D
confirmed that highly SKIV2L-bound transcripts are stabilized
upon Skiv2l knockout, exemplified by replication-dependent his-
tone mRNAs (Figure S1G; Table S3). Some stabilized SKIV2L
targets (e.g., Calr and Pdia4; Figure S1G) did not increase in
abundance (Figure 1I), suggesting that cells partially compensate
for the loss of SKIV2L. Of note, high-confidence SKIV2L targets
(Figure S1G) were expressed at wild-type (WT) levels in our
tagged cell lines, confirming that tagged SKIV2L is functional
(Figure S1H). We conclude that SKIV2L-dependent 30–50 decay
contributes to the steady-state abundanceof a subset ofmRNAs,
including most replication-dependent histone mRNAs. Our
approach thus reveals physiological targets of mRNA decay
pathways.
Cytoplasmic RNA Decay Is Widely Influenced by
Translation
As cytoplasmic decay pathways are less well studied, we now
focused on XRN1 and SKIV2L. A key question is to what extent
they interact with translation. Remarkably, CRAC readsmapping
to ribosomal RNA revealed specific, reproducible binding of
SKIV2L and XRN1 to the 40S subunit mRNA entry and exit
regions (Figure 2A), resembling yeast structures (Schmidt
et al., 2016; Tesina et al., 2019). Therefore, SKIV2L and XRN1
ribosome interactions are conserved to mammals and occur in
unperturbed cells.
To explore whether SKIV2L and/or XRN1 activity is widely
coupled to translation, we examined binding across individual
mRNAs (e.g., Figures 1F and 1G). SKIV2L binding was strongly
biased toward regions occupied by ribosomes, i.e., 50 UTRs,
coding sequences (CDSs), and uORFs (e.g., Ifrd1; Figure 1G).Molecular Cell 77, 1222–1236, March 19, 2020 1223
Figure 1. Mammalian mRNA Decay Pathways Target Distinct Transcripts
(A) RNA decay pathways.
(B) CRAC outline.
(C and D) PCA (C) and correlation matrix (D) based on decay factor binding (CRAC counts) to mRNAs. Replicates correspond to separate experiments for the
same cell line.
(E) t-SNE representation of mRNAs based on relative binding to MTR4, SKIV2L, and XRN1.
(F and G) CRAC coverage across individual mRNAs. Transcripts in (F) illustrate different XRN1:SKIV2L ratios, whereas (G) depicts transcripts highlighed in panel (I).
(H) Conditional knockout strategy for Skiv2l.
(I) Differential expression analysis for Skiv2l knockout for themRNAs in (E), with significantly changing transcripts (DESeq2 padj < 0.05) colored by SKIV2L binding
(as in E).
See also Figure S1 and Tables S1, S2, and S3.
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Figure 2. Cytoplasmic mRNA Decay Is
Widely Influenced by Translation
(A) CRAC signal for SKIV2L and XRN1 on the
ribosomal 40S subunit, based on the mouse rRNA
sequence and human structure (Khatter et al.,
2015). Significantly bound regions are colored by
c2 p value, and the mRNA path (yellow) is taken
from Schmidt et al. (2016).
(B and C) CRAC signal for SKIV2L around start and
stop codons, summed (left) or for individual
mRNAs (right). Data in (B) correspond to untreated
cells, whereas those in (C) correspond to 30-min
cycloheximide or harringtonine treatment.
(D) Ribosome densities for mRNAs grouped by
expression and most abundantly bound decay
factor (defined in Figure 1E).
(E)XRN1CRACsignalaroundstart andstopcodons.
(F) CRAC, monosome, and disome profiling for
individual mRNAs.
(G) Monosome and disome profiling approach.
See also Figure S2 and Table S4.Global analysis of binding around start and stop codons (Fig-
ure 2B) revealed this pattern is universal. Treating cells with
translation inhibitors led to a redistribution of SKIV2L binding
(Figure 2C) that parallels changes in ribosome occupancy, con-
firming that active translation directs SKIV2L binding. Harringto-
nine blocks translation post-initiation to deplete ribosomes from
CDS regions, where we observed loss of SKIV2L binding. In
contrast, cycloheximide stalls elongating ribosomes, leading to
queuing and initiation upstream of the canonical start codon
(Kearse et al., 2019). Consistently, SKIV2L accumulated in 50
UTRs (Figure 2C). Further supporting the role of ribosomes in re-
cruiting SKIV2L, we found that SKIV2L CRAC correlates with the
number of ribosomes on a transcript, which we measured by
ribosome profiling (Figure 2D; Table S4). We conclude that
SKIV2L is specifically and universally recruited to translated re-
gions via ribosome interactions.MoleculaIn contrast to SKIV2L, XRN1 bound the
full length of mRNAs, consistent with its
major role being in bulk mRNA turnover.
Strong XRN1 enrichment in 30 UTRs (Fig-
ure 2E) supports a model where XRN1
follows the last translating ribosome,
which helps remove obstacles. In the 30
UTR, XRN1 may stall at RNA structures
or protein-bound sites. The pattern of
XRN1 binding around the stop codon is
less well defined than that of SKIV2L, sup-
porting this looser relationship with the
ribosome. We conclude that both cyto-
plasmic decay pathways are widely
influenced by translation, but only XRN1
degrades full-length mRNAs.
SKIV2L Functions in Universal
Translation Surveillance
We next sought to identify translation
events leading to SKIV2L recruitment.Unlike the relatively even ribosome profiling coverage across
mRNAs, SKIV2L CRAC signal was enriched at specific sites
(e.g., Figure 2F). Cytoplasmic 30–50 decay acts in many surveil-
lance pathways (e.g., NMD, NGD, and NSD), so we suspected
that SKIV2L peaks reflect RNA features that arrest or stall ribo-
somes. Endonucleolytic cleavage at ribosome stall sites (D’Ora-
zio et al., 2019; Gatfield and Izaurralde, 2004; Glover et al., 2019;
Guydosh and Green, 2017) may enable SKIV2L to engage the 30
end of the upstream fragment (Schmidt et al., 2016). Consistent
with this, some SKIV2L-bound RNA fragments had non-tem-
plated 30 U-tails (Figure S2A). Uridylation facilitates mRNA
degradation by XRN1, DIS3L2, and the exosome (Lim et al.,
2014; Slevin et al., 2014) and may act as a landing pad for
SKIV2L. The U-tails confirm that SKIV2L binds cleaved RNAs.
We also found U-tails on XRN1-bound RNA fragments, consis-
tent with 50–30 and 30–50 pathways being able to act on a singler Cell 77, 1222–1236, March 19, 2020 1225
Figure 3. AVEN and FOCAD are Ski Complex Interactors
(A and B) Mass spectrometry (MS) of streptavidin (A) or tandem FLAG-
streptavidin (B) purification of 3xFLAG-Avi-SKIV2L.
(C) Mouse AVEN protein.
(D) Western blot analysis of endogenously tagged Aven3xFLAG-Avi/3xFLAG-Avi
expression and biotinylation.
(E) MS of streptavidin purification of 3xFLAG-Avi-AVEN.
(F and G) MS of tandem FLAG-streptavidin purification of 3xFLAG-Avi-SKIV2L
(F) and 3xFLAG-Avi-AVEN (G) using high salt. All experiments include RNase
treatment, three technical replicates, and untagged mESCs as a control. FDR,
false discovery rate.
See also Table S5.mRNA and as reported by studies of yeast antiviral activity
(Widner and Wickner, 1993) and for histone mRNAs (Mullen
and Marzluff, 2008).
We reasoned that 30 ends of SKIV2L-bound RNA fragments
should reveal endogenous triggers of ribosome stalling. Indeed,
30 ends were enriched at specific codon pairs, including those
encoding lysine-lysine or proline (Figure S2B). Enrichment at
proline codons was weak but had a clear frame preference,
corroborating reports that proline in the nascent peptide triggers
stalling (Ingolia et al., 2011; Pavlov et al., 2009). Examining longer1226 Molecular Cell 77, 1222–1236, March 19, 2020codon runs, SKIV2L binding was elevated at poly-proline,
-lysine, -glutamate, -aspartate, and -arginine (Figure S2C; Mdk
in Figure 2F). These preferences resemble codons reported to
stall ribosomes based upon mESC ribosome profiling (Ingolia
et al., 2011). As SKIV2L peaks occurred at purine-rich codon
runs, we suspected that for these, the RNA sequence is more
important than the amino acid. Examining runs ofR12 purines,
SKIV2L enrichment was equivalent at lysine-rich and lysine-
poor sequences but more pronounced at A-rich than G-rich se-
quences (Figure S2D). This suggests that A-rich sequences
trigger ribosome stalling and SKIV2L surveillance, as exemplified
by Vdac1 andMdk (Figure 2F, red boxes), and agrees with a re-
porter-based study (Arthur et al., 2015). XRN1 showed slight
enrichment at some of these sites (Figures S2C and S2D), likely
reflecting a minor role in surveillance.
To verify that SKIV2L-bound sites reflect ribosome stalls, we
used a new method (disome profiling) to map collided ribosome
pairs (disomes) (Figure 2G) (Arpat et al., 2019). Disomes form at
ribosome stall sites (Ikeuchi et al., 2019; Juszkiewicz et al., 2018;
Simms et al., 2017) and can be identified from 45- to 70-nt
protected RNA fragments (Arpat et al., 2019;Guydosh andGreen,
2014). We also performed standard ribosome profiling (mono-
some profiling). We calculated A-site positions of monosomes
and leading ribosomes in disomes (Figure 2G). This revealed dis-
ome enrichments over codon and sequence runs (Figures S2C
and S2D) and individual sites (e.g., Vdac1, Mdk, and Noc2l; Fig-
ure 2F) with elevated SKIV2L binding, confirming these reflect
ribosome stalling. In some cases (e.g., polyproline; Figure S2C),
the disome signal was stronger than the SKIV2L CRAC signal.
This suggests that some stalls potently trigger RNA cleavage,
but others (e.g., polyproline) are resolved without mRNA decay.
We conclude that although SKIV2L and XRN1 can target the
same transcript, their roles are highly specialized. XRN1 medi-
ates bulk mRNA decay, with a minor surveillance role, whereas
SKIV2L responds exclusively to aberrant translation.
AVEN and FOCAD Are Ski Complex Interactors
We next wondered if SKIV2L is recruited solely by ribosome and
mRNA interactions or if other factors participate. MTR4 is tar-
geted by adaptor proteins, so analogous Ski complex adapters
could also exist. To identify SKIV2L interactors, we performed
streptavidin affinity purification (including RNase treatment)
and immunoprecipitation mass spectrometry (IP-MS). Using
tagged SKIV2L as bait, we identified various RNA binders, Ski
complex components WDR61 and TTC37, and ribosomal
proteins (Figure 3A; Table S5), consistent with the SKIV2L-ribo-
some interaction detected by CRAC (Figure 2A). To enrich for
more direct SKIV2L interactions, we repeated the experiment
adding a FLAG immunoprecipitation (tandem IP-MS). This
recovered just two proteins, AVEN and FOCAD (KIAA1797), be-
sides the Ski complex (Figure 3B).
FOCAD is a poorly characterized protein whose loss is
associated with glioma (Brockschmidt et al., 2012) and colo-
rectal cancer (Weren et al., 2015). Remarkably, its Arabidopsis
homolog binds the Ski complex (Lange et al., 2019). AVEN is
widely expressed and contributes to acute leukemia/lymphoma
(Eißmann et al., 2013). Its disordered N-terminal glycine- and
arginine-rich (RGG/RG) domain (Figure 3C) interacts with RNA
Figure 4. SKIV2L Binding and 30–50 Decay
Increase upon Aven Knockout
(A and B) CRAC signal for AVEN around start
and stop codons (A) and on the ribosomal 40S
subunit (B).
(C) PCA based on mRNA counts. Shapes indicate
different clones.
(D) CRAC coverage for individual mRNAs.
(E) SKIV2L CRAC around start and stop codons
in WT and Aven/ cells.
(F) Changes in SKIV2L CRAC binding (left) and
RNA-seq counts (right) for Aven/ versus WT
cells. Significantly up/downregulated transcripts
(padj < 0.05) are colored by AVEN CRAC counts in
WT cells, relative to SKIV2L+XRN1+MTR4 counts,
and replication-dependent histone mRNAs are
circled.
(G) Proportion of AVEN or SKIV2L CRAC reads in
mRNAs with 30 U-tails.
See also Figure S3 and Table S3.and localizes AVEN to polysomes (Thandapani et al., 2015).
Furthermore, AVEN aids translation through G-quadruplexes in
two mRNAs, and IP-MS using human AVEN as bait retrieved
the Ski complex and FOCAD (Thandapani et al., 2015). These
studies support our MS results.
To confirm the SKIV2L-AVEN interaction, we endogenously
3xFLAG-Avi-tagged Aven (Figure 3D) and performed IP-MS with
AVEN as bait, recovering the Ski complex and FOCAD (Figure 3E).
We repeated the tandem IP-MS using a higher salt concentration
andSKIV2LorAVENasbait (Figures3Fand3G). AVENnow recov-
ered FOCAD, but not the Ski complex, suggesting AVEN-FOCAD
and SKIV2L-WDR61-TTC37 (Ski complex) are separable com-
plexes that associate transiently with each other.
SKIV2L Binding and 30–50 Decay Increase upon Aven
Knockout
As AVEN associates with polysomes (Thandapani et al., 2015)
and the Ski complex (Figure 3B), we speculated it might recruitMoleculaSKIV2L to targets. To test this, we per-
formed CRAC on 3xFLAG-Avi-tagged
AVEN mESCs to map AVEN-binding
sites. Like SKIV2L, AVEN bound the 50
UTR and CDS of mRNAs (Figure 4A),
albeit with a stronger 50 bias. AVEN
CRAC also revealed ribosome contacts,
oneoverlapping that of SKIV2L (Figure 4B,
marked with an asterisk [*]). PCA based
on mRNA binding revealed that AVEN
and SKIV2L bound common targets (Fig-
ures 4C and S3A), and AVEN and SKIV2L
bound similar regions on individual
mRNAs (Figure 4D). These similarities
suggest that AVEN and SKIV2L function
in the same pathway.
To determine whether AVEN affects Ski
complex recruitment to mRNAs, we
generated Aven/ mESCs by deleting
the C-terminal portion of the protein (Figure S3B). This led to
near-complete knockdown of the entire Aven mRNA (Fig-
ure S3B). SKIV2L CRAC revealed that while the average binding
pattern of SKIV2L along mRNAs was unaffected in Aven/ (Fig-
ure 4E), there were strong differences in which mRNAs were
bound, apparent from a PCA (Figures 4C and S3A). AVEN thus
plays a role in SKIV2L targeting. SKIV2L binding was similarly
perturbed in Focad/mESCs (Figures 4C and S3C), suggesting
that AVEN and FOCAD functionally overlap. Due to its size and
low abundance, FOCAD was challenging to work with, so we
focused on AVEN.
In contrast to our prediction, SKIV2L binding to mRNAs was
not reduced in Aven/ cells but instead increased at many sites
(Figure 4F; examples in Figure 4D). To account for changes in
RNA abundance, we normalized CRAC to RNA-seq counts
fromWT and Aven/ cells (Table S3). Increased SKIV2L binding
was accompanied by elevated 30 uridylation of bound RNAs (Fig-
ure 4G), indicating increased 30–50 decay. This suggests thatr Cell 77, 1222–1236, March 19, 2020 1227
unlikeWT conditions, where SKIV2L transiently scans all transla-
tion events, upon Aven deletion, SKIV2L assists intensively in
30–50 decay at specific sites. These sites are bound by AVEN in
WT cells (Figure 4F, left, and Figure S3D), exemplified by replica-
tion-dependent histonemRNAs (circled in Figure 4F), suggesting
that changes in SKIV2L binding are a direct consequence of
losingAVEN.Changes inmRNA levels inAven/ cells (Figure 4F,
right) were smaller than changes in SKIV2L CRAC and correlate
poorly with AVEN binding (Figure S3E) so likely represent sec-
ondary effects.
In summary, AVEN does not recruit the Ski complex. Instead,
loss of AVEN increases SKIV2L binding and 30–50 RNA decay at
many sites. As aberrant translation events recruit SKIV2L and
AVEN may assist translation (Thandapani et al., 2015), we hy-
pothesize that AVEN prevents ribosome stalls that otherwise
trigger SKIV2L binding and mRNA decay.
AVEN and SKIV2L Counteract Ribosome Stalling
To globally assess how AVEN affects translation and ribosome
stalling, we performed monosome and disome profiling for WT
and Aven/ mESCs (Table S4). We plotted changes in mRNA
disome and monosome densities (Figure 5A), distinguishing
mRNAs with increased, decreased, or unchanged SKIV2L bind-
ing inAven/ versusWT (pink/blue/gray points in Figure 5A) and
calculated best fit lines. This revealed that inAven/, changes in
monosome and disome density occur for all categories of
mRNAs and are correlated, as expected. However, on top of
these changes, mRNAs gaining SKIV2L binding in Aven/
display a further increase in disome occupancy (upward shift
of pink points in Figure 5A; exemplified by replication-dependent
histone mRNAs in Figures 5B and 5C). mRNAs accumulating
disomes upon Aven knockout were bound by AVEN in WT
(Figure S4A), and disome changes in individual transcripts
overlapped with AVEN and SKIV2L binding (Figure 5C). These
data suggest that stalled ribosomes accumulating in Aven/
drive increased SKIV2L recruitment, which presumably clears
these mRNAs.
According to this model, the combined absence of AVEN and
SKIV2L should have an additive effect, as SKIV2L would not be
available to clear stalled messenger RNPs (mRNPs) arising in the
absence of AVEN. AVEN targets should thus be stabilized and
accumulate in a double knockout. To test this, we generated a
Skiv2lfl/fl conditional knockout in Aven/mESCs and performed
RNA-seq after 4OHT treatment (Figure S4B). In contrast to the
single Skiv2lfl/fl knockout, where transcripts accumulated after
4 days of 4OHT (Figure 1I), we observed widespread changes
in Aven/ Skiv2lfl/fl after 2 days (Figure 5D; Table S3). Upregu-
lated transcripts displayed high AVEN binding in WT (Figure 5D,
left) and increased SKIV2L occupancy in Aven/ (Figure 5D,
right), suggesting they are direct SKIV2L and AVEN targets.
Transcriptome-wide half-life measurements following actino-
mycin D transcription shut off confirmed that these targets are
stabilized in the double knockout (Figure S4C; Table S3). The
accumulation of replication-dependent histone mRNAs was
particularly striking (Figures 5D, circled). These results support
a model whereby AVEN and SKIV2L cooperate in translation-
coupled RNA surveillance, with AVEN opposing translational
stalls and SKIV2L eliminating mRNAs if aberrant events accumu-1228 Molecular Cell 77, 1222–1236, March 19, 2020late. Furthermore, SKIV2L and AVEN maintain normal histone
translation and RNA levels.
AVEN and SKIV2L Affect Expression of Many mRNAs
As replication-dependent histone levels are coupled to DNA syn-
thesis, with histone mRNAs accumulating until they are
degraded at the end of S-phase, we suspected that perturbed
histone expression in the absence of AVEN and SKIV2L might
alter cell-cycle progression. To test this, we synchronized
mESCs at G1/S using a double thymidine block and monitored
DNA content by DAPI staining following release (Figure S4D).
Aven/ Skiv2lfl/fl double knockout cells exhibited delayed pro-
gression through S phase, into G2, and ultimately into G1, in
line with their altered histone mRNA abundance (compared to
WT or single knockouts). We conclude that the AVEN-SKIV2L
pathway contributes to cell cycle progression.
While examining individual mRNAs, we noticed that besides
main CDS regions, SKIV2L and ribosomes also accumulate in
uORFs in Aven/ (Figures 5E and 5F). AVEN occupied these
uORFs in WT cells (Figure 5F), and increased ribosome occu-
pancy in Aven/ cells correlated with WT AVEN binding (Fig-
ure S4E) and increased SKIV2L binding in Aven/ (Figure 5E).
Whereas Aven knockout resulted in increased disome occu-
pancy in main CDS regions, changes across uORFs occurred
for monosomes, disomes, or both. AVEN thus has a complex
effect on 50 UTR translation.
As uORF translation can alter mRNA stability or main CDS
translation (Calvo et al., 2009), we wondered whether such
changes occur upon loss of AVEN and/or SKIV2L. We focused
on Atf4 and Ifrd1 mRNAs, with functional uORFs bound by
AVEN and SKIV2L (Figure 5F). Under normal conditions, Ifrd1
uORF translation destabilizes the mRNA via NMD (Zhao et al.,
2010). Ifrd1 RNA accumulated after 4 days of Skiv2l knockout
and 2 days of Aven Skiv2l double knockout (Figure 5G), suggest-
ing that SKIV2L participates in Ifrd1mRNA clearance, and this is
enhanced by increased uORF ribosome occupancy in Aven/.
In contrast to the destabilizing effect of the Ifrd1 uORF, within
Atf4, two uORFs modulate translation of the main CDS (Harding
et al., 2000; Vattem and Wek, 2004). Ribosomes normally trans-
late uORF1 then reinitiate at uORF2, preventing them from trans-
lating the main CDS, but during the integrated stress response
(ISR), phosphorylation of the translation factor eIF2a reduces
preinitiation complex availability. Ribosomes now scan past
uORF2 and reinitiate at the downstream main CDS, producing
ATF4protein. Toexamine theeffectsof increased ribosomeoccu-
pancy over Atf4 uORFs in Aven/, we monitored ATF4 accumu-
lation upon activation of the ISR with thapsigargin. Compared to
WT cells, ATF4 levels peaked earlier in Aven/, despite similar
levels of eIF2a phosphorylation and basal ATF4 pre-induction
(Figure S4F). Therefore, binding of AVEN and SKIV2L to uORFs
modifies transcript stability (Ifrd1) andmainCDS translation (Atf4).
In summary, the roles played by AVEN and SKIV2L in counter-
acting aberrant translation are crucial for expression of uORF-
containing and histone mRNAs, among others.
AVEN Acts on Structured RNAs
We next asked what makes mRNAs dependent on AVEN.
AVEN crosslinks to G-quadruplexes in Mll1 and Mll4 mRNAs
Figure 5. AVEN and SKIV2L Counteract Ribosome Stalling
(A) Changes in mRNA monosome and disome densities in Aven/ versus WT. Transcripts are colored by changes in SKIV2L binding in Aven/ versus WT
(threshold log2 fold change = ±0.5; up, n = 1,856; down, n = 2,019; unchanged, n = 2,373), and a linear best fit is plotted for each group (shaded area represents
95% confidence interval).
(B) Monosome and disome densities in WT (top) and Aven/ (bottom), highlighting histone mRNAs and with a cubic regression trendline.
(C) CRAC and monosome/disome profiling for individual mRNAs.
(D) Changes in mRNA abundance for Skiv2lfl/fl Aven/ cells after 2-day 4-OHT. Significantly changing mRNAs (padj < 0.05) colored by AVEN CRAC inWT (left) or
SKIV2L CRAC changes in Aven/ versus WT (right). Cubic regression trendlines are shown for all mRNAs, grouped by increased/decreased SKIV2L binding in
Aven/ versus WT (right).
(E) Changes in uORF SKIV2L CRAC and monosome profiling counts for Aven/ versus WT cells. Both datasets normalized to main CDS monosome profiling
counts. A best-fit line is shown, with 95% confidence intervals, and AVEN-bound uORFs (defined in Figure S4E) are colored red.
(F) CRAC and monosome/disome profiling for individual mRNAs. uORFs identified from monosome profiling are shown in red.
(G) RNA-seq counts for Ifrd1 in various cell lines showing individual replicates.
See also Figure S4 and Tables S3 and S4.
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Figure 6. AVEN Acts on Structured RNAs
(A and B) Structure (A) and sequence motif analysis (B) for AVEN-binding sites,
based on CRAC versus RNA-seq enrichments in 50-nt 50 UTR and CDS win-
dows. Points (structure motifs) in (A) are scaled by paired nucleotide content.
(C and D) Structure (C) and sequence motif analysis (D) for SKIV2L binding
sites, comparing Aven/ and WT cells. Points in (C) are scaled as for (A), and
points in (D) are scaled by GC content.
(E) Examples of AVEN-bound windows showing their sequence, predicted
structure (bracket/dot annotation for paired/unpaired nucleotides; + =
G-quadruplex), and CRAC coverage for various proteins.
See also Figure S5.(Thandapani et al., 2015), and RGG/RG motifs like AVEN’s
can melt G-rich or G-quadruplex sequences (Loughlin et al.,
2019; Meyer et al., 2019). To test whether AVEN binds specific
RNA sequences or structures, we examined the highest
AVEN-bound 50-nt windows from each mRNA 50 UTR
and CDS (based on CRAC). Compared to control regions,
AVEN-bound regions were enriched for stretches of paired
nucleotides or G-quadruplexes, based on RNAfold predictions
(Figure 6A), and GC-rich sequences (Figure 6B). The same
was true of regions binding SKIV2L in Aven/ (Figures 6C
and 6D), and these preferences were clear for individual
mRNAs (Figure 6E). This suggests that AVEN binding to1230 Molecular Cell 77, 1222–1236, March 19, 2020GC-rich sites with structural propensity avoids sustained
SKIV2L recruitment.
Interestingly, many SKIV2L-bound RNA fragments possessed
30 U-tails in Aven/ cells (Figure 4G), particularly where SKIV2L
binding increased (Figure S5A). As U-tails are added to 50 RNA
cleavage products, we reasoned they could pinpoint sites of
mRNA cleavage and decay in Aven/. Indeed, U-tailed
SKIV2L-bound RNA fragments in Aven/ were enriched up-
stream of predicted structured regions (Figure S5B). Disomes
aligned here in Aven/ (but not WT), and SKIV2L binding
increased (Figure S5B). This suggests that structure-prone
regions impede translation in Aven/, leading to ribosome
stalling, RNA cleavage, SKIV2L recruitment, and decay. We
speculate that AVEN helps suppress or melt RNA structures,
consistent with its binding to structure-prone regions.
sORF Surveillance by AVEN and SKIV2L
As SKIV2L and AVEN specialize in translation surveillance, we
did not expect them to bind non-coding RNAs (ncRNAs). How-
ever, upon Aven knockout, SKIV2L bound transcripts from inter-
genic, upstream, and antisense loci, and AVEN bound these
ncRNAs in WT cells (see examples in Figure 7A). To examine
this globally we divided the genome into 1 kb windows classified
by protein-coding gene overlap, and calculated log2-fold
changes in SKIV2L CRAC in Aven/ versus WT (Table S6).
This revealed increased SKIV2L binding to RNAs from hundreds
of non-coding regions (Figure 7B), accompanied by increased
U-tailing (Figure S5A). These transcripts were GC rich and pre-
dicted to form strong secondary structures (Figures S6A and
S6B), suggesting the same mechanism drives SKIV2L recruit-
ment to ncRNAs and mRNAs upon Aven deletion.
We wondered whether SKIV2L binding is due to ectopic
ribosome occupancy on these ‘‘non-coding’’ RNAs. Indeed,
monosomes and disomes accumulated at sites bound by
SKIV2L in Aven/ (e.g., Figure 7A), which often overlapped
small ORFs (sORFs; Table S7), suggesting they are translated.
Looking globally, we calculated log2-fold changes in monosome
and disome counts for the non-coding 1-kb windows defined in
Figure 7B, classified by differential SKIV2L binding in Aven/.
This revealed a correlation between gain of SKIV2L binding
and increased monosome and disome occupancy (Figure 7C,
‘‘SKIV2L CRAC,’’ ‘‘Monosomes’’, and ‘‘Disomes’’). Elevated dis-
ome occupancy was particularly strong, suggesting increased
ribosome stalling. The peptides generated by these translation
events do not appear to perform conserved functions, as their
sequences have low phyloCSF scores (Figure S6C). Changes
in SKIV2L binding correlated with AVEN occupancy in WT cells,
supporting a direct role for AVEN (Figure 7C, ‘‘AVEN vs SKIV2L
CRAC’’). Overall, our data suggest that loss of AVEN results in
ribosome stalling on sORFs in structured ncRNAs, which is
resolved by surveillance involving RNA cleavage and SKIV2L-
dependent decay.
A prediction of this is that upon Aven deletion, these ncRNAs
should become reliant on SKIV2L-dependent 30–50 decay, which
specializes in degrading RNAs with arrested ribosomes.
Presumably, alternative pathways remove these transcripts
when AVEN is present. Indeed, these ncRNAs do not strongly
accumulate in Aven/ and only slowly accumulate upon Skiv2l
Figure 7. Small ORF Surveillance by AVEN and SKIV2L
(A) CRAC, monosome, and disome profiling across ncRNA regions in WT and Aven/ cells, with small ORFs indicated. RNA-seq of ribosome profiling inputs
shown in blue.
(B) SKIV2L CRAC changes (Aven/ versus WT) for 1-kb genomic windows classified by overlap with protein-coding genes.
(C) CRAC, ribosome profiling, and RNA-seq changes for the indicated comparisons, for non-coding 1-kb genomic windows defined in (B). Windows are
categorized by their change in SKIV2L CRAC for Aven/ versus WT cells (defined in the leftmost plot). The two genes in (A) are highlighted. *p < 104 (‘‘Slight
change’’ versus ‘‘Strongly up’’ categories; Mann-Whitney U test with Bonferroni correction).
See also Figure S6 and Tables S6 and S7.knockout but rapidly accumulate when Skiv2l is knocked out in
Aven/ cells (Figure 7C, ‘‘RNA-seq’’). We conclude that the
absence of AVEN renders cells dependent on SKIV2L to clearncRNAs with trapped ribosomes. The AVEN-SKIV2L pathway
thus plays a universal role in counteracting aberrant translation
on coding RNAs and ncRNAs.Molecular Cell 77, 1222–1236, March 19, 2020 1231
DISCUSSION
Mammalian mRNA Decay: Specialization and Links to
Translation
We are struck by the widespread coupling between cyto-
plasmic mRNA decay and translation revealed by our study.
Evidence of such crosstalk has been mounting, from reports
that SKIV2L and XRN1 associate with polysomes (Mangus
and Jacobson, 1999; Qu et al., 1998) to analyses of decay in-
termediates (Antic et al., 2015; Hu et al., 2009; Pelechano
et al., 2015) and structures of the Ski complex and Xrn1 bound
to yeast ribosomes (Schmidt et al., 2016; Tesina et al., 2019).
We show that XRN1 and SKIV2L ribosome binding sites are
conserved to mammals, these interactions occur under phys-
iological conditions, and remarkably, SKIV2L is exclusively and
universally recruited by ribosomes.
Ski2 was thought to act redundantly with Xrn1 in bulk RNA
decay, based on synthetic lethality in yeast (Anderson and
Parker, 1998; Johnson and Kolodner, 1995). However, yeast
Ski2 binding to 30 UTRs (Sohrabi-Jahromi et al., 2019; Tuck
and Tollervey, 2013) relies on fungus-specific factors such as
Ska1 to antagonize ribosome interactions (Zhang et al., 2019).
Our data argue that mammalian SKIV2L does not function in
full-length mRNA decay but acts almost exclusively in transla-
tion-associated RNA surveillance. As the Ski complex is indis-
pensable for cytoplasmic exosome activity (Anderson and
Parker, 1998; Araki et al., 2001; van Hoof et al., 2000), this implies
that the cytoplasmic exosome acts similarly exclusively in
surveillance. We note that mammals possess an exosome-
independent 30–50 decay pathway (DIS3L2). This might assist
XRN1 in bulk decay, in line with a report that XRN1 and DIS3L2
knockdowns result in broader mRNA changes than DIS3L
(exosome) knockdown (Lubas et al., 2013). The 30 UTR accumu-
lation of XRN1 suggests a passive role for translation in 50–
30 decay. Future biochemical studies should help clarify these
possible differences between SKIV2L- and XRN1-ribosome
interactions.
Interestingly, we found that SKIV2L acts in bulk decay of a few
mRNAs. Unique features might render these accessible to, or
dependent on, ribosome-bound SKIV2L. For example, cleavage
of Ifrd1might generate an access point for SKIV2L (Ottens et al.,
2017), and ribosome-bound SKIV2L could reach the end of short
histone mRNA 30 UTRs. This was proposed for S. cerevisiae
mRNAs (Zhang et al., 2019), and we see SKIV2L binding to
very short 30 UTRs (Figure 2B). Alternatively, surveillance-
inducing ribosome collisions may be rife within histone mRNAs,
whose decay requires stalled ribosome factors HBS1 and
PELOTA (Slevin et al., 2014). Although this pathway is wasteful,
as it eliminates the nascent polypeptide, for replication-depen-
dent histones, this may help to tightly restrict their expression
to S-phase.
For most mRNAs, however, there is a clear division of labor,
with XRN1 specializing in bulk RNA decay (albeit with a minor
role in surveillance) and SKIV2L in surveillance. This ensures
that translation is not interrupted by bulk RNA turnover, as
XRN1 follows the last ribosome, and may reflect a need for
dedicated surveillance factors to wrestle mRNAs from arrested
ribosomes. Indeed, it is even possible that SKIV2L could perform1232 Molecular Cell 77, 1222–1236, March 19, 2020additional roles in resolving stalled mRNA-ribosome complexes,
beyond assisting the exosome in 30–50 decay.
Defining Translation-Dependent mRNA Surveillance
Our data also reveal triggers and components of RNA surveil-
lance. SKIV2L pervasively interacts with ribosome-occupied
regions, establishing it as a central component of translation
surveillance. Based on the low level of U-tailing (a proxy for
RNA cleavage), we suggest SKIV2L binding in WT cells mostly
reflects dynamic probing of translation, which rarely triggers a
full surveillance response. Nonetheless, SKIV2L and disomes
were enriched at A-rich tracts, proline sequences, and uORFs,
suggesting they occasionally trigger ribosome stalling and RNA
decay. For A-rich tracts, the sequence appears key, consistent
with reports that 11 As attenuate translation in human cells
(Arthur et al., 2015). We find this occurs at many endogenous
sites with 8–9 As sufficient.
Besides defining SKIV2L targets, we established AVEN and
FOCAD as components of this pathway. AVEN was reported to
interact with the Ski complex and FOCAD in human cells (Than-
dapani et al., 2015) and identified in an NMD screen (Alexandrov
et al., 2017), and the plant FOCAD homolog Rst1 interacts with
the Ski complex and exosome (Lange et al., 2019). AVEN is
conserved from mammals to flies (Zou et al., 2011) and FOCAD
to plants (Lange et al., 2019), so their RNA decay roles may be
evolutionarily important.
AVEN as an Anti-stalling Factor
We propose that AVEN prevents ribosome stalls, which other-
wise trigger mRNA cleavage and decay. The RNA-binding
preferences and position of AVEN on the ribosome might let it
directly melt structures arresting translation, potentially via its
RGG/RG domain. Supporting this, FUS and AUF1 RGG/RG
domains remodel RNA (Loughlin et al., 2019; Meyer et al.,
2019). Alternatively, AVEN might recruit a helicase (Thandapani
et al., 2015), although besides SKIV2L, we did not detect heli-
case partners for AVEN.
In our model, AVEN acts prior to SKIV2L, to prevent ribosome
stalling, and is potentially loaded with scanning ribosomes.
However, our IP-MS data suggest that AVEN and SKIV2L
directly interact. To resolve this paradox, we propose that the
AVEN-SKIV2L interaction is transient, perhaps serving as a
handover to ensure unresolved ribosome stalls are not left
unchecked. Transient ‘‘connections’’ are common in RNA sur-
veillance, as reported for Ski complex-exosome (Kalisiak et al.,
2017) and nuclear MTR4-ZFC3H1-PABPN1 interactions (Meola
et al., 2016).
Exploring the AVEN-SKIV2L pathway revealed that
uORF-containing and histone mRNAs are particularly sensitive.
AVEN prevents cell-cycle arrest in osteosarcoma andDrosophila
cells (Baranski et al., 2015; Zou et al., 2011) and delays mitotic
entry in Xenopus egg extracts (Guo et al., 2008; Zou et al.,
2011). Our data suggest AVEN also plays a direct role in cell-
cycle progression via reducing ribosome stalling on histone
mRNAs. The most surprising AVEN and SKIV2L substrates,
however, were ncRNAs. Here, an appealing model is that
AVEN assists in functional small peptide production. Although
AVEN-dependent sORFs have low phyloCSF scores and we
could not detect derived peptides, AVEN could enable cells to
express peptides that eventually evolve to become stable and
perform important roles. Alternatively, AVEN and SKIV2L may
target nuclear ncRNAs escaping to the cytoplasm. These struc-
tured RNAs could function in the nucleus but in the cytoplasm
might become stuck on ribosomes if left unchecked.
In conclusion, we find that mammalian RNA decay path-
ways are highly specialized and cytoplasmic decay is widely
coupled to translation. While normal translation may assist
bulk mRNA turnover, aberrant translation events pose a
diverse threat counteracted by the concerted activity of
AVEN and SKIV2L.STAR+METHODS
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Donor oligonucleotides for genome
editing, see Table S1
This paper N/A
50 adapters for CRAC (barcodes highlighted): N/A
/5InvddT/ACACrGrArCrGrCrUrCrUrUrCrCrGr
ArUrCrUrNrNrNrNrUrArArGrC
L5Aa IDT custom synthesis
/5InvddT/ACACrGrArCrGrCrUrCrUrUrCrCr
GrArUrCrUrNrNrNrNrArUrUrArGrC
L5Ab IDT custom synthesis
/5InvddT/ACACrGrArCrGrCrUrCrUrUrCrCrGr
ArUrCrUrNrNrNrNrGrCrGrCrArGrC
L5Ac IDT custom synthesis
/5InvddT/ACACrGrArCrGrCrUrCrUrUrCrCrGr
ArUrCrUrNrNrNrNrCrGrCrUrUrArGrC
L5Ad IDT custom synthesis
/5InvddT/ACACrGrArCrGrCrUrCrUrUrCrCrGr
ArUrCrUrNrNrNrNrArGrArGrC
L5Ba IDT custom synthesis
/5InvddT/ACACrGrArCrGrCrUrCrUrUrCrCrGr
ArUrCrUrNrNrNrNrGrUrGrArGrC
L5Bb IDT custom synthesis
/5InvddT/ACACrGrArCrGrCrUrCrUrUrCrCrGr
ArUrCrUrNrNrNrNrCrArCrUrArGrC
L5Bc IDT custom synthesis
/5InvddT/ACACrGrArCrGrCrUrCrUrUrCrCrGr
ArUrCrUrNrNrNrNrUrCrUrCrUrArGrC
L5Bd IDT custom synthesis
/5InvddT/ACACrGrArCrGrCrUrCrUrUrCrCrGr
ArUrCrUrNrNrNrNrCrUrArGrC
L5Ca IDT custom synthesis
/5InvddT/ACACrGrArCrGrCrUrCrUrUrCrCrGr
ArUrCrUrNrNrNrNrUrGrGrArGrC
L5Cb IDT custom synthesis
/5InvddT/ACACrGrArCrGrCrUrCrUrUrCrCrGr
ArUrCrUrNrNrNrNrArCrUrCrArGrC
L5Cc IDT custom synthesis
/5InvddT/ACACrGrArCrGrCrUrCrUrUrCrCrGr
ArUrCrUrNrNrNrNrGrArCrUrUrArGrC
L5Cd IDT custom synthesis
AATGATACGGCGACCACCGAGATCTACACT
CTTTCCCTACACGACGCTCTTCCGATCT
P5 IDT custom synthesis
CAAGCAGAAGACGGCATACGAGATCGGTCT
CGGCATTCCTGGCCTTGGCACCCGAGAATTCC
PE IDT custom synthesis
Software and Algorithms
STAR 2.5.0a Dobin et al., 2013 N/A
Bedtools 2.26.0 Quinlan, 2014 N/A
Samtools 1.6 Li et al., 2009 N/A
R version 3.5.1 Patched (2018-11-02 r75543) R Core Team, 2013 https://www.r-project.org/
ggplot2 3.1.0 Wickham, 2016 N/A
FASTX Toolkit 0.0.14 http://hannonlab.cshl.edu/
fastx_toolkit/
pyCRAC Webb et al., 2014 N/A
prinseq-lite-0.20.4 Schmieder and Edwards, 2011 N/A
bowtie2-2.3.4.1 Langmead and Salzberg, 2012 N/A
(Continued on next page)
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
DESeq2 Love et al., 2014 N/A
RNAfold 2.1.5 Lorenz et al., 2011 N/A
cutadapt Martin, 2011 N/A
StringTie 1.3.3b Pertea et al., 2015 N/A
edgeR v3.16.5 Robinson et al., 2010 N/ALEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Marc
B€uhler (marc.buehler@fmi.ch). All unique reagents generated in this study are available from the Lead Contact with a completed
Materials Transfer Agreement.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Male 129 3 C57BL/6 mouse embryonic stem cells (mESC) (Mohn et al., 2008) were grown in serum/LIF media (DMEM (GIBCO
21969-035) supplemented with 15% fetal bovine serum (GIBCO 10270106), 2 mM L-glutamine (GIBCO 25030024), 1x non-essential
amino acids (GIBCO 11140035), 1 mM sodium pyruvate (GIBCO 11360070), 0.1 mM 2-mercaptoethanol (Sigma M-7522), 50 mg
ml1 penicillin, 80 mg ml1 streptomycin and homemade LIF) at 37 C in 5% CO2. Cells were cultured on dishes coated with
0.1% gelatin (Sigma G1890).
METHOD DETAILS
Generation of endogenously tagged cell lines
Endogenous gene tagging with a 3xFLAG-AviTag was performed in mES 1293 C57BL/6 cells expressing BirA ligase and CreERT2
from the Rosa26 locus (cMB063) (Ostapcuk et al., 2018), using TALEN or CRISPR-Cas9 homology-directed repair with single-
stranded oligodeoxynucleotide (ssODN) donor templates encoding the tag, flanked by 50 and 30 homology arms. The ssODNs donors
were synthetized as ultramers by Integrated DNA Technologies. N-terminally tagged Skiv2l3xFLAG-Avi/3xFLAG-Avi clone 8F (cMB331)
and Aven3xFLAG-Avi/3xFLAG-Avi clone 2B (cMB323) were generated using TALENs and Cas9/gRNA, respectively, cutting near the
start codon. Xrn13xFLAG-Avi/3xFLAG-Avi clone 4F (cMB315) was C-terminally tagged using Cas9/gRNA cutting near the stop codon.
N-terminally tagged Mtr4 cell lines (cMB376 and cMB503) were previously described (Tuck et al., 2018). C-terminally tagged
Rps103xFLAG-Avi/3xFLAG-Avi clone 4E (cMB395) was generated using Cas9/gRNA cutting near the stop codon. N-terminally tagged
Dis3l2xHA-FKBP12(F36V)/ 2xHA-FKBP12(F36V) (cMB510) was generated in the Skiv2l3xFLAG-Avi/3xFLAG-Avi (cMB331) background using
Cas9/gRNA cutting near the start codon. For homology-directed repair, the donor sequence encoding the 2xHA-FKBP12(F36V)
tag, flanked by 550bp Dis3l 50 and 30 homology arms was cloned into a pBLU plasmid and transfected together with the Cas9/
gRNA. All clones were screened for homozygous integration of the tag by PCR and Sanger sequencing and expression of the fusion
proteins was confirmed by western blot with an anti-FLAG or anti-HA antibody. Biotinylation of the tag was verified by western blot
using streptavidin-HRP. A full list of genome-edited cell lines together with TALENs, gRNAs and donor ssODN ultramer sequences
can be found in Table S1.
Generation of straight KO cell lines
Aven/ clones 4H (cMB399) and 6G (cMB400) were generated in a Skiv2l3xFLAG-Avi/3xFLAG-Avi background (cMB331) using Cas9/
gRNAs targeting Aven exon 3 and exon 6 (last exon), resulting in a deletion of approximately 5.7 kb. Focad/ clones 2F
(cMB396) and 4B (cMB397) were generated in a Skiv2l3xFLAG-Avi/3xFLAG-Avi background (cMB331) with Cas9/gRNAs targeting intron
2 and intron 4. The resulting deletion of approximately 7.3 kb introduces a frameshift in exon 5. Homozygous knockout clones were
screened by PCR and Sanger sequencing and deletion was confirmed by western blot or RT-qPCR. See also Table S1.
Generation of conditional KO cell lines
Skiv2lfl/fl cell lines were generated in a 1293 C57BL/6 WT background expressing a CreERT2 recombinase fusion from the Rosa26
locus (cMB052) as well as in Aven/ cells where Skiv2l is endogenously tagged (cMB399). A plasmid expressing Cas9 and gRNAs
targeting Skiv2l intron 10 and intron 17 was co-transfected with ssODN containing homology arms and LoxP sites for integration.
Recombination of the LoxP sites eliminates exons 11-17 containing the catalytic DExH box and results in out-of-frame translation
of the last 18 exons. Clones with homozygous insertions of LoxP sites in both intron 10 and intron 17 were screened by PCR
and Sanger sequencing. Proper recombination of the LoxP sites was tested by RT-qPCR, or western blot, following treatment
with 0.1 mM 4-hydroxytamoxifen (4-OHT) (Sigma) for 2, 4 or 6 days. See also Table S1.e4 Molecular Cell 77, 1222–1236.e1–e13, March 19, 2020
Transfections
For genome editing with CRISPR-Cas9, gRNAswere cloned into the SpCas9-2A-mCherry vector (Knuckles et al., 2017). To generate
endogenously tagged Xrn1 (cMB315), Aven (cMB323) and Rps10 (cMB395), cells were transfected with 1000 ng SpCas9-2A-
mCherry, 1400 ng ssODN donor and 100 ng pRRE GFP homologous recombination reporter (Flemr and B€uhler, 2015). mCherry
and GFP double-positive cells were FACS-sorted 24 hours after the transfection and seeded sparsely (10,000 cells) on 10 cm plates
for clonal expansion. After 5-7 days, colonies were individually picked into 96-well plates, expanded and genotyped by PCR. Cells
with proper in-frame homozygous insertions of the tag were further confirmed by Sanger sequencing and western blot.
For endogenous tagging of Skiv2l (cMB331) with TALENs, cells were transfected with 400 ng of each TALEN, 1000 ng ssODN
donor and 100 ng of pRRP puromycin recombination reporter (Flemr and B€uhler, 2015). 24 hours post-transfection, the cells were
selected with 2 mg/ml puromycin for 28 hours and surviving cells were plated at clonal densities as described above. Skiv2lfl/fl cell
lines were generated by transfecting 450 ng of each SpCas9-2A-mCherry gRNA plasmid, 500 ng of each LoxP ssODN donor and
50 ng of each pRRP puromycin reporter and selection with 2 mg/ml puromycin.
To create Aven/ (cMB399 and cMB400) and Focad/ (cMB396 and cMB397), cells were transfected with 500 ng of each
SpCas9-2A-mCherry gRNA vector and 50 ng of each pRRP or pRRE-GFP reporter. Aven/ cells were selected on 2 mg/ml
puromycin and Focad/ cells were selected by FACS-sorting mCherry-GFP double-positives.
To generate endogenously tagged Dis3l2xHA-FKBP12(F36V)/ 2xHA-FKBP12(F36V) (cMB510), Skiv2l3xFLAG-Avi/3xFLAG-Avi (cMB331) cells were
transfected with 500 ng SpCas9-2A-mCherry, 700 ng pBLU 2xHA-FKBP12(F36V) donor plasmid and 100 ng pRRP puromycin
reporter. The cells were selected with 2 mg/ml puromycin and genotyped as described above. All transfections were carried out
with Lipofectamine 3000 reagent at 3 ml per 1 mg of total DNA in OptiMem media. Approximately 500,000 cells were used for
each transfection.
RNA sequencing
Total RNA was extracted from 80% confluent 6 cm dishes using the Agilent Absolutely RNA Miniprep Kit with on-column DNase
digestion. After ribosomal RNA depletion with the Illumina Ribozero kit, libraries were constructed using either ScriptSeq v2 or
TruSeq v2 kits and sequenced on an Illumina HiSeq2500 platform (50 nt single-end reads). Total RNA from Skiv2lfl/fl conditional
knockouts was extracted after culturing the cells in media supplemented with 0.1 mM 4OHT for 0, 2, 4 or 6 days to induce
Skiv2l knockout.
To measure transcriptome-wide RNA half-lives, 300,000 mESCs were seeded per well of a six-well dish and grown for 48 h
in serum + LIF medium. The medium was replaced by fresh medium with 5 mM actinomycin D (from a 5 mg/ml stock in DMSO)
and the cells were incubated for 120, 240 or 360min. Amock treatment (360min) was included, usingmediumwith the same amount
of DMSO but no actinomycin D. After the indicated times, cells were washed twice with 37C PBS and RNA extracted using the
Agilent Absolutely RNAMiniprep kit. ERCC RNA spike-ins were added to the lysis buffer (1.7 mL of a 1:10 dilution per sample) before
it was added to the cells. Three technical replicates were performed for each cell line, treatment and time point.
CRAC
CRAC was performed as described in (Tuck et al., 2018), with minor modifications, and is described in full here:
mESCswere grown in 2x 15-cmdishes to80%confluency, disheswashed 2xwith PBS, the PBS removed, then cells crosslinked
on ice (with dishes facing up) in a Stratagene Stratalinker 2400 (400 mJ cm2). Cells were lysed by incubating with 5 mL of either
TN150+NP40 (50 mM Tris-HCl pH 7.8, 150 mM NaCl, 0.5% Nonidet P40 substitute and 1x cOmplete Protease Inhibitor Cocktail),
or of RIPA (50 mM Tris-HCl pH 7.8, 300 mM NaCl, 1.0% Nonidet P40 substitute, 0.1% SDS, 10% (v/v) glycerol, 0.5% sodium
deoxycholate, 1 mM beta-mercaptoethanol, 1x cOmplete Protease Inhibitor Cocktail), as indicated in Table S2. The harsher buffer
(RIPA) was initially used to ensure complete extraction, but as this can reduce FLAG binding we later switched to a milder buffer
(TN150), which did not affect library content. The cells were further disrupted using a cell scraper then lysates collected and
centrifuged (6500 xg for 20 min at 4C). Supernatants were frozen in liquid nitrogen and stored at 80C.
Lysates were thawed on ice and incubated with 100 mL anti-FLAG M2 magnetic beads overnight. The supernatant was discarded
and beads washed 3x with 1 mL TN150 (50 mM Tris-HCl pH 7.8, 150 mM NaCl, 0.1% Nonidet P40 substitute). Protein:RNA
complexes were eluted by incubating beads in 1.5 mL TN150 supplemented with 5 mM beta-mercaptoethanol and 0.3 mg/ml
3xFLAG peptide, rotating at 4C for 2 hr. The eluate was then incubated with 50 mL Dynabeads M-280 Streptavidin, rotating at
4C overnight. Beads were washed 2x in TN600 (50 mM Tris-HCl pH 7.8, 600 mM NaCl, 0.1% Nonidet P40 substitute, 5 mM
beta-mercaptoethanol) and 2x in TN150 supplemented with 5mMbeta-mercaptoethanol. RNAwas fragmented by incubating beads
in 500 mL TN150 supplemented with 5mMbeta-mercaptoethanol and 1 mL of 0.1 U diluted RNace-IT. After 4min at 37C, the RNases
were denatured by replacing the solution with 400 mLWBI (50mMTris-HCl pH 7.8, 300mMNaCl, 0.1%Nonidet P40 substitute, 5mM
beta-mercaptoethanol and 4.0 M guanidine hydrochloride). The beads were washed 2x in WBI, then 3x in 400 mL 1xPNK (50 mM
Tris-HCl pH 7.8, 10 mM MgCl2, 0.5% Nonidet P40 substitute, 5 mM beta-mercaptoethanol).
The following four enzymatic reactions were then performed in 80 mL 1xPNK buffer (omitting the Nonidet P40 substitute), to ligate
30 and 50 adapters onto RNA fragments. After each reaction, beads were washed 1x in WBI and 3x in 1xPNK:
(i) Alkaline phosphatase treatment (30 min, 37C): 8 U TSAP, 80 U RNasIN.Molecular Cell 77, 1222–1236.e1–e13, March 19, 2020 e5
(ii) 30 linker ligation (overnight, 16C): 0.1 nmol miRCat-33 DNA linker, 40 U T4 RNA Ligase 1, 80 U RNasIN, 12.5% (v/v) PEG8000.
(iii) 50 phosphorylation (1 hr, 37C): 40 U T4 PNK, 2 mL g32P-ATP (after 30 min, add 1 mL 100 mM rATP and an additional 20 U
T4 PNK).
(iv) 50 linker ligation (overnight, 16C): 0.2 nmol 50 linker, 40 U T4 RNA Ligase 1, 1.25 mM rATP, 80 U RNasIN, 12.5% (v/v)
PEG8000.
After the final reaction, beads were washed 3x in WBII (50 mM Tris-HCl pH 7.8, 50 mM NaCl, 0.1% Nonidet P40 substitute, 5 mM
beta-mercaptoethanol), resuspended in 30 mL 1x NuPAGE LDS sample buffer, heated at 95C for 2 min, and the eluate quickly
removed and loaded onto a NuPAGE 4%–12% polyacrylamide gel. The gel was run at 100 V for 1 hr, then protein:RNA complexes
transferred to Hybond-C extra nitrocellulose membrane (Amersham) at 150 V for 1.5 hr using a wet transfer system and NuPAGE
transfer buffer with 15% methanol. The membrane was then briefly dried, exposed to BioMax MS film (4 hr to overnight) and the
region corresponding to the protein:RNA complex cut out.
The membrane slice was then incubated in 400 mL WBII with 1% (w/v) SDS, 5 mM EDTA and 100 mg Proteinase K at 55C for 2 hr.
The solution was then removed to another tube, 50 ml 3M NaAc pH 5.2 and 500 ml of 1:1 phenol:chloroform mix added, and the
mixture vortexed then centrifuged at 14,000 xg for 20 min. The top phase was transferred into a new tube and 1 mL ethanol and
20 mg glycogen added. The solution was stored at 20C overnight to precipitate RNA, then centrifuged at 14,000 xg for 1 hr.
The pellet was washed once with 70% ethanol and allowed to briefly air dry, before resuspending in 11 mL water + 1 mL 10 mM
miRCat-33 RT oligo + 1 mL 10 mM dNTP mix. The solution was heated to 80C for 3 min, snap cooled on ice for 5 min, then the
following mix added: 4 mL 5x first strand buffer (SSIII kit) + 1 mL 100 mM DTT (SSIII kit) + 1 mL recombinant RNasIN. After incubating
for 3 min at 50C, 200 U of SuperScript III was added and the reverse transcription allowed to proceed for 1 hr at 50C. The reaction
was stopped by heating to 65C for 15min, then RNA digestedwith 10 URNaseH at 37C for 30min. PCR reactions (80 mL) were then
prepared, eachwith 2 mL cDNA, 10 pmol P5, 10 pmol PE, 12.5 nmol each dNTP and 2.5 U LA Taq. Typically, we ran five PCR reactions
and then concentrated the products by ethanol precipitation before resolving on a 3% metaphor agarose gel in 0.5x TBE. A smear
corresponding to the size of the two adapters plus inserts (total size 120-300 bp) was then excised, and DNA extracted using the
MinElute gel extraction kit, eluting in 20 mL water. If the experiment was successful, we repeated the PCRs with the remaining half of
the cDNA.
The above CRAC protocol is referred to as the ‘‘long’’ protocol. For some samples (indicated in Table S2), a shorter version
of the protocol was used, which did not affect library content. The shorter version omits radiolabelling (using cold rATP instead),
SDS-PAGE and transfer to nitrocellulose. Instead, after 30 linker ligation, beads were washed and added directly to 400 mL WBII
with 1% (w/v) SDS, 5 mM EDTA and 100 mg Proteinase K. This version of the CRAC protocol is referred to as the ‘‘short’’ protocol
(indicated in Table S2).
Translation inhibition experiments for CRAC
Cells grown to 80% confluency on 15cm dishes were incubated with media supplemented with either 100 mg/mL cycloheximide
or 5 mM harringtonine for 30 min at 37C. Cells were then washed twice with PBS containing the same concentration of the corre-
sponding inhibitors. PBS was removed after the last wash and the cells were cross-linked on ice, with the dishes facing up, in a
Stratagene Stratalinker 2400 (400 mJ$cm2) and processed for CRAC as described above.
Ribosome profiling
Cells were harvested (without cycloheximide pretreatment) and flash-frozen in liquid nitrogen. From the cell pellets, lysates were
prepared and ribosome-protected mRNA fragments were generated by RNase I digestion as previously described (Janich et al.,
2015). For the excision of footprints from 15% urea-polyacrylamide gels, single strand RNA oligonucleotides of 26 nt and 34 nt
(for monosome footprints) and of 52 nt and 69 nt (for disome footprints) served as size markers for excision of footprints. After
fragment purification with miRNeasy RNA Extraction kit, 5mg fragmented RNA was used for ribosomal RNA removal using
Ribo-Zero Gold rRNA Removal Kit according to Illumina’s protocol for TruSeq Ribo Profile (RPHMR12126 Illumina).
Sequencing libraries were generated according to Illumina’s TruSeq Ribo-Profile protocol with minor modifications. Monosomes
and disomes were treated as independent libraries. cDNA fragments were separated on a 10% urea-polyacrylamide gel and gel
slices between 70-80 nt for monosomes and 97-114 nt for disomes were excised. The PCR-amplified libraries were size selected
on an 8% native polyacrylamide gel. Monosome libraries were at 150 bp and disome libraries at 180 bp.
Parallel RNA-seq libraries were prepared essentially following the Illumina protocol (Janich et al., 2015); briefly, after total
RNA extraction using miRNeasy RNA Extraction kit, ribosomal RNA was depleted using Ribo-Zero Gold rRNA Kit, and sequencing
libraries generated from the heat-fragmented RNA as described (Janich et al., 2015). All libraries were sequenced on Illumina
HiSeq 2500.
Western Blotting
Cells were lysed for 30 min on ice in 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Triton-X, 0.5 mM EDTA, 5% glycerol, 1x protease
inhibitor cocktail (Roche) and 1 mM DTT. Lysates were clarified by centrifugation at 16,000 xg for 10 min at 4C and protein
concentration was measured using the BioRad protein assay. Approximately 20 mg of total protein extract was resolved one6 Molecular Cell 77, 1222–1236.e1–e13, March 19, 2020
NuPAGE-Novex Bis-Tris 4%–12% gradient gels (Thermo Fisher NP0322BOX), transferred semi-dry to a polyvinylidene fluoride
(PVDF) membrane, blocked in 5% non-fat milk in TBS+0.05% Tween (TBST) for 30 min at room temperature and incubated with
primary antibodies at 4 C overnight. The following primary antibodies were used for western blotting: mouse anti-Flag (1:1,000,
Sigma clone M2), rabbit anti-AVEN (1:2,000, ProScience 2417), rabbit anti-ATF4 (1:1,000, Cell Signaling D4B8 mAb11815), rabbit
anti- Phospho-eIF2a Ser51 (1:1,000, Cell Signaling D9G8 mAb3398), rabbit anti-eIF4E (1:1,000, Bethyl A301-154A) and rat anti-
tubulin (1:5,000, Abcam clone YL1/2). Following incubation with corresponding HRP-conjugated secondary antibodies, signal
was visualized using Immobilon Western Chemiluminiscent HRP Substrate. To detect biotinylated proteins, after transfer, mem-
branes were blocked in 2% bovine serum albumin (BSA) in TBST for 30 min and incubated with HRP-conjugated streptavidin
(Strep-HRP) diluted 1:10,000 in 2% BSA-TBST for 30 min at room temperature. For detection of ATF4 and Phospho-eIF2a Ser51,
membranes were first probed for ATF4, stripped in 25 mM Glycine, pH 2 and 1% SDS for 5 min at room temperature, rinsed with
TBST, blocked in 5% non-fat milk TBST for 30 min and re-probed for Phospho-eIF2a Ser51.
Co-immunoprecipitations
Dis3l2xHA-FKBP12(F36V)/2xHA-FKBP12(F36V) (cMB510) cells grown to80% confluency in a 10 cm dish were trypsinized, collected in media
and washed twice with PBS. The cells were lysed for 40 min at 4C in 500 ml lysis buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl,
2.5 mM MgCl2, 0.5% NP-40), supplemented with 1X protease inhibitor cocktail (Roche). Lysates were clarified by centrifugation
at 16,000 g for 5 min and mixed with 30 ml Protein-G Dynabeads (Thermo Fisher 10004D) coupled to 2 mg anti-HA antibody (Roche
11867423001). The sample was incubated for 1 hour at 4C on a rotating wheel. The beads were then washed four times in wash
buffer (10mMTris-HCl, pH 7.4, 150mMNaCl, 2.5mMMgCl2, 0.1%NP-40), resuspended in 60 ml 1X Bolt LDS Sample Buffer (Thermo
Fisher B0007) and incubated at 85C for 5 min to elute captured proteins from the beads. Following this, 2% of the input and 30% of
the IPmaterial were resolved on a NuPAGE-Novex Bis-Tris 4%–12%gradient gel (Thermo Fisher NP0322BOX), transferred semi-dry
to a polyvinylidene fluoride (PVDF) membrane, blocked in 5% non-fat milk in TBS+0.05% Tween (TBST) for 30 min at room temper-
ature and incubated with primary antibodies at 4 C overnight. The following primary antibodies were used for western blotting: rat
anti-HA (1:1,000, Roche 11867423001), mouse anti-Flag (1:1,000, Sigma clone M2), rabbit anti-Mtr4 (1:1,000, Thermo Fisher
PA5-57927).
Affinity purification for LC–MS/MS
For tandem FLAG-streptavidin affinity purification, two confluent 15 cm dishes seeded with equal number Skiv2l3xFLAG-Avi/3xFLAG-Avi
cells or the corresponding untagged parental line were harvested by trypsinization, washed twice in PBS and lysed 2 hours to
overnight at 4C in whole cell lysis buffer (10 mM Tris-HCl pH 7.4, 150 mM KCl, 2.5 mM MgCl2, 0.5% NP-40), supplemented with
1X protease inhibitor cocktail, 50 units benzonase and 10 mg RNase A. Lysates were clarified by centrifugation at 16,000 g for
15 min and incubated with 20 ml anti-FLAG M2 Dynabeads for 4 hours at 4C. After washing the FLAG beads three times with
wash buffer (10mM Tris-HCl (pH 7.4), 150 mM KCl. 2.5 mM MgCl2, 0.1% NP-40), proteins were eluted from the beads three times
for 15 min at 4C with 100 mg/ml 3xFLAG peptide diluted in 150 ml wash buffer. The eluates were combined and incubated with
20 ml M-280 Streptavidin Dynabeads for 2 hours at 4C, washed four times in wash buffer and two times in wash buffer
without NP-40. For mass spectrometry analysis, captured proteins were digested with trypsin directly on the streptavidin beads.
High-salt tandem FLAG-strep affinity purifications were essentially carried out as described above with the following modifications:
cells from two confluent 10 cm dishes were lysed in buffer containing 350mMKCl. For single-step streptavidin pull-downs, the FLAG
purification step was omitted and total cell lysates from two confluent 10 cmdishes were applied directly to streptavidin beads. Every
affinity purification experiment contained three separate technical replicates for each cell line.
Mass spectrometry analysis
Peptides generated by trypsin digestion (see ‘Affinity purification for LC–MS/MS’) were acidified with 0.8% TFA (final) and analyzed
by LC–MS/MS on an EASY-nLC 1000 with a two column set-up (Thermo Scientific). The peptides were applied onto a peptide trap
(Acclaim PepMap 100, 75 mm 3 2 cm, C18, 3 mm, 100 A˚) in 0.1% formic acid, 2% acetonitrile in H2O at a constant pressure of
80 MPa. Using a flow rate of 150 nl min1, peptides were separated with a linear gradient of 2%–6% buffer B in buffer A in 3 min
followed by an linear increase from 6 to 22% in 40 min, 22%–28% in 9 min, 28%–36% in 8 min, 36%–80% in 1 min and the column
was finally washed for 14 min at 80% buffer B in buffer A (buffer A: 0.1% formic acid; buffer B: 0.1% formic acid in acetonitrile) on
a 50 mm3 15 cm ES801 C18, 2 mm, 100 A˚ column (Thermo Scientific) mounted on a DPV ion source (New Objective) connected to a
Orbitrap Fusion (Thermo Scientific). Data acquisition was performed using 120,000 resolution for the peptide measurements in
the Orbitrap and a top T (3 s) method with HCD fragmentation for each precursor and fragment measurement in the ion trap following
the manufacturer guidelines (Thermo Scientific).
Peptide identification was performed with MaxQuant version 1.5.3.8 using Andromeda as search engine (Cox et al., 2011). The
mouse subset of the UniProt version 2015_01 combined with the contaminant DB from MaxQuant was searched and the protein
and peptide FDR values were set to 0.05. All MaxQuant parameters can be found in Table S5.
Statistical analysis was done in Perseus (version 1.5.2.6) (Tyanova et al., 2016). Results were filtered to remove reverse hits,
contaminants and peptides found in only one sample. Missing values were imputed and potential interactors were determined using
t test and visualized by a volcano plot. Significance lines corresponding to an FDR of 0.05 and S0 (curve bend) between 0.2 andMolecular Cell 77, 1222–1236.e1–e13, March 19, 2020 e7
2.0 are shown in the corresponding Figures. Results were exported from Perseus and visualized using statistical computing
language R.
Cell cycle analysis
Cells were synchronized at the G1/S boundary using a double-thymidine block. Briefly, 300,000 cells of each indicated cell line
were seeded on 6-well plates and grown overnight in normal serum/LIF media, or media containing 0.1 mM 4-OHT to induce
Skiv2l knockout where necessary. On the following day, the cells were switched to media supplemented with 2 mM Thymidine
and cultured for 18 hours, released into the cell cycle for 9 hours by removal of the drug with three PBS washes and cultured in
2mM thymidinemedia for another 18 hours. The cells were then released from the second block by three PBSwashes and harvested
at 0, 4 and 8 hours after thymidine withdrawal. For each sample, equal number of cells were fixed in ice-cold 70% ethanol and
incubated overnight at 4C. The cells were then permeabilized with PBS + 0.1% triton X200 for 2 min, stained with 1 mg/mL DAPI
in PBS+0.1% triton X200 and DNA content was analyzed by flow cytometry. Histogram plots were generated using the FlowJo
software.
ATF4 induction with Thapsigargin
Approximately 120,000 cells per sample were seeded in 24-well plates and cultured in normal serum/LIF media overnight. On the
following day the cells were switched to media supplemented with 200 mM Thapsigargin to induce the integrated stress response
and upregulation of ATF4, and harvested for western blot analysis at 0, 0.5, 2 or 4 hours of incubation with the drug.
RT-qPCR
Total RNA was extracted from mES cells with the Agilent Absolutely RNA Miniprep Kit and 500ng of RNA was reverse-transcribed
using the PrimeScript RT-PCR Kit. qPCR was performed with SsoAdvanced SYBR Green Supermix on a CFX96 Real-Time PCR
System (Bio-Rad) and relative RNA levels were calculated using the DCt method and normalization to TBP mRNA abundance. A
list of qPCR primers is provided in Table S1.
QUANTIFICATION AND STATISTICAL ANALYSIS
CRAC data preprocessing and alignment
CRAC reads were preprocessed with the FASTX Toolkit 0.0.14. Adapters were removed with fastx_clipper, low quality bases
trimmed/reads removed using fastq_quality_trimmer -t 25 and fastq_quality_filter -q 20 -p 90, and sequencing artifacts removed
using fastx_artifacts_filter. Duplicate reads (including UMI) were collapsed, then pyCRAC (Webb et al., 2014) used to split samples
by their inline barcodes and extract the UMIs . Low complexity regions were removed (‘‘low complexity stripping’’) from the 30 end of
sequences (defined as stretches of 2 nt more where 80% of positions are the same nucleotide, e.g., AAAAGAA), and prinseq-lite-
0.20.4 (Schmieder and Edwards, 2011) used as an additional filter to remove low complexity reads (settings -lc_threshold 20 -lc_
method dust). We then applied a set of filters to obtain uniquely mapping reads, and remove reads mapping to repeats or abundant
non-coding RNAs (e.g., tRNA, snoRNA or rRNA). For this, reads were separately mapped with bowtie2-2.3.4.1 (Langmead and
Salzberg, 2012) (settings–local -p 10 -a–very-sensitive) to three indexes:
Genome: mm10 genomic sequence.
Gencode non-coding RNAs: Gencode release M16 Mt_rRNA, Mt_tRNA, miRNA, rRNA, scRNA, snoRNA, sRNA, scaRNA and
snRNA features from the file gencode.vM16.annotation.gtf, and predicted tRNAs from the file gencode.vM16.tRNAs.gtf,
and a repeat-masked version of mouse pre-rRNA (Grozdanov et al., 2003).
Gencode mRNAs/lincRNAs: Gencode release M16 protein_coding and lincRNA features from the file gencode.
vM16.annotation.gtf.
Reads were assigned as ‘‘repeats/ncRNAs’’ and excluded if they mapped best or equally well either to regions of the genome
overlapping RepeatMasker repeats (downloaded from UCSC table browser, version 2012-02-07) or to Gencode non-coding
RNAs. From the remaining reads, those mapping better or equally well to Gencode mRNA/lincRNAs as to the genome were
extracted. A filter was then applied, by mapping these reads (bowtie2-2.3.4.1–local -p 10 -a–very-sensitive) to an index with one
transcript isoform per protein-coding gene (the APPRIS principal isoform was selected, taking one at random if a gene possessed
multiple; were refer to these as ‘‘Appris transcripts’’), and selecting reads with (i) a second best match score (if detected) < 0.8 times
the best match score and (ii) a MAPQR 8. Reads were removed if the 50 end was soft-clipped, and duplicate reads collapsed based
on their UMIs and 50 end mapping positions (retaining one read at random).
For comparing CRAC data with ribosome profiling, an identical procedure was used, except using a list of transcripts robustly
detected in the ribosome profiling experiments instead of Appris transcripts. Where multiple transcripts were detected from the
same gene, alignments were prioritized to the primary isoform if it could be determined (see ribosome profiling methods).e8 Molecular Cell 77, 1222–1236.e1–e13, March 19, 2020
CRAC quantification of non-templated 30 tails
To identify reads containing non-templated 30 tails, preprocessed reads identified as uniquely mapping to Appris transcripts were
extracted, then filtered to retain those for which the 30 adaptor could be identified and stripped. Bowtie2-2.3.4.1 was then used to
align these reads (which were not subject to low complexity stripping from the 30 end) to the genome, transcriptome and Appris
transcripts (defined above), with the following settings, as described in (Travis et al., 2014): -D 20 -R 3 -N 0 -L 16–local
-i S,1,0.50–score-min L,18,0–ma 1–np 0–mp 2,2–rdg 5,1–rfg 5,1. Tails were extracted by identifying examining alignments for
30 soft clipping. Reads were required to align better to the transcriptome than to the genome (to prevent ‘‘tails’’ being identified
that in fact correspond to exon-exon junctions). Only homopolymeric tails were analyzed, with no minimum length requirement.
CRAC PCA, correlation matrix and tSNE
Filtered, uniquely mapping CRAC reads were counted for all mRNAs (using alignments to Appris transcripts, as defined above, and
thus excluding reads mapping to introns). Each CRAC replicate was processed separately. For tSNE analysis, CRAC replicates were
pooled, to give one dataset each for MTR4, SKIV2L and XRN1. These three count datasets were then normalized to the sum of
the smallest dataset, and mRNAs retained with > 1 normalized count in all datasets, and > 10 normalized counts in at least one
dataset. To obtain ‘‘relative binding’’ to MTR4, SKIV2L and XRN1, for each transcript the normalized counts were divided by its total
normalized counts. Therefore, for each transcript, the ‘‘relative binding’’ of MTR4 + SKIV2L + XRN1 sums to 1. In parallel, to check
that small differences in transcript levels between cell lines do not distort the analysis, relative binding valueswere normalized to rpkm
values taken from RNA-seq analysis of the three cell lines.
Differential SKIV2L binding analysis
As genes were differentially expressed in Aven/ cells versus WT, an interaction model accounting for differences in transcript
levels, as described by (Chothani et al., 2017), was used to compare SKIV2L binding for these two cell lines.
Identification of rRNA binding sites by CRAC
The human ribosome structure was downloaded from PDB (4UG0) and its 18S rRNA sequence extracted. This was then substituted
to match the mouse 18S rRNA sequence where possible, to facilitate alignment. CRAC reads with adapters and barcodes removed
were aligned to this modified 18S rRNA sequence using bowtie2-2.2.3 (–sensitive mode). Alignments were filtered to remove those
less than 20 bp long, or with an edit distance > 1. Reads were then piled up across the modified 18S rRNA sequence using samtools-
1.3 (depth command) (Li et al., 2009). For each CRAC sample, these values were converted to single position counts per million, then
mean normalized counts calculated for 20 nt bins across the entire 18S rRNA. This was repeated for 99 CRAC datasets, including
several replicates each for SKIV2L, AVEN and XRN1, and an in-house collection of datasets from many unrelated proteins or
untagged cell lines which served as controls. This extensive control dataset enabled specific signal to be robustly distinguished
from background or technical artifacts. We also included additional SKIV2L, AVEN and XRN1 datasets for which global coverage
was too low for mRNA analysis, but rRNA coverage sufficiently high for rRNA analysis. All raw data are deposited in GEO under
accession GSE134020 and the control datasets indicated.
To quantify specific binding of AVEN, a negative binomial model was then used to fit the AVEN and control values for each 20 nt 18S
rRNA bin. This model contained AVEN versus control as a factor, and was compared to a null (intercept only) model using a c2 test
(accounting for multiple hypothesis testing using the Benjamini Hochberg method with an FDR of 0.05). The c2 p values were then
used to color significantly bound regions of the 18S rRNA, in the context of the 40S ribosome structure. This procedure was repeated
for SKIV2L and XRN1. Note that SKIV2L and XRN1were included as controls for each other, and XRN1 (but not SKIV2L) was included
as a control for AVEN.
CRAC plots around start and stop codons
Uniquely mapping CRAC reads were piled up across each Appris transcript, and each transcript normalized by dividing by its the
maximum read depth, and transcripts with fewer than five reads excluded. These normalized values were then either plotted around
the start or stop codon of each individual transcript (arranging transcripts by 50 UTR or 30 UTR length), or values were summed to
produce a metaplot.
CRAC enrichment at amino acid combinations
The 30 end positions of filtered uniquelymapping (but not low complexity stripped) SKIV2L CRAC readswere extracted for all mRNAs.
These reads were further filtered to retain only those for which the 30 adaptor had been identified and removed (so the 30 end of the
remaining read corresponds to the true 30 end of a captured RNA fragment). Taking mRNAs with at least five CRAC reads passing
these filters, 204 nt sliding windows were generated across the CDS, with an offset of 1 between each window. For each window, the
hexamer (6 nt sequence) at its center was recorded, together with its frame (0, 1 or 2) relative to the start codon. SKIV2L CRAC 30 ends
were then piled up across every window for each transcript, and windows with at least five counts retained. The values for each
position of a given window were then divided by the sum for that window. Windows were then grouped by their central
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group. This provides an average distribution of SKIV2L-bound RNA fragment 30 ends around every 6 nt motif, for frames 0, 1 and 2.
This process was repeated for XRN1, RPS10 (a ribosomal protein) and TRIM71 CRAC datasets, which were used as controls.
For each dataset, hexamer and frame, the values for the central 6 nt were summed (these correspond precisely to the hexamer).
‘‘SKIV2L-bound’’ hexamer/frame combinations were then defined as those for which the SKIV2L value was higher than any of the
other (control) datasets, and higher than that expected if SKIV2L reads had been distributed evenly across the 204 nt window.
Hexamers were then translated into amino acid pairs (e.g., AAAAAG = > KK), then for each amino acid pair, the proportion of
SKIV2L-bound hexamers calculated. This was repeated for in-frame hexamers (frame 0) and out of frame hexamers (frames 1
and 2). Only amino acid pairs with at least four contributing hexamers were evaluated. These final values (ranging from 0 to 1)
give an indication of whether SKIV2L binds preferentially to particularly amino acid pairs, and whether this is frame specific (i.e., likely
to reflect the encoded amino acids) or not (i.e., likely to reflect the underlying sequence).
CRAC and disome profiling repeat analyis
For plots around amino acids repeats, the 30 ends of uniquely mapping CRAC reads (not low complexity stripped) for which adapters
were detected and removed, and uniquely mapping ribosome profiling reads, were used. These were piled up across windows
centered on all 3-4 amino acid repeat tracts in Appris mRNAs (e.g., KKKK, AAA, etc), including 96 nt either side. Data were binned
into 6 nt bins and normalized to the maximum count for each window. Values were then summed for each repeat type (e.g., K, A, etc)
at each position.
For plots around polypurine ([G/A]12+) tracts, a similar approach was used, piling up CRAC 3
0 read positions or ribosome profiling
reads across windows centered on the GA tract and including 96 nt flanks. For each window, pileups were normalized to the total
counts, then pileups summed for windows grouped by G or A content, or grouped by the encoded amino acids (e.g., those with
> 30% lysine). Note that repeat tracts were only identified in-frame, and were required to be a multiple of three nt long (to enable
them to be translated into an amino acid sequence).
RNA-seq analysis
RNA-seq reads were aligned to mm10 and counted using STAR_2.5.0a (–runMode alignReads –outSAMtype BAM
SortedByCoordinate–outFilterType BySJout–outFilterMultimapNmax 1–outFilterMismatchNmax 3–outSAMmultNmax 1–out
SAMattributes NH HI NM MD AS nM–outMultimapperOrder Random–outSAMunmapped None–quantMode GeneCounts). The
STAR index was made using the Mus_musculus.GRCm38.75.dna.primary_assembly.fa file, providing gencode.vM16.annotation.gtf
as the sjdbGTF file. DESeq2 (Love et al., 2014) was used to test for differential gene expression, with the model formula including
biological clone (where at least twowere available), sequencing batch (wheremore than onewas performed) and genotype/treatment
(WT versus knockout, or time of 4OHT treatment).
RNA half-life analysis
Mapped RNA-seq reads (ERCC sequences were included as extra chromosomes for the mapping) were counted for each gene and
ERCC using the–quantMode GeneCounts mode in STAR. Counts were normalized separately for each time point using the
estimateSizeFactorsForMatrix function from DESeq2, then recombined. A single size factor was calculated for each time point to
account for the overall decay of mRNAs. For this, the ratio of total mRNA counts to total ERCC counts (using the set of ERCCs
with a mean of > 50 counts across all samples) was calculated for each sample. A median value (size factor) was then calculated
for each time point, size factors scaled so that the size factor for time = 0 was 1, then all mRNA count tables for a given time point
divided by the corresponding size factor.
Half-lives were then calculated by fitting a linear model for ln(normalized counts + 1) versus time, and using the formula t1/2 = -ln(2)/
k, where k is the coefficient for time (i.e., the gradient of the linear fit in semi-log space). The residual standard error was also calcu-
lated, as a measure of fit.
CRAC sequence and structure motif analysis
Our approach was based on that described in (Welte et al., 2019). Filtered CRAC reads aligned to mRNAs robustly detected in ribo-
some profiling experiments were counted for 50 nt sliding windows (offset 10 nt) across the 50 UTRs and CDSes of these transcripts.
These windows were also folded in silico using RNAfold 2.1.5 (Lorenz et al., 2011) (including the option -g, to incorporate G-quad-
ruplex formation into the prediction). A given ‘‘foreground’’ sample (e.g., AVEN) together with several control datasets (‘‘background’’
samples, comprisingMTR4, XRN1, RPS10 (a ribosomal protein) and TRIM71 (Welte et al., 2019) were analyzed, and for each dataset,
counts converted to RPKM. Median RNA-seq RPKM values for our SKIV2L, XRN1 andMTR4 tagged mESCs were also extracted for
each transcript, removing transcripts with < 10 RPKM. CRAC values were then divided by RNA-seq values to obtain enrichments for
each window and foreground or background dataset. ‘‘Bound’’ windows were defined as those where the foreground enrichment
was higher than any of the background enrichments, and at least 10 (i.e., 10x CRAC coverage versus RNA-seq coverage). The
highest bound 50 UTR and CDS window was then selected for each transcript (final foreground window set). Transcripts with fewer
than six analyzed windows were excluded. As a control, windows were randomly selected from the same transcripts, requiring them
to be within 400 nt of the foreground window set, and excluding the foreground window set. This process was repeated 100 times, to
generate a 100 final background window sets.e10 Molecular Cell 77, 1222–1236.e1–e13, March 19, 2020
For the final foreground and each final background window set, the total number of windows containing each possible 10-mer
structural motif (based on the RNAfold output) or 6-mer sequence motif were counted. For each motif, the mean background total
and its standard deviation were calculated, and used to calculate a z-score (foregroundminusmean background occurrence, divided
by background standard deviation). The z-score was plotted for each motif, versus its log2 total occurrence (foreground plus mean
background). Motifs with a z-score magnitude > 2.5, and sufficiently high log2 total occurrence, were highlighted.
To compare SKIV2L CRAC data fromWT and Aven/ cells, the same approach was used, except both rather than comparing the
number of bound windows containing each structure/sequence motif to a randomly sampled set of windows, SKIV2L-bound win-
dows for the two cell lines were compared directly.
CRAC/ribosome profiling at structured regions
FormRNAs robustly detected in ribosome profiling experiments, 50 nt non-overlappingwindowswere defined across the 50 UTR and
CDS, and folded in silico using RNAfold 2.1.5. Windows with a minimum free energy < 12 kcal/mol and continuous stretch ofR 10
paired nucleotides were selected, and extended by 96 nt either side. CRAC and ribosome profiling reads were piled up across these
242 nt windows, and these values normalized for each dataset and window to the window sum. Windows were then divided into 6 nt
bins, and normalized counts summed for each bin and plotted.
CRAC/ribosome profiling for genomic windows
For this analysis, CRAC reads uniquely mapping to the genome were used. RNA-seq reads, and ribosome profiling reads that had
been trimmed, quality filtered, size selected ([26,35] for monosome footprints, [45,70] for disome footprints and [21,70] for total input
RNA), and filtered against rRNA and tRNA libraries, were mapped to the genome using STAR_2.5.0a (settings–runMode alignReads–
outSAMtype BAM SortedByCoordinate–outFilterType BySJout–outFilterMultimapNmax 1–outFilterMismatchNmax 3–outSAM-
multNmax 1–outSAMattributes NH HI NM MD AS nM–outMultimapperOrder Random–outSAMunmapped None–quantMode Gene-
Counts. CRAC, RNA-seq and ribosome profiling reads were then counted (in a strand specific manner) for 1 kb windows tiling the
genome in both orientations, generated using bedtools (Quinlan, 2014).
Windows were also overlapped with protein-coding genes, or genes encoding abundant ncRNAs (e.g., rRNA, snRNA and snoRNA
genes) but not lincRNAs. This enabled windows to be classified based upon whether they overlapped abundant ncRNAs, mRNA
exons (sense orientation), mRNA introns (sense orientation), 1 kb regions upstream of mRNAs (sense orientation), mRNA exons (anti-
sense orientation), mRNA introns (antisense orientation) or 1 kb regions upstream of mRNAs (antisense orientation), with priority
given in that order (i.e., if a window overlapped an mRNA exon and a ncRNA, it would be classified as a ncRNA window). All other
windows were classified as intergenic. GC contents, predicted minimum free energy (using RNAfold), potential small ORFs (se-
quences starting with ATG and ending with an in-frame stop codon), and average phyloCSF scores for these small ORFs, were
also calculated for each window.
Window counts were then normalized using the DESeq2 function ‘‘estimateSizeFactorsForMatrix’’ (for RNA-seq and ribosome
profiling) or to the minimum library size (for CRAC). Normalized counts were then log2 transformed, including a pseudocount of 4.
Log2 fold changes were then calculated for Aven
/ versus WT datasets, or comparing CRAC datasets (e.g., AVEN versus SKIV2L),
as indicated. Genomic windows were also classified based on their SKIV2L CRAC counts in Aven/ versus WT, into the categories
‘‘down,’’ ‘‘slight change,’’ ‘‘up’’ and ‘‘strongly up.’’ This enabled log2 fold changes (e.g., comparing RNA-seq for Aven
/ versus WT)
to be median centered on the ‘‘down’’ category of windows, facilitating comparison of different data types. Where more than one
batch was available for RNA-seq datasets, batchesweremerged by calculatingmean values for each window at the end of the above
procedure.
Ribosome profiling analysis
Preprocessing of Ribosome Footprints
Initial quality assessment of the sequencing reads was conducted based on the preliminary quality values produced by the Illumina
pipeline 2.19.1 such as the percentage of clusters passed filtering (%PF clusters) and the mean quality score (PF clusters).
Adaptor sequences were removed using cutadapt utility (Martin, 2011) with following options: -a AGATCGGAAGAGCACACGTCT
GAACTCCAGTCAC–match-read-wildcards. Next, trimmed read sequences were filtered by their size using an in-house
Python script with following inclusive ranges: [26,35] for monosome footprints, [45,70] for disome footprints and [21,70] for
total RNA. Smaller or larger fragments were kept separately and not used in further analysis. Finally, the reads were filtered for quality
using fastq_quality_filter tool from the FASTX-toolkit with the following arguments: -Q33 -q 30 -p 80.
Mapping of Footprints to Mouse Genome
The preprocessed insert sequences were mapped sequentially to following databases: mouse rRNA, human rRNA, mt-tRNA, mouse
tRNA, mouse cDNA from Ensembl mouse database release 91 (Flicek et al., 2013) and, finally, mouse genomic sequences (Genome
Reference Consortium GRCm38.p2). In all but the final mapping against genomic sequences, bowtie version 2.3.0 (Langmead and
Salzberg, 2012) was used with the following parameters: -p 2 -L 15 -k 20–no-unal,
After each alignment, only reads that were not aligned were used in the following mapping. For further analysis, only alignments
against mouse cDNA were used, unless specifically stated otherwise. For each query sequence, only alignments with maximum
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Separately from this sequential alignment strategy, trimmed and filtered total RNA sequences from each sample were also directly
aligned against the mouse genome. This mapping and the final mapping of the sequential alignment strategy were performed using
STAR version 2.5.3a (Dobin et al., 2013) with the following parameters:
--runThreadN 6 –genomeDir=mouse/star/Mmusculus.GRCm38.91
--readFilesCommand zcat –genomeLoad LoadAndKeep
--outSAMtype BAM SortedByCoordinate Unsorted
--alignSJDBoverhangMin 1 –alignIntronMax 1000000
--outFilterType BySJout –alignSJoverhangMin 8
--limitBAMsortRAM 15000000000
The output of this alignment was used to estimate expressed transcript models out of all models contained in Ensembl mouse
database release 91. To this end, we used StringTie version 1.3.3b (Pertea et al., 2015) to estimate the number of fragments per
kilo base of exon per million fragments mapped (FPKM) for each transcript, with the following parameters:
-p 8 -G Mmusculus.GRCm38.91.gtf -A gene_abund.tab
-C cov_refs.gtf -B -e
The resulting FPKM estimate information was parsed with an in-house Python script to identify transcripts which had an FPKM >
0.2 and an isoform abundance fraction > 0.05 in at least 2 samples. A database of expressed transcripts based on this filtering
was used in further analysis. Among those, genes that were estimated to have a single expressed isoform were annotated as single
transcript genes.
Quantification of Footprint Abundance/Density
Abundance of mRNA and monosome or disome protected fragments was estimated per gene as described in (Janich et al., 2015).
For this quantification, only reads that were mapped uniquely to a single gene and only to transcripts that were identified to be
expressed (see Mapping of Footprints to Mouse Genome) were used. We used a limited size range of disome fragments
(56-64 nt), as this facilitated subsequent A-site assignment and high-resolution analysis of stall sites.
Read counts of total RNA and RPF were normalized with upper quantile method of R package edgeR v3.16.5 (Robinson et al.,
2010). Prior to normalization, transcripts which did not have at least 10 counts in at least one third of the samples were removed
from the datasets. For better comparability between datasets, RPKM values were calculated as the number of counted reads per
1000 mappable and countable bases per geometric mean of normalized read counts per million. Genes that had an average total
RNA RPKM > 5 were designated as robustly expressed.
Ribosome densities (alternatively known as translational efficiencies, TE) were then calculated as the ratio of footprint-RPKM to
total RNA-RPKM for monosomes and disomes per sample. For most analysis downstream, densities were log2 transformed.
Significant changes in abundances of total RNA, monosomes and disomes between control and treated samples were assessed
by DESeq2 package for the R statistical environment (Team, 2013). Significant changes in densities of monosomes and disomes
between control and treated samples were assessed by R package xtail. The false discovery rate (FDR) adjusted p values were
used to identify statistically significant changes at 0.05 FDR.
Monosome and Disome Positions on Transcripts
For total RNA and RPF reads that were counted toward genes, we have also tracked the position of the reads relative to the 50 end of
its corresponding transcript. For total RNA reads and monosome footprints we have used the 50 end of the reads and the estimated
A-site of the ribosomes, respectively, as described in (Janich et al., 2015). For disome footprints we have established an empirical
offsetting scheme based on the size and the frame (relative to the main CDS) of the footprints. We estimated the A-site of the pausing
ribosome at the disome site by adding 45, 44, or 43 to the map position of the 50 end of 58nt-long foot- prints that were at 1st, 2nd or
3rd frame, respectively. Similarly, we used the following offsets for 59nt, 60nt, 62nt and 63nt long disome footprints, respectively:
[45, 44, 46], [45, 44, 46], [48, 47, 46], [48, 47, 49]. These coordinates then were converted intoWiggle Track Format (WIG) by in-house
Python scripts.
Ribosome profiling versus CRAC for uORFs
uORFs were defined using our ribosome profiling data, as described in (Castelo-Szekely et al., 2019). Briefly, transcripts that are the
only protein-coding isoform expressed were used (n = 7593), so that footprints can be unambiguously assigned to the 50 UTR. uORFs
were annotated based on the following criteria: 1) startedwith AUG, 2) had an in-frame stop codonwithin the 50 UTRor within the CDS
(overlapping uORFs) and 3) were at least 6 nt long (including the stop codon).
CRAC and ribosome profiling reads overlapping with uORFs and main CDSes were counted, and normalized to 100000 for each
sample. To group uORFs by AVEN occupancy in WT cells, AVEN uORF CRAC was normalized to uORF ribosome profiling counts in
WT cells, then uORFs classified by this value (low% 5; medium > 5 and% 20; high > 20). Differential uORF translation for Aven/
versus WT cells was then calculated by normalizing uORF ribosome profiling counts to main CDS ribosome profiling counts for the
two cell lines, then calculating a log2 fold change.
A similar approach was used to compare SKIV2L binding to uORFs in Aven/ versus WT cells, whereby SKIV2L uORF CRAC
counts were normalized to main CDS ribosome profiling counts (to account for changes in overall mRNA translation) beforee12 Molecular Cell 77, 1222–1236.e1–e13, March 19, 2020
calculating a log2 fold change forAven
/ versusWT. Only uORFswith at least 20 counts per 100k for either SKIV2L inWT, or SKIV2L
in Aven/, were used. Additionally, the main CDS was required to have at least 2 counts per 100k for monosomes in both WT and
Aven/ conditions. The rationale here was to only include uORFs where uORF:CDS ratios could be calculated without being
dominated by noise/background.
DATA AND CODE AVAILABILITY
The accession number for the sequencing data reported in this paper is GEO: GSE134020. R code and scripts used for analysis are
available upon request. Original western blots were deposited in Mendeley Data and are available at https://data.mendeley.com/
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SUPPLEMENTAL FIGURE LEGENDS 
Figure S1: Profiling mammalian RNA decay pathways (related to Figure 1). A Western blots showing 
expression and biotinylation of endogenously tagged 3xFLAG-AviTag SKIV2L, XRN1 and MTR4. B 
Scree plot for the PCA in Figure 1C. C Western blot analysis of a co-immunoprecipitation using anti-HA 
to capture 2xHA-FKBP12-tagged DIS3L, and probing inputs and eluates with anti-FLAG (to detect 
3xFLAG-Avi-SKIV2L) and anti-MTR4. D tSNE representation of mRNAs based on relative binding to 
MTR4, SKIV2L and XRN1, and highlighting functional classes of mRNAs. E RT-qPCR analysis of 
Skiv2lfl/fl mRNA expression levels in clones 5F and 9E (Table S1) after 0.1 µM 4OHT treatment for 0, 2, 4 
and 6 days. Error bars denote standard deviation of two technical replicates. Values are normalized to TBP 
expression and then to untreated samples (day 0). F Boxplot for the 7240 mRNAs analyzed in Figure 1I, 
grouped by differential expression after four days of Skiv2l knockout, and showing the extent to which they 
bind SKIV2L in WT cells (relative binding based on CRAC, defined in Figure 1E). Box widths are 
proportional to the number of contained transcripts. p < 10-15 for upregulated versus downregulated 
transcripts (Mann-Whitney U test). G Log2-fold changes in transcriptome-wide mRNA half-lives for 
Skiv2lfl/fl cells following 0.1 µM 4OHT treatment for 4 or 0 days.  Half-lives were calculated by fitting an 
exponential decay model to RNA-seq counts from an actinomycin D-mediated transcription shut-off time 
course. The x-axis shows the extent of SKIV2L binding as a fraction of total SKIV2L+XRN1 binding (i.e. 
SKIV2L CRAC divided by SKIV2L+XRN1 CRAC, using “relative binding” values defined in Figure 1E). 
High confidence SKIV2L targets are indicated in red, and are defined as mRNAs with an increased half-
life after Skiv2l knockout (y-axis > 0.1), high SKIV2L binding (x-axis > 0.5) and significant RNA increase 
after 4 days of Skiv2l knockout (Figure 1I). The half-lives of the 200 most highly SKIV2L-bound mRNAs 
(right of green dashed line) were compared to those of all other mRNAs using a Student’s t-test. H RNA 
levels for high confidence SKIV2L targets (red circles in G) for wild-type, tagged (Skiv2l3xFLAG-Avi/3xFLAG-Avi, 
Mtr43xFLAG-Avi/3xFLAG-Avi and Xrn13xFLAG-Avi/3xFLAG-Avi) and Skiv2lfl/fl (+ 4 days 4OHT) cells. Each point refers to 
a separate cell line. See also Tables S1-S3. 
 Figure S2: Defining triggers of RNA decay (related to Figure 2). A Proportion of CRAC mRNA reads 
with non-templated homopolymeric 3’ tails, for XRN1, SKIV2L and MTR4. B SKIV2L specific 
enrichment at amino acid pairs, compared to a panel of control datasets. For each amino acid pair, the 
proportion of hexamers encoding that amino acid pair and bound by SKIV2L is shown. This calculation 
was performed for in-frame hexamers (y-axis) and out-of-frame hexamers (x-axis). C Disome profiling (A 
sites) and SKIV2L and XRN1 CRAC coverage (3’ end of RNA fragments) around runs of 3-4 identical 
amino acids (e.g. KKK/KKKK), normalized to downstream signal. D Pileups around polypurine tracts for 
monosome and disome profiling and SKIV2L, MTR4 and XRN1 CRAC signal. Polypurine tracts are 
divided by lysine content (top) or A versus G content (≥ 50 % A, or > 50 % G).  
 
Figure S3: AVEN modulates SKIV2L binding (related to Figure 4). A Scree plot for the PCA in Figure 
4C. B Left, schematic of CRISPR-Cas9-induced Aven knockout and RNA-seq tracks in the parental 
Skiv2l3xFLAG-Avi/3xFLAG-Avi and Aven-/- clones 4H and 6G. Right, western blot analysis of AVEN expression. C 
RT-qPCR analysis of Focad mRNA levels in Focad-/- clones 2F and 4B and WT cells. Error bars denote 
standard deviation of four technical replicates. D and E Boxplot representation of the data shown in Figure 
4F, including all transcripts (not only those differentially bound or expressed). AVEN CRAC counts in WT 
are shown (y-axis) for transcripts grouped by changes in SKIV2L binding (B; p < 10-15) or RNA abundance 
(C; p = 0.002) in Aven-/- versus WT (x-axis). P-values calculated using a Mann-Whitney U test to compare 
up- and down-regulated transcripts. See also Tables S1 and S3. 
 
Figure S4: AVEN and SKIV2L counteract ribosome stalling (related to Figures 4 and 5). A Changes 
in mRNA monosome and disome densities in Aven-/- versus WT. Transcripts are colored by AVEN binding 
in WT cells (calculated as in Figure 4F; high, n = 777; low, n = 5471), and a linear best fit line plotted for 
each group (shaded area = 95 % confidence interval). B Western blot analysis of SKIV2L levels in Aven-/- 
Skiv2l3xFLAG-Avi/3xFLAG-Avi Skiv2lfl/fl cells after treatment with 0.1 µM 4OHT for 0, 2 or 4 days to induce Skiv2l 
knockout. C Log2 fold change in the half-lives of AVEN targets, which are defined as mRNAs that 
accumulate upon combined knockout of Aven and Skiv2l (p < 0.01; Figure 5D) and that have increased 
SKIV2L binding in Aven-/- cells (differential binding > 0.5, Figure 5D). Three comparisons are shown (left 
to right): (i) Skiv2lfl/fl 0 vs 4 days 4OHT (i.e. Skiv2l knockout vs wild-type), (ii) Skiv2lfl/fl vs Aven-/- 
Skiv2l3xFLAG-Avi/3xFLAG-Avi Skiv2lfl/fl with no 4OHT treatment (i.e. Aven knockout vs wild-type), and (iii) Aven-
/- Skiv2l3xFLAG-Avi/3xFLAG-Avi Skiv2lfl/fl 0 vs 4 days 4OHT (i.e. Skiv2l Aven double knockout versus Aven 
knockout). Half-lives are calculated from RNA-seq decay curves following actinomycin D-mediated 
transcription shut-off. Replication-dependent histone mRNAs are colored red. For each of the three 
comparisons, a Student’s t-test was used to test whether the distribution of half-life log2-fold changes for 
the set of mRNAs shown here (AVEN targets) differs from that of all other mRNAs. D Top, scheme 
depicting mESC cell cycle synchronization at the G1/S boundary using a double-thymidine block. Bottom, 
flow cytometry analysis of DAPI-stained asynchronous or thymidine-synchronized cells at 0, 4 and 8 hours 
after release from the second thymidine block for the indicated cell lines. E Boxplot showing the change in 
uORF monosome profiling counts (normalized to main CDS counts) for Aven-/- versus WT cells. uORFs 
are categorized (x-axis) by their AVEN CRAC counts in WT cells (n = 558, 215 and 53 for low, medium 
and high categories; Mann-Whitney U test p = 3.19x10-6 comparing high and low categories). E Western 
blot analysis of ATF4 and eIF2α-phospho-Serine51 levels in WT and Aven-/- cells after 0, 0.5, 2 and 4 hours 
of treatment with 200 nM thapsigargin. See also Tables S3 and S4. 
 
Figure S5: Defining sites dependent on AVEN and SKIV2L (related to Figure 6). A Log2 fold changes 
in SKIV2L CRAC counts for 1 kb windows tiling the genome, in Aven-/- versus WT cells. Points are colored 
by the proportion of U-tailed reads within each window in WT (left) or Aven-/- (right) cells. B SKIV2L 
CRAC, disome and monosome profiling reads piled up around predicted structured regions (minimum free 
energy <-12 kcal/mol and continuous stretch of paired nucleotides ≥10), normalized to the downstream 
region. For SKIV2L CRAC in Aven-/-, U-tailed reads are also shown. 
 
Figure S6: Features of translated non-coding RNAs (related to Figure 7). A GC content and B predicted 
free energy for the “non-coding” 1 kb genomic windows analyzed in Figure 7C. Windows are split into 
four categories based on differential SKIV2L CRAC counts in Aven-/- versus WT cells (defined in Figure 
7C). C PhyloCSF scores for predicted small ORFs within these windows. Windows are classified based 
upon whether SKIV2L CRAC and monosome profiling counts increase in Aven-/- versus WT cells, or not. 
See also Tables S6 and S7. 






